<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="review-article">
  <?properties open_access?>
  <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
    <restricted-by>pmc</restricted-by>
  </processing-meta>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Gut Microbes</journal-id>
      <journal-id journal-id-type="iso-abbrev">Gut Microbes</journal-id>
      <journal-title-group>
        <journal-title>Gut Microbes</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1949-0976</issn>
      <issn pub-type="epub">1949-0984</issn>
      <publisher>
        <publisher-name>Taylor &amp; Francis</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">35866234</article-id>
      <article-id pub-id-type="pmc">9311318</article-id>
      <article-id pub-id-type="doi">10.1080/19490976.2022.2096995</article-id>
      <article-id pub-id-type="publisher-id">2096995</article-id>
      <article-version vocab="JAV" vocab-identifier="http://www.niso.org/publications/rp/RP-8-2008.pdf" vocab-term="Version of Record" article-version-type="VoR">Version of Record</article-version>
      <article-categories>
        <subj-group subj-group-type="article-type">
          <subject>Review Article</subject>
        </subj-group>
        <subj-group subj-group-type="heading">
          <subject>Review</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Impact of gut microbiome on skin health: gut-skin axis observed through the lenses of therapeutics and skin diseases</article-title>
        <alt-title alt-title-type="left-running-head">MD. R. MAHMUD ET AL.</alt-title>
        <alt-title alt-title-type="right-running-head">GUT MICROBES</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-7903-8014</contrib-id>
          <name>
            <surname>Mahmud</surname>
            <given-names>Md. Rayhan</given-names>
          </name>
          <xref rid="aff0001" ref-type="aff">
<sup>a</sup>
</xref>
          <xref rid="an0001" ref-type="corresp"/>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-0066-2496</contrib-id>
          <name>
            <surname>Akter</surname>
            <given-names>Sharmin</given-names>
          </name>
          <xref rid="aff0002" ref-type="aff">
<sup>b</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-9193-5594</contrib-id>
          <name>
            <surname>Tamanna</surname>
            <given-names>Sanjida Khanam</given-names>
          </name>
          <xref rid="aff0002" ref-type="aff">
<sup>b</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-6463-9418</contrib-id>
          <name>
            <surname>Mazumder</surname>
            <given-names>Lincon</given-names>
          </name>
          <xref rid="aff0002" ref-type="aff">
<sup>b</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-4640-3898</contrib-id>
          <name>
            <surname>Esti</surname>
            <given-names>Israt Zahan</given-names>
          </name>
          <xref rid="aff0002" ref-type="aff">
<sup>b</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-7490-0189</contrib-id>
          <name>
            <surname>Banerjee</surname>
            <given-names>Sanchita</given-names>
          </name>
          <xref rid="aff0002" ref-type="aff">
<sup>b</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-0844-2490</contrib-id>
          <name>
            <surname>Akter</surname>
            <given-names>Sumona</given-names>
          </name>
          <xref rid="aff0002" ref-type="aff">
<sup>b</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-4880-9311</contrib-id>
          <name>
            <surname>Hasan</surname>
            <given-names>Md. Rakibul</given-names>
          </name>
          <xref rid="aff0002" ref-type="aff">
<sup>b</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-0287-2537</contrib-id>
          <name>
            <surname>Acharjee</surname>
            <given-names>Mrityunjoy</given-names>
          </name>
          <xref rid="aff0003" ref-type="aff">
<sup>c</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-5910-1824</contrib-id>
          <name>
            <surname>Hossain</surname>
            <given-names>Md. Sajjad</given-names>
          </name>
          <xref rid="aff0004" ref-type="aff">
<sup>d</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-2455-6375</contrib-id>
          <name>
            <surname>Pirttil&#xE4;</surname>
            <given-names>Anna Maria</given-names>
          </name>
          <xref rid="aff0005" ref-type="aff">
<sup>e</sup>
</xref>
        </contrib>
        <aff id="aff0001"><label>a</label>Department of Production Animal Medicine, Faculty of Veterinary Medicine, <institution-wrap><institution>University of Helsinki</institution></institution-wrap>, <city>Helsinki</city>, <country>Finland</country></aff>
        <aff id="aff0002"><label>b</label>Department of Microbiology, <institution-wrap><institution>Jagannath University</institution></institution-wrap>, <city>Dhaka</city>, <country>Bangladesh</country></aff>
        <aff id="aff0003"><label>c</label>Department of Bioscience, <institution-wrap><institution>Graduate School of Science and Technology, Shizuoka University</institution></institution-wrap>, <city>Shizuoka</city>, <country>Japan</country></aff>
        <aff id="aff0004"><label>d</label>Institute of Biology, <institution-wrap><institution>E&#xF6;tv&#xF6;s Lor&#xE1;nd University</institution></institution-wrap>, <city>Budapest</city>, <country>Hungary</country></aff>
        <aff id="aff0005"><label>e</label>Ecology and Genetics, Faculty of Science, <institution-wrap><institution>University of Oulu</institution></institution-wrap>, <city>Oulu</city>, <country>Finland</country></aff>
      </contrib-group>
      <author-notes>
        <corresp id="an0001">CONTACT Md. Rayhan Mahmud <email xlink:href="mailto:rayhan.mahmud@helsinki.fi">rayhan.mahmud@helsinki.fi</email> Department of Production Animal Medicine, Faculty of Veterinary Medicine, <institution-wrap><institution>University of Helsinki</institution></institution-wrap>, <country>Finland</country></corresp>
      </author-notes>
      <pub-date date-type="pub" publication-format="electronic">
        <day>22</day>
        <month>7</month>
        <year>2022</year>
      </pub-date>
      <pub-date date-type="collection" publication-format="electronic">
        <year>2022</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>22</day>
        <month>7</month>
        <year>2022</year>
      </pub-date>
      <volume>14</volume>
      <issue>1</issue>
      <elocation-id seq="111">2096995</elocation-id>
      <pub-history>
        <event event-type="tagger">
          <event-desc>Integra</event-desc>
          <date>
            <day>20</day>
            <month>7</month>
            <year>2022</year>
          </date>
        </event>
        <event event-type="final">
          <event-desc>Integra</event-desc>
          <date>
            <day>20</day>
            <month>7</month>
            <year>2022</year>
          </date>
        </event>
        <event event-type="received">
          <date>
            <day>13</day>
            <month>1</month>
            <year>2022</year>
          </date>
        </event>
        <event event-type="revised">
          <date>
            <day>10</day>
            <month>6</month>
            <year>2022</year>
          </date>
        </event>
        <event event-type="accepted">
          <date>
            <day>27</day>
            <month>6</month>
            <year>2022</year>
          </date>
        </event>
      </pub-history>
      <permissions>
        <copyright-statement>&#xA9; 2022 The Author(s). Published with license by Taylor &amp; Francis Group, LLC.</copyright-statement>
        <copyright-year>2022</copyright-year>
        <copyright-holder>The Author(s)</copyright-holder>
        <license>
          <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <self-uri content-type="pdf" xlink:href="KGMI_14_2096995.pdf"/>
      <abstract>
        <title>ABSTRACT</title>
        <p>The human intestine hosts diverse microbial communities that play a significant role in maintaining gut-skin homeostasis. When the relationship between gut microbiome and the immune system is impaired, subsequent effects can be triggered on the skin, potentially promoting the development of skin diseases. The mechanisms through which the gut microbiome affects skin health are still unclear. Enhancing our understanding on the connection between skin and gut microbiome is needed to find novel ways to treat human skin disorders. In this review, we systematically evaluate current data regarding microbial ecology of healthy skin and gut, diet, pre- and probiotics, and antibiotics, on gut microbiome and their effects on skin health. We discuss potential mechanisms of the gut-skin axis and the link between the gut and skin-associated diseases, such as psoriasis, atopic dermatitis, acne vulgaris, rosacea, alopecia areata, and hidradenitis suppurativa. This review will increase our understanding of the impacts of gut microbiome on skin conditions to aid in finding new medications for skin-associated diseases.</p>
      </abstract>
      <kwd-group kwd-group-type="author">
        <title>KEYWORDS</title>
        <kwd>Gut microbiome</kwd>
        <kwd>gastrointestinal health</kwd>
        <kwd>gut dysbiosis</kwd>
        <kwd>skin disease</kwd>
        <kwd>probiotics</kwd>
        <kwd>prebiotics</kwd>
        <kwd>skin-gut axis</kwd>
        <kwd>dietary components</kwd>
      </kwd-group>
      <support-group>
        <funding-group>
          <award-group>
            <funding-source>
<institution-wrap><institution>Open access to this publication is funded by Helsinki University Library</institution></institution-wrap>
</funding-source>
          </award-group>
          <funding-statement>Open access to this publication is funded by Helsinki University Library.</funding-statement>
        </funding-group>
      </support-group>
      <counts>
        <fig-count count="4"/>
        <table-count count="2"/>
        <ref-count count="253"/>
        <page-count count="1"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro" disp-level="1" id="s0001">
      <title>Introduction</title>
      <p>Skin and gut both are active, complex immunological and neuroendocrine organs that are exposed to the outside environment on a frequent basis and host a wide range of microbiomes.<sup><xref rid="cit0001" ref-type="bibr">1</xref>,<xref rid="cit0002" ref-type="bibr">2</xref></sup> The skin and gut must operate appropriately in order to enable organisms to maintain homeostasis and survive.<sup><xref rid="cit0003" ref-type="bibr">3</xref></sup> Notably, the skin is the body&#x2019;s largest organ and serves as a defensive obstruction against injuries and microbial assault.<sup><xref rid="cit0004" ref-type="bibr">4</xref></sup> The gut, on the other hand, consists of trillions of microbial communities, being recognized as a virtual organ closely associated with health and longevity of the host. The gut microbiome has both beneficial and adverse impacts on normal physiology and homeostasis of both gut and skin tissues.<sup><xref rid="cit0003" ref-type="bibr">3</xref>,<xref rid="cit0005" ref-type="bibr">5</xref></sup></p>
      <p>The three most essential roles that the gut microbiome plays from birth are protection, providing metabolic activities and immune system development and regulation.<sup><xref rid="cit0006" ref-type="bibr">6</xref>,<xref rid="cit0007" ref-type="bibr">7</xref></sup> At the beginning of life, gut microbial communities have a role in defending the host against pathogenic organisms. Throughout the life, they provide metabolic services, such as digestion of breast milk and other food. Members of microbiome help in degradation of toxins and drugs and in the biosynthesis of vitamins.<sup><xref rid="cit0006" ref-type="bibr">6</xref></sup> The gut is considered to be in a state of symbiosis, because it is populated by a diverse group of microorganisms, and the host tolerates these commensal bacteria and associated benign antigens.<sup><xref rid="cit0008" ref-type="bibr">8&#x2013;10</xref></sup> The ability of the immune system to build a tolerance to benign antigens is built through ontogeny and the reduction of microbiome-dependent inflammatory responses.<sup><xref rid="cit0010" ref-type="bibr">10</xref>,<xref rid="cit0011" ref-type="bibr">11</xref></sup> For example, in mice, long-term colonization by benign <italic toggle="yes">Hymenolepis diminuta</italic> results in modification of the immune system without causing dysbiosis and give protection against immune-mediated inflammatory diseases (IMIDs).<sup><xref rid="cit0012" ref-type="bibr">12</xref></sup></p>
      <p>However, any alteration among gut microbial diversity (dysbiosis) can increase host vulnerability and disrupt mucosal immunological tolerance,<sup><xref rid="cit0007" ref-type="bibr">7</xref></sup> which can subsequently influence skin health.<sup><xref rid="cit0013" ref-type="bibr">13</xref></sup> Several dermatologic conditions, such as acne, atopic dermatitis, psoriasis, and rosacea are linked with intestinal dysbiosis.<sup><xref rid="cit0223" ref-type="bibr">223</xref></sup> Many studies have associated gastrointestinal health with skin homeostasis and allostasis, and there is evidence of a bidirectional interaction between the gut and the skin.<sup><xref rid="cit0002" ref-type="bibr">2</xref></sup> Members of the gut microbiome can influence skin conditions through their metabolic activity and immunological impact.<sup><xref rid="cit0003" ref-type="bibr">3</xref></sup> For example, commensal gut microbes can foster skin allostasis by controlling T-cell differentiation.<sup><xref rid="cit0002" ref-type="bibr">2</xref></sup></p>
      <p>Based on existing studies, we hypothesize that the gut microbiomes are vital to the gut-skin axis.<sup><xref rid="cit0003" ref-type="bibr">3</xref></sup> Thus, this review is intended to evaluate the interlinks between gut and skin microbiome and following skin conditions. Our primary objective is to review and analyze microbial ecology of skin and gut tissues and to study the characteristics and mechanisms of microbe-transmitted interactions along the gut-skin axis. Diet and probiotics have an enormous impact on the composition and metabolic activities of gut microbiome, which subsequently impacts the skin.<sup><xref rid="cit0014" ref-type="bibr">14</xref></sup> Earlier, Polkowska-Pruszyska et al.,<sup><xref rid="cit0015" ref-type="bibr">15</xref></sup> have discussed how changes in gut microbial communities could trigger an immunological response, resulting in allergies, acne vulgaris, atopic dermatitis (AD), alopecia areata (AA), rosacea, hidradenitis suppurativa (HS) and other skin diseases. De Pessemier et al.,<sup><xref rid="cit0016" ref-type="bibr">16</xref></sup> recently demonstrated an association between dietary products and skin dysbiosis in their research. The present review paper, on the contrary, will give an integrated and structured view of the therapeutic effects of drugs, prebiotics, and probiotics on the gut microbiome and skin, as well as dietary effects on skin conditions. The secondary objective of this paper is to discuss the connection between microbial communities of the gut and skin, and their significance in dermatologic conditions, such as psoriasis, atopic dermatitis (AD), acne vulgaris, rosacea, alopecia areata (AA), and hidradenitis suppurativa (HS).</p>
    </sec>
    <sec disp-level="1" id="s0002">
      <title>Methodology</title>
      <sec disp-level="2" id="s0002-s2001">
        <title>Criteria for literature search, study selection, and exclusion</title>
        <p>The present review paper followed the PRISMA guideline. <xref rid="f0001" ref-type="fig">Figure 1</xref>. depicts a flow diagram. Articles published between 2000 and 2021 were searched to find related information on the association between the gut microbiome and skin health. Articles were searched on Google Scholar, ResearchGate and PubMed using keywords like gut microbiome, skin microbiome, intestinal dysbiosis, skin&#x2013;gut interactions, gut&#x2013;skin microbiome, skin homeostasis, skin&#x2013;gut allostasis, commensal bacteria, alteration in the gut microbiome, skin and gut microbial ecology, the role of the gut microbiome in the pathogenesis of skin diseases, gut microbes in skin disease prevention and treatment, gut&#x2013;skin axis, diet influencing skin inflammation through gut microbes, drugs affecting gut-skin axis, biologics influencing skin-gut axis. The selection of such keywords ensured that all papers relating to gut microbiota and skin diseases were included. The current analysis only included peer-reviewed, high-quality research data, omitting preprints, non-English papers, and duplicate databases.
<fig position="float" id="f0001" fig-type="figure"><label>Figure 1.</label><caption><p><bold>Prisma flowchart.</bold> This diagram represents the Prisma flowchart and demonstrates database searching, screening, excluding, retrieval, and eligibility findings for the final full-text studies used in this review. This illustration is based on<sup><xref rid="cit0017" ref-type="bibr">17</xref></sup> and created with BioRender.com (2022).</p></caption><alternatives><graphic xlink:href="KGMI_A_2096995_F0001_OC" content-type="color" specific-use="web-only" position="float"/><graphic xlink:href="KGMI_A_2096995_F0001_PB" content-type="black-white" specific-use="print-only" position="float"/></alternatives></fig></p>
      </sec>
      <sec disp-level="2" id="s0002-s2002">
        <title>The skin and gut microbial ecology</title>
        <p>As the composition of human microbiome varies significantly between individuals and contributes both positively and negatively to host immunity, a broad understanding on the microbial ecology of humans is necessary. Humans acquire a maternal microbiome mainly from the birth canal, and the microbial community changes over time.<sup><xref rid="cit0018" ref-type="bibr">18</xref>,<xref rid="cit0019" ref-type="bibr">19</xref></sup> Skin, oral tissues, airways, gut and vagina generally harbor hundreds of microbial genera and species unlike other tissues and organs.<sup><xref rid="cit0018" ref-type="bibr">18</xref>,<xref rid="cit0020" ref-type="bibr">20</xref></sup></p>
        <p>The skin is the largest organ of the human body and provides multiple niches for colonization by diverse microbial communities, such as the stratum corneum, hair follicles, and sebaceous glands.<sup><xref rid="cit0021" ref-type="bibr">21</xref></sup> Skin acts as the boundary between the external and internal environment of the human body, and the skin microbiome is an interface that contributes to human immunity.<sup><xref rid="cit0022" ref-type="bibr">22</xref></sup> Culture-independent methods have revealed that healthy human skin harbors &gt;1,000 bacterial species, mainly within the genera <italic toggle="yes">Brevibacterium, Propionibacterium, Micrococcus, Staphylococcus, Streptococcus</italic>, and <italic toggle="yes">Corynebacterium</italic>, and <italic toggle="yes">Malassezia</italic> is the main fungal genus.<sup><xref rid="cit0021" ref-type="bibr">21</xref>,<xref rid="cit0023" ref-type="bibr">23</xref></sup> The normal microbial communities of the skin can interact with the host in both commensal and parasitic ways.<sup><xref rid="cit0024" ref-type="bibr">24</xref></sup></p>
        <p>A number of studies have highlighted the predominant factors contributing to the ecosystem of the human skin microbiome. Several skin regions with versatile characteristics, such as dry sites (volar forearm, buttock, hypothenar palm), moist sites (axillary vault, antecubital fossa, inguinal crease, umbilicus), and oily sites (glabella, alar crease, occiput, manubrium) differ from each other based on microbial composition (<xref rid="f0002" ref-type="fig">Figure 2</xref>).<sup><xref rid="cit0029" ref-type="bibr">29</xref></sup>
<fig position="float" id="f0002" fig-type="figure"><label>Figure 2.</label><caption><p><bold>Microbial composition of gut and skin</bold>. Skin, the largest organ of the human body, shelters numerous commensal microbes (bacteria, fungi and viruses) and prevents entry by foreign pathogens by acting as a physical barrier. Skin can be broadly categorized as sebaceous or oily (glabella), moist (antecubital fossa) or dry (volar forearm), according to the physiological characteristics of each skin site. Specific microbial groups dominate different skin sites. Like skin, human gut is a home to innumerable amounts of microbes. A number of gut bacteria (e.g, <italic toggle="yes">Lactobacilli, E. coli, Bifidobacterium, Streptococcus thermophilus</italic>) contribute to maintenance of human health state, whereas others (e.g., <italic toggle="yes">Clostridium difficile, Campylobacter, Enterococcus faecalis, Helicobacter pylori</italic>) are more prevalent in disease states. The illustration was adapted from &#x201C;Immune Organs in the Human Body&#x201D;, by BioRender.com (2022). Retrieved from <ext-link xlink:href="https://app.biorender.com/biorender-templates" ext-link-type="uri">https://app.biorender.com/biorender-templates</ext-link>, associated information based on .<sup><xref rid="cit0025" ref-type="bibr">25&#x2013;27</xref>,<xref rid="cit0028" ref-type="bibr">28</xref></sup></p></caption><alternatives><graphic xlink:href="KGMI_A_2096995_F0002_OC" content-type="color" specific-use="web-only" position="float"/><graphic xlink:href="KGMI_A_2096995_F0002_PB" content-type="black-white" specific-use="print-only" position="float"/></alternatives></fig></p>
        <p>Ecology of gut microbes has been extensively studied for decades, as the human gastrointestinal (GI) tract is one of the most complex systems in the human body. The gastrointestinal system starts from the oral cavity and finishes in the anus after passing through the stomach and intestines.<sup><xref rid="cit0030" ref-type="bibr">30</xref></sup> The GI tract is considered more microbially enriched than any other organ in the human body and has the highest diversity of microorganisms. Up to 10<sup>13</sup> microbial cells, belonging to all three domains of life (Bacteria, Archaea and Eukarya), and viruses, comprise the microbial community of the GI tract. Microbial diversity in the gut varies between individuals.<sup><xref rid="cit0018" ref-type="bibr">18</xref>,<xref rid="cit0031" ref-type="bibr">31</xref></sup> Based on chemical composition and physical state, the GI tract can be divided into distinct sections. The upper portion of the GI tract, stomach, and small intestine have comparatively low numbers of bacteria (10<sup>3</sup> to 10<sup>4</sup> cells in total) due to low pH and shorter transition period. The colon is the most colonized region of the GI tract, where an estimate of 10<sup>10</sup> to 10<sup>11</sup> bacterial cells resides.<sup><xref rid="cit0030" ref-type="bibr">30</xref></sup> The gut can harbor 1000 different bacterial species belonging to phyla such as <italic toggle="yes">Bacteroidetes, Firmicutes, Actinobacteria, Proteobacteria</italic>, Verrucomicrobia, Fusobacteria, Tenericutes, Spirochaetes
, Cyanobacteria, and Saccharibacteria (<xref rid="f0002" ref-type="fig">Figure 2</xref>).<sup><xref rid="cit0030" ref-type="bibr">30&#x2013;32</xref></sup></p>
        <p>Fungal diversity, in contrast, is relatively limited in the human gut. Pyrosequencing has revealed nearly 66 genera of fungi from 98 human individuals; the prevalent fungal genera being <italic toggle="yes">Saccharomyces, Candida</italic>, and <italic toggle="yes">Cladosporium</italic>.<sup><xref rid="cit0033" ref-type="bibr">33</xref></sup> Abundance of fungi such as <italic toggle="yes">Candida, Aspergillus, Fusarium</italic>, and <italic toggle="yes">Cryptococcus</italic> in the gut may have a pathogenic effect on the host.<sup><xref rid="cit0030" ref-type="bibr">30</xref></sup> For example, children with type I diabetes have high numbers of <italic toggle="yes">Saccharomyces</italic> and <italic toggle="yes">Candida</italic> yeasts in their gut.<sup><xref rid="cit0034" ref-type="bibr">34</xref></sup> Among Archaea, the predominant genera in the human gut are <italic toggle="yes">Methanobrevibacter, Methanosphaera, Nitrososphaera, Thermogynomonas</italic>, and <italic toggle="yes">Thermoplasma</italic>.<sup><xref rid="cit0033" ref-type="bibr">33</xref>,<xref rid="cit0035" ref-type="bibr">35</xref></sup> Viruses and phages, on the other hand, can act as reservoirs of genetic material in the gut and destroy microbial cells.<sup><xref rid="cit0036" ref-type="bibr">36</xref></sup></p>
      </sec>
      <sec disp-level="2" id="s0002-s2003">
        <title>Characteristics of a healthy gut</title>
        <p>Microbes colonize the human gut at birth.<sup><xref rid="cit0037" ref-type="bibr">37&#x2013;40</xref></sup> The initial colonization plays an essential role in determining the composition of the gut microbiome as the person grows older.<sup><xref rid="cit0041" ref-type="bibr">41</xref></sup> Progression of the intestinal microbiome is influenced by contact between host and microbes. For instance, analogous microbiomes are present in the intestine of infants and the vagina of their mothers.<sup><xref rid="cit0042" ref-type="bibr">42</xref></sup> During the early life (above the age of 3), the composition of gut microbiome changes with time until it becomes relatively stable.<sup><xref rid="cit0005" ref-type="bibr">5</xref></sup> A normal gut harbors bacterial genus such as <italic toggle="yes">Bacillus, Lactobacillus, Enterococcus, Clostridium</italic>, and <italic toggle="yes">Ruminococcus</italic>.<sup><xref rid="cit0043" ref-type="bibr">43</xref></sup> One of the most notable changes in the gut microbiome is the ratio between the phyla Firmicutes and Bacteroidetes, as higher Firmicutes level is reported in obesity.<sup><xref rid="cit0044" ref-type="bibr">44</xref></sup> The gut microbiome has a number of functions, including gathering of indigestible food particles in feces and assimilating nutritious particles, such as vitamins and minerals,<sup><xref rid="cit0045" ref-type="bibr">45</xref></sup> while collaborating with the liver to detoxify and eliminate xenobiotics, which are toxic foreign compounds that are omnipresent in the environment.<sup><xref rid="cit0046" ref-type="bibr">46</xref></sup> Millions of microbial genes have been identified in the gut that support essential and necessary human functions.<sup><xref rid="cit0047" ref-type="bibr">47</xref>,<xref rid="cit0048" ref-type="bibr">48</xref></sup> The gut is the primary site of intricate interactions between the genes and the extrinsic immunological influence on the body, making it one of the most important organs for communicating with the environment.<sup><xref rid="cit0049" ref-type="bibr">49</xref></sup> Several microbial ecosystems consisting of the entire mucosal lining are maintained in the human gastrointestinal tract.<sup><xref rid="cit0050" ref-type="bibr">50</xref></sup> When villi, microvilli, crypts, and folds are considered, the gut epithelium of an adult spans a surface area of around 300 m<sup>2</sup>; this barrier typically contains just one cell layer and is therefore vulnerable. Bacteria that enter through the gut wall and into the bloodstream can cause a systemic inflammation in the absence of a healthy intestinal wall.<sup><xref rid="cit0051" ref-type="bibr">51</xref></sup> The gut wall, on the other hand, is protected by a variety of chemical and physical innate defense mechanisms that function in tandem with a local adaptive immune system.<sup><xref rid="cit0052" ref-type="bibr">52</xref></sup></p>
        <p>The role of gut microbiome in epithelial cell renewal and intestinal integrity regulation is crucial to a person&#x2019;s overall and intestinal immune systems.<sup><xref rid="cit0051" ref-type="bibr">51</xref></sup> The local adaptive immune system is dominated by an immunoglobulin A (IgA)-producing B-cell population, which primarily offers an anti-inflammatory first-line response by producing secretory IgA (sIgA) antibodies that conduct immune exclusion.<sup><xref rid="cit0052" ref-type="bibr">52</xref>,<xref rid="cit0053" ref-type="bibr">53</xref></sup> Immune tolerance toward dietary and environmental antigens is modified by gut microorganisms, which also protect against potential pathogens.<sup><xref rid="cit0002" ref-type="bibr">2</xref></sup> Such protection is achieved, besides directly triggering the immune protective responses, indirectly by attachment of microbes to epithelial cells.<sup><xref rid="cit0048" ref-type="bibr">48</xref></sup> Their attachment to gut epithelium can provide colonization resistance in the gut. By such process, resident microorganisms can block colonization of the gut by exogenous pathogenic microbes, such as <italic toggle="yes">Clostridium difficile</italic> and <italic toggle="yes">Helicobacter pylori</italic>.<sup><xref rid="cit0054" ref-type="bibr">54</xref></sup></p>
      </sec>
      <sec disp-level="2" id="s0002-s2004">
        <title>Gut-skin communication through immuno-cross-linking</title>
        <p>Gut-skin communication occurs through the activities of immunological components which are present between the gut and the skin. Regulating host&#x2019;s interaction with the microbiota is a fundamental function of immune system, thereby the regions colonized by commensals, such as the skin and the GI tract, encase the substantial volume of immune cells in the body. Through the dominant activity on the immune system, the commensal microbial communities play an important role in boosting barrier immunity along with their own confinement to safeguard their ecological niche. Curtailing the contact between microorganisms and the gut epithelial membrane to minimize the inflammatory responses and microbial translocation is crucial in preserving the host&#x2019;s homeostatic balance. To achieve this segregation, gut epithelial cell barrier, mucus layer, T cells, IgA, and dendritic cells (DCs) collectively forge the shield named &#x2018;mucosal firewall&#x2019; (<xref rid="f0003" ref-type="fig">Figure 3</xref>). The mucosal firewall limits the translocation of commensal bacteria to the lymphoid tissues, preventing the inflammation of the gut and skin.<sup><xref rid="cit0059" ref-type="bibr">59</xref></sup> These lymphoid tissues are usually known as gut-associated lymphoid tissues (GALTs) (<xref rid="f0003" ref-type="fig">Figure 3</xref>). GALTs are typically mucosa-associated lymphoid tissues (MALTs) that work as a barrier between the host and the environment.<sup><xref rid="cit0055" ref-type="bibr">55</xref></sup> GALTs are comprised of microfold cells (M cells), which have evolved into phagocytose and transcytose (a process through which particles are transported across the mucosal barrier to the lamina propria via unique cellular pathways) gut lumen macromolecules, particulate antigens, and harmful or commensal bacteria through epithelium (<xref rid="f0003" ref-type="fig">Figure 3</xref>).<sup><xref rid="cit0060" ref-type="bibr">60</xref>,<xref rid="cit0061" ref-type="bibr">61</xref></sup> Along with M cells, conventional lymphocytes (regulatory T cells (Tregs), helper T cells (Th cells), cytotoxic T lymphocytes, IgA producing B cells), and professional phagocytes (DCs, mast cells, neutrophils, and macrophages) and unconventional lymphocytes, such as innate lymphoid cells (ILCs) and mucosal-associated invariant T (MAIT) cells, are also the constituents of GALTs (<xref rid="f0003" ref-type="fig">Figure 3</xref>).<sup><xref rid="cit0055" ref-type="bibr">55</xref>,<xref rid="cit0062" ref-type="bibr">62</xref></sup> In addition, reports indicate that gut microbiota is behind the fundamental development mechanism of GALTs (<xref rid="f0003" ref-type="fig">Figure 3</xref>).<sup><xref rid="cit0063" ref-type="bibr">63</xref>,<xref rid="cit0064" ref-type="bibr">64</xref></sup> Peyer&#x2019;s patches, crypt cells of the intestinal epithelium, isolated lymphoid follicles (ILFs) of the intestine, appendix, and mesenteric lymph nodes (mLNs) are the most common histologic components of GALTs.<sup><xref rid="cit0063" ref-type="bibr">63</xref>,<xref rid="cit0064" ref-type="bibr">64</xref></sup> The hematopoietic cell type lymphoid tissue inducer (LTi) cell and its interplay with gut microbial colonization control the formation of gut secondary lymphoid organs.<sup><xref rid="cit0055" ref-type="bibr">55</xref></sup>
<fig position="float" id="f0003" fig-type="figure"><label>Figure 3.</label><caption><p><bold>Gut-Skin communication through immuno-cross-linking.</bold> This illustration represents the immunological crosstalk between the gut and skin. <bold>(A)</bold> CX3CR1+&#xA0;DCs generate dendrites for phagocytosis at homeostatic condition, whereas CD103+&#xA0;DCs relocate to Peyer&#x2019;s patches or mesenteric lymph nodes to deliver antigens to naive T lymphocytes. DC secretes interleukin (IL)-12, IL-15, and interferon (IFN) in response to commensal activation to stimulate conventional NK (cNK) cells. <bold>(B)</bold> As metabolic by-products, short-chain fatty acids (SCFAs) upregulate H3K4me3 in DC and enhance the production of IL-6, IL-12, IFN, and tumor necrosis factor (TNF), which is an alternative way to train cNK cells. Trained cNK cells have the necessary cytotoxicity and cytokine production capacity to fight bacteria and viruses. <bold>(C)</bold> MAIT cells can be directly stimulated to create IFN-&#x3B3; by IL-12 or IL-15 in combination with IL-18 produced by APCs in response to TLR ligands. <bold>(D)</bold> TNF-like protein, a gut-associated pro-inflammatory cytokine, activates MAIT cells when coupled with IL-12 and IL-18. Phagocytes help the body defend itself by phagocytosing and producing cytokines like IL-6 and IL-23. <bold>(E)</bold> Foxp3+&#xA0;Treg cells and Tfh/ex-Th17 cells cluster in Peyer&#x2019;s patches, promoting B cell class switching and secretory (s)IgA production. These help to compartmentalize the commensal microbiome and modulate the diversity of the homeostatic microbiome. <bold>(F)</bold> ILC2 is activated by IL-25, IL-33, and thymic stromal lymphopoietin (TSLP) produced by intestinal epithelial cells (IEC) in response to commensal bacteria. <bold>(G)</bold> ILC3 expressing MHC II is capable of delivering commensal antigens to CD4&#xA0;+&#xA0;T cells, reducing their self-reactivity. <bold>(H)</bold> In an ID2-dependent manner, microbial signals are also used to prime ILC3. ILC3, which has been primed secretes IL-22 and participates in the pathogen defense by stimulating the synthesis of antimicrobial peptides, such as REGIII&#x3B2; and REGIII&#x3B3;. This illustration was based on <sup><xref rid="cit0055" ref-type="bibr">55&#x2013;58</xref></sup> and created in BioRender.com (2022).</p></caption><alternatives><graphic xlink:href="KGMI_A_2096995_F0003_OC" content-type="color" specific-use="web-only" position="float"/><graphic xlink:href="KGMI_A_2096995_F0003_PB" content-type="black-white" specific-use="print-only" position="float"/></alternatives></fig></p>
        <p>Both conventional lymphocytes and professional phagocytes secrete antimicrobial peptides (AMPs) for the maintenance of homeostasis. AMPs are convoluted evolving compounds produced by gut epithelial cells, paneth cells, and immunological cells in the digestive tract (<xref rid="f0003" ref-type="fig">Figure 3</xref>).<sup><xref rid="cit0065" ref-type="bibr">65</xref></sup> AMPs, such as &#x3B1;- and &#x3B2;- defensins, are secreted by localized immune cell types, namely macrophages, T cells, B cells and mast cells (MC).<sup><xref rid="cit0066" ref-type="bibr">66</xref></sup> Furthermore, MCs can produce the AMP cathelicidin and contribute to microbiome-tissue homeostasis in the dermis. Pathogens or their components can directly bind to the TLRs, (NOD)-like receptors (NLRs), and (RIG-I)-like receptors (RLRs) and activate complement receptors of MCs, subsequently releasing inflammatory mediators, which aid in antimicrobial immune responses.<sup><xref rid="cit0067" ref-type="bibr">67</xref></sup> By expression of co-stimulatory molecules and secretion of inflammatory cytokines, TLR4 elicits innate responses. An earlier study in a mouse model substantiated that TLRs generally function as pattern-recognition receptors (PRRs) with the ability to recognize a wide range of pathogen-associated molecular patterns (PAMPs), including proteins, lipoproteins, lipids, nucleic acids, and glycans, and aid the initiation of innate immunity.<sup><xref rid="cit0068" ref-type="bibr">68</xref></sup> Development of ILFs occurs as soon as PRRs recognize PAMPs of enteric bacteria and activate the downstream signaling pathways. Several AMPs, such as REGIII&#x3B2; and REGIII&#x3B3; can be produced as the result of Peyer&#x2019;s patch priming by TLR pathways. On the other hand, enteric bacterial infection can occur due to the inhibition of TLR pathway. For example, TLR2 deficiency impairs the integrity of the intestinal epithelial barrier and disrupts the balance between commensal bacteria and host defense, exacerbating colitis.<sup><xref rid="cit0055" ref-type="bibr">55</xref>,<xref rid="cit0069" ref-type="bibr">69</xref></sup></p>
        <p>As antigen presenting cells, DCs play an important role in producing tight junction proteins and extending dendrites into the lumen through the junctions.<sup><xref rid="cit0070" ref-type="bibr">70</xref></sup> Through the adherence to C-X3-C Motif Chemokine Receptor 1 (CX3CR1), DCs give rise to the formation of trans-epithelial dendrites and the delivery of antigens for sampling (<xref rid="f0003" ref-type="fig">Figure 3</xref>). DCs are also capable of forming trans-epithelial dendrites and phagocytosing invasive enteric pathogens.<sup><xref rid="cit0071" ref-type="bibr">71</xref></sup></p>
        <p>ILCs play imperative parts in immunity, homeostasis, and inflammation in various tissues, including the intestine, lungs, skin, liver, adipose tissue, and mesenteric lymph nodes.<sup><xref rid="cit0072" ref-type="bibr">72</xref>,<xref rid="cit0073" ref-type="bibr">73</xref></sup> ILCs are classified in three groups by the developmental process, transcription factor expression, and secretion profiles of interleukins (IL)-17A, IL-17&#xA0;F, IL-22, and GM-CSF, namely, ILC1, ILC2, and ILC3, which are the innate counterparts of T helper cells, Th1, Th2, and Th17, respectively.<sup><xref rid="cit0073" ref-type="bibr">73&#x2013;75</xref></sup> Among the helper ILC subsets, ILC1 has a comparatively low frequency in the fetal intestine, as the gut microbiome is not established. This indicates that ILC1 development depends on commensal bacteria.<sup><xref rid="cit0055" ref-type="bibr">55</xref>,<xref rid="cit0071" ref-type="bibr">71</xref></sup> Th1 cells and ILC1s eradicate viruses, bacteria, or protozoa from the body through production of IFN-&#x3B3;.<sup><xref rid="cit0075" ref-type="bibr">75</xref></sup> Th2 and ILC2 cells, which produce IL-5 and IL-13, respectively, are behind development of allergies and assist in the elimination of helminths. ILC3s and Th17 cells also contribute to autoimmunity by the secretion of IL-17 and IL-22, respectively, which provide protection against fungal and extracellular bacterial infections (<xref rid="f0003" ref-type="fig">Figure 3</xref>).<sup><xref rid="cit0075" ref-type="bibr">75</xref></sup></p>
        <p>Meanwhile, the most common subgroup of T-cells that can identify bacterial particles is mucosal-associated invariant T (MAIT) cells, also known as evolutionarily conserved T-cells.<sup><xref rid="cit0076" ref-type="bibr">76</xref></sup> MAIT cells play a crucial role in elimination of bacterial infections from the body, and their role in defense against viral infection has also been reported.<sup><xref rid="cit0067" ref-type="bibr">67</xref></sup> MAIT cells detect antigens via Major histocompatibility complex class I-related gene protein (MR1), a protein predominantly expressed by B cells.<sup><xref rid="cit0077" ref-type="bibr">77</xref></sup> When MAIT cells come into contact with a variety of bacteria, they respond by detecting vitamin B2 biosynthesis pathway products via T-cell receptor (TCR) recognition.<sup><xref rid="cit0067" ref-type="bibr">67</xref></sup></p>
      </sec>
      <sec disp-level="2" id="s0002-s2005">
        <title>Mechanisms of the interaction at the gut-skin axis</title>
        <p>Disruption of gut integrity, and an imbalance within microbial communities can have a significant impact on the overall homeostasis of skin.<sup><xref rid="cit0002" ref-type="bibr">2</xref></sup> Gut-skin axis is a term used for the intricate interaction between the gut and the skin.<sup><xref rid="cit0016" ref-type="bibr">16</xref></sup> The gut microbiome interacts with the skin largely to manage systemic and local inflammation through engaging with the immune system (<xref rid="f0004" ref-type="fig">Figure 4</xref>).<sup><xref rid="cit0015" ref-type="bibr">15</xref>,<xref rid="cit0078" ref-type="bibr">78</xref></sup> The microbial communities maintain the gut barrier integrity mainly by converting undigestible complex polysaccharides into vitamins (specifically K and B12), and SCFAs (specifically butyrate and propionate).<sup><xref rid="cit0079" ref-type="bibr">79</xref>,<xref rid="cit0080" ref-type="bibr">80</xref></sup> For example, butyrate wanes the intestinal barrier permeability and enhances epithelial barrier integrity.<sup><xref rid="cit0016" ref-type="bibr">16</xref></sup> The mucus layer of the gut acts as the primary barrier and prevents microbial relocation to other host tissues (<xref rid="f0004" ref-type="fig">Figure 4</xref>).<sup><xref rid="cit0081" ref-type="bibr">81</xref>,<xref rid="cit0082" ref-type="bibr">82</xref></sup> The gut mucosal defense is provided by innate immune cells of GALT. They recognize nonspecific infections and activate both the innate and adaptive immune systems by presenting those antigens.<sup><xref rid="cit0063" ref-type="bibr">63</xref>,<xref rid="cit0083" ref-type="bibr">83</xref></sup> AMPs, macrophages, and CD103<sup>+</sup> CD11b<sup>+</sup> DCs mainly limit the translocation of pathogenic microbes by eliminating them.<sup><xref rid="cit0081" ref-type="bibr">81</xref>,<xref rid="cit0084" ref-type="bibr">84</xref>,<xref rid="cit0085" ref-type="bibr">85</xref></sup> Defensins act against bacteria by generating pores in their membranes. This results in cell death if appropriate thresholds are exceeded. Cathelicidins (LL-37 in humans) help to keep the epithelial barrier intact. While their principal mechanism of action is to break bacterial membranes, they also possess immunomodulatory effects. Enhanced tight junction protein production, as well as post-translational effects, such as tight junction repositioning, are principally responsible for the gut epithelial barrier integrity maintenance. As a result, cathelicidins predominantly are employed when the epithelial barrier is breached.<sup><xref rid="cit0065" ref-type="bibr">65</xref></sup> Differentiation of gut commensal bacteria-specific Tregs, IgA-producing B cells, and Th17 cells are the outcomes of commensal antigens presentation by DCs.<sup><xref rid="cit0084" ref-type="bibr">84</xref></sup> DCs establish the specificity of CD4+&#xA0;Th17 cells toward commensal microbes as the result of Major histocompatibility complex II (MHCII) antigen presentation. The CD4+&#xA0;Th17 cells produce the cytokine Interleukin 22 (IL-22), which enhances secretion of host AMPs.<sup><xref rid="cit0086" ref-type="bibr">86</xref>,<xref rid="cit0087" ref-type="bibr">87</xref></sup> The integrity of the intestinal barrier along with the action of mucus, immune cells, IgA, and antimicrobial peptides (AMPs) produced by epithelial cells prevents the entrance of gut bacteria into the bloodstream, ultimately maintaining skin homeostasis.<sup><xref rid="cit0059" ref-type="bibr">59</xref></sup> Especially, secretory IgA controls the inflammatory responses against the gut microbes by spatially dissociating the host tissue and gut microbes.<sup><xref rid="cit0011" ref-type="bibr">11</xref>,<xref rid="cit0088" ref-type="bibr">88</xref>,<xref rid="cit0089" ref-type="bibr">89</xref></sup> The commensal bacteria-specific lymphocytes accumulate in Peyer&#x2019;s patches and lamina propria of the gut, which shapes the gut microbial profile toward homeostatic balance. Promotion of class switching by Tregs and IgA production against the commensal bacteria takes place in the Peyer&#x2019;s patches of the gut.<sup><xref rid="cit0090" ref-type="bibr">90</xref>,<xref rid="cit0091" ref-type="bibr">91</xref></sup> However, the link between skin health and immunological responses caused by the gut microbiome is still largely unclear and requires further research.<sup><xref rid="cit0092" ref-type="bibr">92</xref>,<xref rid="cit0093" ref-type="bibr">93</xref></sup>
<fig position="float" id="f0004" fig-type="figure"><label>Figure 4.</label><caption><p><bold>Mechanisms of the interaction at the gut-skin axis.</bold> This illustration represents the underlying mechanisms of gut-skin interaction. Various dietary components, illnesses, lifestyles, prebiotics, antibiotics, probiotics, and novel biological drugs can alter gut microbial communities. <bold>A</bold>. The alteration can lead to dysbiosis, which can further <bold>(i)</bold> decrease the gut mucus layer, <bold>(ii)</bold> results in the passage of microbes through the intestinal barrier, <bold>(iii)</bold> cause the production of toxic products, <bold>(iv)</bold> induce harmful effects by neurotransmitters of the gut microbes or the host, <bold>(v)</bold> produce B cell hyperresponsiveness, <bold>(vi)</bold> impair T cell differentiation, <bold>(vii)</bold> create low levels of IgA secretion. <bold>B</bold>. Dysbiotic gut microbes, toxic products, neurotransmitters, and altered immune cells pass through the circulatory system turning the skin condition from healthy (<bold>left</bold>) to dysbiotic (<bold>right</bold>). <bold>(i)</bold> Healthy skin possesses a balanced composition of microbes and proper quantities of human and microbial AMPs. <bold>(ii)</bold> A dysbiotic skin condition is induced by the pathogen due to improper immune system functioning and low quantities of human and microbial AMPs. <bold>C</bold>. Dysbiotic skin microbes trigger skin inflammation and can be involved in the onset of a variety of skin illnesses. This illustration is based on <sup><xref rid="cit0015" ref-type="bibr">15</xref></sup>and <sup><xref rid="cit0016" ref-type="bibr">16</xref></sup>and created with BioRender.com (2022).</p></caption><alternatives><graphic xlink:href="KGMI_A_2096995_F0004_OC" content-type="color" specific-use="web-only" position="float"/><graphic xlink:href="KGMI_A_2096995_F0004_PB" content-type="black-white" specific-use="print-only" position="float"/></alternatives></fig></p>
        <p>In the first part of the twentieth century, dermatologists Stokes and Pillsbury were the first to suggest that the gut and skin communicate with the brain.<sup><xref rid="cit0003" ref-type="bibr">3</xref>,<xref rid="cit0094" ref-type="bibr">94</xref></sup> GABA, acetylcholine, dopamine, and serotonin are among the neurotransmitters produced by gut microbes. These neurotransmitters can modulate the function of the skin through the nervous system. They can also create systemic effects by entering the bloodstream through the intestinal epithelium (<xref rid="f0004" ref-type="fig">Figure 4</xref>).<sup><xref rid="cit0095" ref-type="bibr">95</xref></sup> For example, an experiment conducted on NC/Nga mice (an inbred mouse line employed as a human AD model) demonstrated the role of GABA in AD-like skin lesion mitigation. This experiment led to the conclusion that by increasing the production of serum immunoglobulin E (IgE) and splenocyte IL-4, GABA balances the T helper cell type 1 (Th1) and T helper cell type 2 (Th2) levels, keeping the Th1 predominant, which effectively wanes AD-like skin lesions in human.<sup><xref rid="cit0096" ref-type="bibr">96</xref></sup> By suppressing the type I collagen degrading enzyme matrix metalloproteinase-I (MMP-I), GABA also increases the expression of human type I collagen (COL1A1 and COL1A2) and maintains skin elasticity.<sup><xref rid="cit0097" ref-type="bibr">97</xref></sup> Neurotransmitters can also create negative effects, e.g., dopamine can inhibit hair growth by stimulating catagen induction.<sup><xref rid="cit0098" ref-type="bibr">98</xref></sup></p>
        <p>Antibiotics, prebiotics, probiotics, lifestyles, long-term diets, and illnesses can influence the gut microbiome. Furthermore, changes in the major strains of the gut microbiome can occur as people age.<sup><xref rid="cit0099" ref-type="bibr">99&#x2013;102</xref></sup> Skin inflammation may also result from minute changes in a single bacterial species of the intestinal microbiome.<sup><xref rid="cit0092" ref-type="bibr">92</xref>,<xref rid="cit0093" ref-type="bibr">93</xref></sup> These, in turn, may lead to diseases e.g., acne, alopecia areata, atopic dermatitis, psoriasis, rosacea, and hidradenitis suppurativa (<xref rid="f0004" ref-type="fig">Figure 4</xref>).<sup><xref rid="cit0016" ref-type="bibr">16</xref>,<xref rid="cit0103" ref-type="bibr">103</xref>,<xref rid="cit0104" ref-type="bibr">104</xref></sup>
<xref rid="t0001" ref-type="table">Table 1</xref> lists the microbial species and metabolites associated with various skin effects.<table-wrap position="float" id="t0001"><label>Table 1.</label><caption><p>Microbial species and metabolites from the gut that have been associated with skin effects.</p></caption><!--OASIS TABLE HERE--><table frame="hsides" rules="groups"><colgroup><col width="1*" align="left"/><col width="1*" align="left"/><col width="1*" align="left"/><col width="1*" align="left"/><col width="1*" align="center"/><col width="1*" align="center"/></colgroup><thead><tr><th colspan="6" align="left"><bold>A. Microbial species</bold><hr/></th></tr><tr><th colspan="2" align="left">Organism</th><th align="left">Effects on skin</th><th colspan="2" align="left">Mechanism</th><th align="center">References</th></tr></thead><tbody><tr><td colspan="2" align="left"><italic toggle="yes">Faecalibacterium prausnitzii, Akkermansia muciniphila</italic> and <italic toggle="yes">Ruminoccocus</italic></td><td align="left">Protection against psoriasis</td><td colspan="2" align="left">Prevention of colonization of pathogenic flora on skin by competitive inhibition and the SCFAs production</td><td align="center"><sup><xref rid="cit0158" ref-type="bibr">158</xref>,<xref rid="cit0159" ref-type="bibr">159</xref>,<xref rid="cit0169" ref-type="bibr">169</xref>,<xref rid="cit0213" ref-type="bibr">213</xref></sup></td></tr><tr><td colspan="2" align="left"><italic toggle="yes">Helicobacter pylori</italic></td><td align="left">Rosacea-related signs and symptoms</td><td colspan="2" align="left">Production of cytotoxin and by proliferating the production of reactive oxygen species-nitric oxide [NO], which causes gut mucosal inflammation and changes physiological processes in the skin including vasodilation, inflammation and immunomodulation.</td><td align="center"><sup><xref rid="cit0194" ref-type="bibr">194</xref></sup></td></tr><tr><td colspan="2" align="left"><italic toggle="yes">Faecalibacterium prausnitzii</italic></td><td align="left">Chronic atopic dermatitis progression resulting in gut epithelial barrier impairment</td><td colspan="2" align="left">Dysregulation of gut epithelial inflammation</td><td align="center"><sup><xref rid="cit0180" ref-type="bibr">180</xref></sup></td></tr><tr><td colspan="2" align="left"><italic toggle="yes">Lactobacillus casei</italic></td><td align="left">Decrease skin inflammation</td><td colspan="2" align="left">Alteration of the number of cytotoxic CD8&#xA0;+&#xA0;T cells</td><td align="center"><sup><xref rid="cit0171" ref-type="bibr">171</xref></sup></td></tr><tr><td colspan="2" align="left"><italic toggle="yes">Lactobacillus paracasei</italic></td><td align="left">Reduce the size of acne lesions as well as inflammation</td><td colspan="2" align="left">Inhibition of mast cell degranulation, TNF-&#x3B1; release, edema and vasodilation, and thereby speeding up the restoration of barrier function</td><td align="center"><sup><xref rid="cit0145" ref-type="bibr">145</xref>,<xref rid="cit0171" ref-type="bibr">171</xref></sup><break/><sup><xref rid="cit0136" ref-type="bibr">136</xref></sup></td></tr><tr><td colspan="2" align="left"><italic toggle="yes">Bifidobacterium animalis</italic> subsp. <italic toggle="yes">lactis</italic> [LKM512]</td><td align="left">Reduce the scratching behavior in atopic dermatitis</td><td colspan="2" align="left">Increase of levels of the kynurenic acid metabolite</td><td align="center"><sup><xref rid="cit0223" ref-type="bibr">223</xref></sup></td></tr><tr><td colspan="2" align="left"><italic toggle="yes">Bacteroides thetaiotaomicron</italic></td><td align="left">Alleviate the allergic symptoms of atopic dermatitis as well as Crohn&#x2019;s disease like other chronic inflammatory diseases</td><td colspan="2" align="left">Anti-inflammatory action</td><td align="center"><sup><xref rid="cit0228" ref-type="bibr">228</xref></sup></td></tr><tr><td colspan="2" align="left">Larger number of<break/><italic toggle="yes">Clostridium difficile</italic> and <italic toggle="yes">Escherichia coli</italic></td><td align="left">Onset of atopic dermatitis symptoms in childhood</td><td colspan="2" align="left">Immune dysregulation as a result of decreased Treg cell inducing beneficial bacteria</td><td align="center"><sup><xref rid="cit0016" ref-type="bibr">16</xref>,<xref rid="cit0224" ref-type="bibr">224</xref></sup></td></tr><tr><td colspan="2" align="left">Decrease in Firmicutes and increase in Bacteroides<hr/></td><td align="left">Development of acne vulgaris<hr/></td><td colspan="2" align="left">Dysbiosis by altering the serological cytokine levels promoting inflammation<hr/></td><td align="center"><sup><xref rid="cit0015" ref-type="bibr">15</xref>,<xref rid="cit0188" ref-type="bibr">188</xref></sup><hr/></td></tr><tr><td colspan="6" align="left"><bold>B. Metabolites</bold><hr/></td></tr><tr><td align="left">Metabolites<hr/></td><td colspan="2" align="left">Effects on skin<hr/></td><td align="left">Mechanism<hr/></td><td colspan="2" align="center">References<hr/></td></tr><tr><td align="left">SCFAs</td><td colspan="2" align="left">Increase the epithelial barrier function and skin-inflammation</td><td align="left">Development of Tregs within the colon, DCs<break/>precursors, and IL-10 production</td><td colspan="2" align="center"><sup><xref rid="cit0120" ref-type="bibr">120</xref>,<xref rid="cit0229" ref-type="bibr">229</xref></sup><break/><sup><xref rid="cit0013" ref-type="bibr">13</xref>,<xref rid="cit0106" ref-type="bibr">106</xref></sup></td></tr><tr><td align="left">GABA</td><td colspan="2" align="left">Itch restriction</td><td align="left">Inhibition of neurons which are responsible for itch-signaling in the spinal cord</td><td colspan="2" align="center"><sup><xref rid="cit0230" ref-type="bibr">230</xref>,<xref rid="cit0223" ref-type="bibr">223</xref></sup></td></tr><tr><td align="left">Tryptophan</td><td colspan="2" align="left">Regulate skin inflammation</td><td align="left">Activation of AhR and inhibition of TSLP production in keratinocytes</td><td colspan="2" align="center"><sup><xref rid="cit0231" ref-type="bibr">231</xref></sup></td></tr><tr><td align="left">Dopamine</td><td colspan="2" align="left">Inhibition of hair growth</td><td align="left">Through the stimulation of catagen induction</td><td colspan="2" align="center"><sup><xref rid="cit0098" ref-type="bibr">98</xref></sup></td></tr><tr><td align="left">Serotonin</td><td colspan="2" align="left">Involved in skin pigmentation</td><td align="left">Modulation of melatonin</td><td colspan="2" align="center"><sup><xref rid="cit0016" ref-type="bibr">16</xref>,<xref rid="cit0223" ref-type="bibr">223</xref></sup></td></tr><tr><td align="left">Acetylcholine</td><td colspan="2" align="left">Barrier function</td><td align="left">Not reported</td><td colspan="2" align="center"><sup><xref rid="cit0016" ref-type="bibr">16</xref></sup></td></tr><tr><td align="left">Phenol &amp; p-cresol</td><td colspan="2" align="left">Impaired epidermal barrier function</td><td align="left">Skin hydration reduction and disruption of keratinization</td><td colspan="2" align="center"><sup><xref rid="cit0171" ref-type="bibr">171</xref>,<xref rid="cit0232" ref-type="bibr">232</xref></sup></td></tr><tr><td align="left">Propionic acid</td><td colspan="2" align="left">Promote skin homeostasis by reducing inflammation</td><td align="left">Antimicrobial effects</td><td colspan="2" align="center"><sup><xref rid="cit0002" ref-type="bibr">2</xref></sup></td></tr><tr><td align="left">Sodium butyrate</td><td colspan="2" align="left">Treat psoriasis and other hyperproliferative skin diseases</td><td align="left">Modulation of several key cellular processes including differentiation, proliferation, and apoptosis.</td><td colspan="2" align="center"><sup><xref rid="cit0137" ref-type="bibr">137</xref></sup></td></tr><tr><td align="left">Galactoligosaccharides<break/>and fructooligosaccharides</td><td colspan="2" align="left">Reduction of infant eczema and allergy</td><td align="left">Through the stimulation of Tregs</td><td colspan="2" align="center"><sup><xref rid="cit0013" ref-type="bibr">13</xref>,<xref rid="cit0107" ref-type="bibr">107</xref></sup></td></tr><tr><td align="left">Polysaccharide A and retinoic acid</td><td colspan="2" align="left">Suppress inflammation</td><td align="left">Induction of accumulation of Tregs</td><td colspan="2" align="center"><sup><xref rid="cit0153" ref-type="bibr">153</xref></sup></td></tr><tr><td align="left">Saturated<break/>fats and higher amount of glycemic load</td><td colspan="2" align="left">Development of acne</td><td align="left">Impairment in nutrient signaling. SREBP-1 overexpression and increased sebum synthesis of fatty acids (e.g., free oleic acid) and triglycerides which promotes flourishing. <italic toggle="yes">P. acnes</italic> growth</td><td colspan="2" align="center"><sup><xref rid="cit0107" ref-type="bibr">107</xref></sup></td></tr><tr><td align="left">High-peptides and unsaturated omega-3 fatty acids</td><td colspan="2" align="left">Act against hypersensitivity (allergies) and asthma</td><td align="left">Through the development of Tregs</td><td colspan="2" align="center"><sup><xref rid="cit0013" ref-type="bibr">13</xref></sup></td></tr><tr><td align="left">High-fat and alcohol</td><td colspan="2" align="left">Promote skin inflammation and oxidative <break/>stress. Impairment of colonic epithelial integrity and barrier function.</td><td align="left">Increase of pro-inflammatory cytokines secretion</td><td colspan="2" align="center"><sup><xref rid="cit0122" ref-type="bibr">122</xref>,<xref rid="cit0123" ref-type="bibr">123</xref></sup></td></tr></tbody></table></table-wrap></p>
      </sec>
      <sec disp-level="2" id="s0002-s2006">
        <title>Diet, drugs and other consumed substances affect skin through gut microbiome</title>
        <p>Several studies have related the diversity and pathogenicity of the gut microbiome to skin disorders, which can be significantly altered by long-term dietary patterns.<sup><xref rid="cit0043" ref-type="bibr">43</xref>,<xref rid="cit0105" ref-type="bibr">105&#x2013;107</xref></sup> Diet can affect the skin condition both positively and negatively through alteration of the gut microbiome, indicating that there is a relationship between the skin and the gut.<sup><xref rid="cit0016" ref-type="bibr">16</xref></sup> Not only diet, but also many synthetic and natural products consumed by humans as drugs can provide direct and indirect evidence on the connection between gut microbiome and skin. Direct effects of antibiotics are perhaps the finest example of the link between gut and skin microbiota.<sup><xref rid="cit0108" ref-type="bibr">108</xref></sup> Although the prime target of antibiotics use is the elimination of infectious pathogens, they can also be useful in treating noninfectious cutaneous diseases because of their anti-inflammatory and immunomodulatory properties.<sup><xref rid="cit0109" ref-type="bibr">109</xref>,<xref rid="cit0110" ref-type="bibr">110</xref></sup> In contrast to antibiotics, prebiotics and probiotics invigorate the gut mirobiome.<sup><xref rid="cit0111" ref-type="bibr">111</xref></sup> Prebiotics are typically known as nondigestible carbohydrates, which promote the flourishment of probiotic bacteria in the gut.<sup><xref rid="cit0112" ref-type="bibr">112</xref>,<xref rid="cit0113" ref-type="bibr">113</xref></sup> On the other hand, probiotics influence the gut and skin according to nutritional status and medical conditions.<sup><xref rid="cit0113" ref-type="bibr">113</xref></sup> They are the key players in balancing the gut microbiome, which eventually also regulates human health.<sup><xref rid="cit0223" ref-type="bibr">223</xref></sup> The effects of diet, antibiotics, prebiotics, probiotics, and novel biologic drugs on the relationship of the gut microbiome with skin health are discussed below.</p>
        <sec disp-level="3" id="s0002-s2006-s3001">
          <title>Breastmilk and formula</title>
          <p>The gut microbiome of a newborn is highly dependent on diet. Breastfed infants have much higher levels of bacteria belonging to the class Actinobacteria.<sup><xref rid="cit0114" ref-type="bibr">114</xref>,<xref rid="cit0115" ref-type="bibr">115</xref></sup> Breastfeeding influences gut microbiome diversity by increasing especially colonization of genera belonging to <italic toggle="yes">Lactobacillus</italic> and <italic toggle="yes">Bifidobacterium</italic>.<sup><xref rid="cit0114" ref-type="bibr">114&#x2013;118</xref></sup> Colonization of the gut by the bacterial class &#x3B3;-Proteobacteria, which contains many proinflammatory species<sup><xref rid="cit0118" ref-type="bibr">118</xref></sup> is often observed in formula-fed infants.<sup><xref rid="cit0119" ref-type="bibr">119</xref></sup> Furthermore, babies fed with formula are more likely to be colonized by members of the phylum Bacteroides, and the opportunists <italic toggle="yes">Escherichia coli</italic> and <italic toggle="yes">Clostridium difficile</italic>.<sup><xref rid="cit0013" ref-type="bibr">13</xref>,<xref rid="cit0120" ref-type="bibr">120</xref></sup> High quantities of oligosaccharides and various fatty acids present in breast milk positively influence the gut microbiome and its metabolites that can act against hypersensitivity (allergy) and asthma through stimulation of Tregs.<sup><xref rid="cit0013" ref-type="bibr">13</xref></sup></p>
        </sec>
        <sec disp-level="3" id="s0002-s2006-s3002">
          <title>High and low-fat diet</title>
          <p>In the gut, a diet high in industrial trans-fatty acids increases the number of harmful microbes (such as <italic toggle="yes">Desulfovibrionaceae</italic> and <italic toggle="yes">Proteobacteria</italic>) while suppressing populations of advantageous microorganisms (e.g. members of Bacteroidetes, Lachnospiraceae, and Bacteroidales).<sup><xref rid="cit0121" ref-type="bibr">121</xref></sup> Refined and hydrogenated oils (e.g., soybean, sunflower, safflower, canola, corn, and vegetable oils) can cause inflammation in the gut, which then manifests on the skin. Skin wound healing may also be delayed by a high-fat diet and alcohol, which exacerbate the inflammation of the skin and oxidative stress.<sup><xref rid="cit0122" ref-type="bibr">122</xref></sup> High-fat diets are responsible for reducing gut microbial diversity and inducing the production of higher concentrations of lipopolysaccharides. This leads to a loss of colonic epithelial integrity and barrier function, a reduction in mucus layer thickness, and an increase in the release of pro-inflammatory cytokines, all of which further lead to systemic inflammation.<sup><xref rid="cit0123" ref-type="bibr">123</xref></sup></p>
        </sec>
        <sec disp-level="3" id="s0002-s2006-s3003">
          <title>Protein-rich diet</title>
          <p>The gut microbiome can synthesize and subsequently export excessive dietary proteins and amino acids, resulting in the production of indoxyl sulfate (IS), trimethylamine N-oxide (TMAO), and p-cresyl sulfate-like toxins.<sup><xref rid="cit0005" ref-type="bibr">5</xref></sup> These toxins are involved in several skin diseases, e.g., peripheral arthritis and psoriasis.<sup><xref rid="cit0106" ref-type="bibr">106</xref>,<xref rid="cit0124" ref-type="bibr">124</xref></sup> In contrast, a high-collagen peptide diet, which contains high quantities of microbes, can protect the skin from aging and promote wound healing.<sup><xref rid="cit0125" ref-type="bibr">125</xref></sup> The abundance of gut-commensal genera, such as <italic toggle="yes">Lactobacillus</italic> and <italic toggle="yes">Bifidobacterium</italic>, is increased with the ingestion of a diet containing whey and pea protein extracts, and the presence of pathogenic <italic toggle="yes">Bacteroides fragilis</italic> and <italic toggle="yes">Clostridium perfringens</italic> is simultaneously decreased. SCFA levels in the intestinal mucosa are increased with the consumption of pea proteins, which are critical for keeping the mucosal barrier intact.<sup><xref rid="cit0106" ref-type="bibr">106</xref></sup></p>
        </sec>
        <sec disp-level="3" id="s0002-s2006-s3004">
          <title>Dietary fiber</title>
          <p>In general, a fiber-rich diet has a remarkably beneficial effect on the gut microbiome and is therefore well studied. Dietary fiber cannot be digested by the human body and is mainly metabolized by the microbiome in the colon.<sup><xref rid="cit0105" ref-type="bibr">105</xref></sup> The metabolic process induces the growth of many bacterial groups. Eating foods rich in dietary fiber, especially whole grains, dramatically increases the populations of Bifidobacteria and the <italic toggle="yes">Lactobacillus</italic>/<italic toggle="yes">Enterococcus</italic> group.<sup><xref rid="cit0105" ref-type="bibr">105</xref></sup> Foods containing complex dietary carbohydrates can be converted into SCFAs, including propionate, acetate, and butyrate through fermentation by the gut microbiome.<sup><xref rid="cit0002" ref-type="bibr">2</xref>,<xref rid="cit0005" ref-type="bibr">5</xref>,<xref rid="cit0105" ref-type="bibr">105</xref>,<xref rid="cit0120" ref-type="bibr">120</xref></sup> Gut commensal microorganisms influence mucosal immunity through the development of Tregs within the colon, which is mediated through SCFAs.<sup><xref rid="cit0120" ref-type="bibr">120</xref></sup> By increasing epithelial barrier function and inducing various anti-inflammatory effects, the SCFAs strengthen the gut&#x2019;s function and integrity,<sup><xref rid="cit0005" ref-type="bibr">5</xref></sup> modulate respiratory diseases,<sup><xref rid="cit0013" ref-type="bibr">13</xref></sup> prevent the development of inflammatory disorders, e.g., allergy, arthritis, and colitis,<sup><xref rid="cit0002" ref-type="bibr">2</xref></sup> regulate the metabolism of lipids and glucose,<sup><xref rid="cit0005" ref-type="bibr">5</xref></sup> and inhibit the buildup of potentially harmful metabolic by-products, such as D-lactate.<sup><xref rid="cit0041" ref-type="bibr">41</xref></sup> SCFAs play a role in the expression of Foxp3 (Forkhead box protein P3) that helps in regulating the development and function of Tregs, thus improving the regulatory T cell function.<sup><xref rid="cit0126" ref-type="bibr">126</xref>,<xref rid="cit0127" ref-type="bibr">127</xref></sup> The anti-inflammatory effects by SCFAs are aided by G-protein coupled receptor 43, TGF-&#x3B2;, and/or IL-10, in addition to Tregs.<sup><xref rid="cit0128" ref-type="bibr">128</xref></sup> On the skin, the anti-inflammatory actions could be mediated through resident Tregs, which become less abundant in certain inflammatory dermatoses.<sup><xref rid="cit0120" ref-type="bibr">120</xref></sup> SCFAs derived from fiber through the gut can also influence the prevalence of certain skin microbial groups, which subsequently affect cutaneous immune defense mechanisms. By preventing the growth of harmful bacteria on the skin and lowering inflammation, the skin microbiome can collaborate with the immune system to promote skin homeostasis.<sup><xref rid="cit0026" ref-type="bibr">26</xref></sup> For example, propionic acid, which is formed during the fermentation of dietary fiber by the <italic toggle="yes">Propionibacterium</italic> genus, is antibacterial and can kill the most prevalent community-acquired methicillin-resistant <italic toggle="yes">Staphylococcus aureus</italic> strains USA300.<sup><xref rid="cit0002" ref-type="bibr">2</xref></sup></p>
        </sec>
        <sec disp-level="3" id="s0002-s2006-s3005">
          <title>Antibiotics</title>
          <p>One of the most well-studied effects on the gut microbiome is that of antibiotics. They have the potential to change the composition and function of the gut microbiome by killing or inhibiting the growth of specific microbial groups and by changing the molecular patterns associated with the microbiome. The effect of antimicrobials on the gut microbiome leads to dysbiosis,<sup><xref rid="cit0108" ref-type="bibr">108</xref></sup> and consequently, skin abnormalities may occur. For example, oral administration of vancomycin for the treatment of skin wounds reduced bacterial diversity and regenerating gene III gamma (RegIII&#x3B3;) expression, potentially delaying wound-healing repair mechanisms.<sup><xref rid="cit0226" ref-type="bibr">226</xref></sup> Antibiotic use, over time, leads to spread of antibacterial resistance and a decline in non-target bacterial populations, which can result in flourishment of pathogenic bacteria or fungi.<sup><xref rid="cit0111" ref-type="bibr">111</xref>,<xref rid="cit0129" ref-type="bibr">129</xref></sup> For example, the use of a set of antimicrobials, levofloxacin and moxifloxacin, is associated with significantly increased numbers of <italic toggle="yes">Candida</italic> species in the human gut.<sup><xref rid="cit0130" ref-type="bibr">130</xref></sup> The yeast <italic toggle="yes">Candida</italic> can colonize the small intestine and manifest as skin redness, which in turn accelerates aging.<sup><xref rid="cit0131" ref-type="bibr">131</xref></sup></p>
        </sec>
        <sec disp-level="3" id="s0002-s2006-s3006">
          <title>Prebiotics</title>
          <p>International Scientific Association for Probiotics and Prebiotics (ISAPP) declares that the substrates that upon utilization by microorganisms provide useful properties to the host are prebiotics.<sup><xref rid="cit0132" ref-type="bibr">132</xref></sup> They play a significant role in enhancing the number of gut microbes and their function.<sup><xref rid="cit0133" ref-type="bibr">133</xref>,<xref rid="cit0134" ref-type="bibr">134</xref></sup> Prebiotics, such as fructooligosaccharides, galactooligosaccharides, inulin, polydextrose, lactulose, sorbitol, and xylitol are a promising group of compounds that modulate the gut microbiome and can also provide skin benefits.<sup><xref rid="cit0135" ref-type="bibr">135</xref></sup> The prebiotics, galactooligosaccharides (GOS), are one of the major components of breast milk that can be fermented into SCFAs by members in the genus <italic toggle="yes">Bifidobacterium</italic>. This was shown by the number of human milk oligosaccharides (HMOs) decreasing in feces along with the increased presence of <italic toggle="yes">Bifidobacterium</italic> genera. HMO utilization by <italic toggle="yes">Bifidobacterium</italic> spp. can be considered as a prebiotic impact on the infant gut microbiome. Similarly, the human milk fatty acid palmitate plays a prebiotic effect on the infant gut microbiome by positively influencing the abundance of <italic toggle="yes">Bifidobacterium</italic> spp. and <italic toggle="yes">Lactobacillus</italic> spp.<sup><xref rid="cit0043" ref-type="bibr">43</xref></sup></p>
          <p>The effect of prebiotics on the skin condition is also obvious. For example, a <italic toggle="yes">Lactobacillus</italic> extract helps to reduce the size of acne lesions as well as inflammation by reducing skin erythema, improving skin barrier function and lowering the microbial counts on skin.<sup><xref rid="cit0136" ref-type="bibr">136</xref></sup> Furthermore, GOSs have been used in the treatment of photoaging diseases for decades.<sup><xref rid="cit0137" ref-type="bibr">137</xref></sup> In a study, the combination of GOS and <italic toggle="yes">Bifidobacterium</italic> reduced trans-epidermal water loss (TEWL or TWL) and prevented skin erythema.<sup><xref rid="cit0137" ref-type="bibr">137</xref>,<xref rid="cit0138" ref-type="bibr">138</xref></sup> Atopic dermatitis and eczema have also been treated with GOS.<sup><xref rid="cit0139" ref-type="bibr">139</xref></sup> Another prebiotic (carbohydrate) derived metabolite, sodium butyrate,<sup><xref rid="cit0140" ref-type="bibr">140</xref></sup> is commonly used to treat hyperproliferative skin diseases (including psoriasis) through its modulation of key cellular processes, such as differentiation, proliferation, and apoptosis.<sup><xref rid="cit0137" ref-type="bibr">137</xref></sup> Sodium butyrate is a compound derived from the gut microbiome that commonly affects the cell cycle, protease enzymes, and tumor growth factors (TGF-&#x3B2;). Apoptosis in keratinocyte (HaCaT) cells can be induced by sodium butyrate through up-regulation of the Fas receptor (death receptor) with the concomitant triggering of caspases 8 and 3. Another effect is an induced expression of p52 and TGF-&#x3B2;, suggesting a connection with cell proliferation and terminal differentiation.<sup><xref rid="cit0137" ref-type="bibr">137</xref></sup> Differentiation of keratinocytes can also be enhanced by the joint action of sodium butyrate and PD153035 (an epidermal growth factor receptor inhibitor).<sup><xref rid="cit0141" ref-type="bibr">141</xref></sup></p>
        </sec>
        <sec disp-level="3" id="s0002-s2006-s3007">
          <title>Probiotics</title>
          <p>Probiotics are living organisms that, when consumed in sufficient proportions, confer health benefits. They can be formulated, for example, as food, drugs, and dietary supplements.<sup><xref rid="cit0006" ref-type="bibr">6</xref>,<xref rid="cit0113" ref-type="bibr">113</xref>,<xref rid="cit0142" ref-type="bibr">142</xref></sup> Probiotics can prevent gut colonization by pathogens and support anti-inflammatory responses by producing metabolites with anti-inflammatory properties. The most common probiotic microbes currently in use belong to the genera <italic toggle="yes">Bacillus, Bifidobacterium, Enterococcus, Escherichia, Lactobacillus, Saccharomyces</italic>, and <italic toggle="yes">Streptococcus</italic>.<sup><xref rid="cit0143" ref-type="bibr">143</xref>,<xref rid="cit0144" ref-type="bibr">144</xref></sup> Several beneficial effects of probiotic consumption have been demonstrated on many dermatological conditions, thus proving the existence of the gut-skin axis. For example, skin sensitivity and significant restoration of skin barrier function were reported in individuals after daily oral administration of <italic toggle="yes">Lactobacillus paracasei</italic>.<sup><xref rid="cit0145" ref-type="bibr">145</xref></sup> In a study conducted on mice, addition of <italic toggle="yes">Lactobacillus reuteri</italic> to drinking water resulted in improved epidermal thickness, increased folliculogenesis, lower skin pH, and enhanced production of sebum-producing epithelial cells. Accordingly, mice provided with the supplemented water had shinier and thicker fur than those that did not receive the probiotic.<sup><xref rid="cit0002" ref-type="bibr">2</xref>,<xref rid="cit0003" ref-type="bibr">3</xref></sup> In another experiment, administration of <italic toggle="yes">Lactobacillus johnsonii</italic> in mice exhibited a therapeutic effect in restoring skin damage after exposure to UV radiation.<sup><xref rid="cit0015" ref-type="bibr">15</xref></sup> The beneficial role of probiotics in preventing dermatological diseases has also been shown. For example, administration of <italic toggle="yes">E. coli</italic> strain Nissle improved skin health in patients with acne vulgaris.<sup><xref rid="cit0015" ref-type="bibr">15</xref>,<xref rid="cit0146" ref-type="bibr">146</xref></sup> Orally administered doxycycline and probiotics were effective in a study in patients suffering from rosacea.<sup><xref rid="cit0135" ref-type="bibr">135</xref></sup> In another study, the probability of developing atopic dermatitis was decreased throughout the postnatal period in mice by <italic toggle="yes">Lactobacillus sakei</italic> WIKIM30 consumption. The mice that had probiotics exhibited altered gut microbial composition along with improved skin lesions due to induction of Tregs. The risk of atopic dermatitis development was also found considerably lower in children who took probiotic supplements in the post-neonatal period of life.<sup><xref rid="cit0015" ref-type="bibr">15</xref></sup></p>
        </sec>
        <sec disp-level="3" id="s0002-s2006-s3008">
          <title>Novel biologic drugs</title>
          <p>&#x2018;Novel biologics&#x2019; refers to substances generated from products of biological entities and may become therapeutic for dermatological conditions.<sup><xref rid="cit0147" ref-type="bibr">147</xref></sup> A few immune-based diseases are now being treated with novel biologic drugs by therapeutic manipulation. Some therapeutic biologicals authorized by the European Medicines Agency are Adalimumab (Humira), Infliximab (Remicade), Rituximab (MabThera), and Etanercept (Enbrel). All of these drugs have a direct involvement with skin and gastrointestinal tract.<sup><xref rid="cit0148" ref-type="bibr">148</xref>,<xref rid="cit0149" ref-type="bibr">149</xref></sup> Among all intrinsic and extrinsic factors, drugs are indicated as the major one that can remarkably interrupt gut microbial ecology. Gut microbial composition may be affected by drugs in two common ways. First, drugs can influence the translocation of microbes from other body parts to the intestine, and secondly, they can affect the local bacterial growth directly.<sup><xref rid="cit0150" ref-type="bibr">150</xref></sup> Biologics such as Etanercept and Infliximab, which are used to treat psoriasis, may affect some microbial species, e.g. <italic toggle="yes">Clostridium citroniae</italic>, <italic toggle="yes">Collinsella aerofaciens</italic>, <italic toggle="yes">Dorea formicigenerans</italic>, <italic toggle="yes">Parabacteroides distasonis</italic>, <italic toggle="yes">Prevotella copri</italic>, and <italic toggle="yes">Ruminococcus gnavus</italic>.<sup><xref rid="cit0149" ref-type="bibr">149</xref>,<xref rid="cit0151" ref-type="bibr">151</xref></sup></p>
          <p>Technological advancements have opened up new possibilities for the selection and manufacture of monoclonal antibodies that target specific diseases.<sup><xref rid="cit0149" ref-type="bibr">149</xref></sup> For example, the only monoclonal antibody authorized for individuals suffering from chronic spontaneous urticaria is omalizumab. These novel biologics are regarded as an efficient and safe treatment, but their availability and high cost severely impair their usefulness.<sup><xref rid="cit0152" ref-type="bibr">152</xref></sup></p>
        </sec>
      </sec>
      <sec disp-level="2" id="s0002-s2007">
        <title>The link between gut and skin disease</title>
        <p>Although a healthy gut is essential for host health, gut microbiome overgrowth and changes in diversity can result in a skin disease. Specific metabolic byproducts of gut microbes can directly influence normal physiology and disease processes,<sup><xref rid="cit0005" ref-type="bibr">5</xref></sup> as discussed in previous paragraphs. Factors that influence the diversity and composition of the gut microbial community can be grouped into categories, namely non-host factors (such as environmental determinants), host factors (such as pancreatic enzymes, bile acids, pH), and bacterial factors (such as microbial enzymes, adhesive ability).<sup><xref rid="cit0225" ref-type="bibr">225</xref></sup> Gut dysbiosis<sup><xref rid="cit0153" ref-type="bibr">153</xref></sup> negatively impacts skin health and is considered to contain biomarkers such as free phenol, p-cresol, and aromatic amino acid derivatives produced by a disturbed gut.<sup><xref rid="cit0003" ref-type="bibr">3</xref></sup> Dysbiosis in the gut contributes to the three common skin disorders: psoriasis, atopic dermatitis, and acne.<sup><xref rid="cit0002" ref-type="bibr">2</xref></sup> There are also reports on the association of gut dysbiosis with some less common but potentially more serious diseases, such as rosacea, alopecia areata, hidradenitis suppurativa,<sup><xref rid="cit0015" ref-type="bibr">15</xref></sup> erythema nodosum, and pyoderma gangrenosum.<sup><xref rid="cit0135" ref-type="bibr">135</xref></sup> Furthermore, epidemiological studies and clinical trials suggest that modulation of the gut microbiome may influence susceptibility to allergic diseases and asthma.<sup><xref rid="cit0154" ref-type="bibr">154</xref></sup></p>
        <p>The skin plays a crucial part in maintaining homeostasis of the body by performing several important functions, such as regulation of water balance and temperature control. For these functions to be performed, the skin must undergo a renewal and turnover process, known as skin regeneration. Once epidermal cells differentiate from stem cells, epidermal cells undergo a differentiation process called keratinization, which is regulated by specific transcriptional processes. The gut microbiome influences the signaling processes that maintain epidermal differentiation and thus affect skin homeostasis.<sup><xref rid="cit0155" ref-type="bibr">155</xref></sup> Several studies provided more information regarding a correlation between the gut microbiome and skin health. For example, the genetic material of gut bacteria has been identified in plasma samples of patients with psoriasis. In the study of 54 patients and 27 healthy controls, bacterial DNA was found in 16 out of 54 plaque psoriasis patients and was not detected in any controls. Furthermore, those patients with psoriasis were also detected with an increase in systemic inflammatory response markers (SIRs) such as IFN-&#x3B3;, IL-1&#x3B2;, IL-6, IL-12, and TNF compared with the healthy control. Sequencing of the bacterial DNA identified the same type of organisms commonly found in the gut flora, pointing toward a possible link between the gut microbiome with psoriasis.<sup><xref rid="cit0003" ref-type="bibr">3</xref>,<xref rid="cit0005" ref-type="bibr">5</xref>,<xref rid="cit0156" ref-type="bibr">156</xref></sup> Patients with Crohn&#x2019;s disease are also mostly encountered with psoriasis as a comorbidity.<sup><xref rid="cit0107" ref-type="bibr">107</xref>,<xref rid="cit0155" ref-type="bibr">155</xref></sup> Such findings suggest a correlation between altered gut microbiome and skin condition.<sup><xref rid="cit0002" ref-type="bibr">2</xref></sup>
<xref rid="t0002" ref-type="table">Table 2</xref> represents several human clinical studies that have used gut microbial interventions for human skin diseases. Next, we will take a closer look at the specific diseases where gut microbiome affects the development of the condition.<table-wrap position="float" id="t0002"><label>Table 2.</label><caption><p>Human clinical studies that have used gut microbial interventions for human skin diseases.</p></caption><!--OASIS TABLE HERE--><table frame="hsides" rules="groups"><colgroup><col width="1*" align="left"/><col width="1*" align="left"/><col width="1*" align="left"/><col width="1*" align="left"/></colgroup><thead><tr><th align="left">Participants</th><th align="left">Intervention</th><th align="left">Key findings</th><th align="left">References</th></tr></thead><tbody><tr><td align="left">43 children (aged 4&#x2013;17&#xA0;years)</td><td align="left"><italic toggle="yes">Bifidobacterium animalis</italic> subsp. <italic toggle="yes">lactis</italic> CECT 8145, <italic toggle="yes">Lactobacillus casei</italic> CECT 9104, and <italic toggle="yes">Bifidobacterium longum</italic> CECT 7347 (mixture) for 12 weeks.</td><td align="left">Reducing the severity of AD according to the SCORAD index</td><td align="left"><sup><xref rid="cit0233" ref-type="bibr">233</xref></sup></td></tr><tr><td align="left">50 children (aged 4 to 17&#xA0;years)</td><td align="left"><italic toggle="yes">Bifidobacterium lactis</italic> CECT8145, <italic toggle="yes">Bifidobacterium longum</italic> CECT 7347, and <italic toggle="yes">Lactobacillus casei</italic> CECT 9104 (mixture) for 12 weeks</td><td align="left">Reducing the severity of AD according to the SCORAD index</td><td align="left"><sup><xref rid="cit0234" ref-type="bibr">234</xref></sup></td></tr><tr><td align="left">31 patients (aged 18&#x2013;75&#xA0;years)</td><td align="left"><italic toggle="yes">Lactobacillus johnsonii</italic> NCC 533, twice daily for 3&#xA0;weeks</td><td align="left">Reducing the severity of AD according to the SCORAD index</td><td align="left"><sup><xref rid="cit0235" ref-type="bibr">235</xref></sup></td></tr><tr><td align="left">20 Caucasian adult</td><td align="left"><italic toggle="yes">Lactobacillus rhamnosus</italic> for 12 weeks</td><td align="left">Reducing the acne severity</td><td align="left"><sup><xref rid="cit0236" ref-type="bibr">236</xref></sup></td></tr><tr><td align="left">101 Japanese female students (aged 18&#x2013;23&#xA0;years)</td><td align="left"><italic toggle="yes">B. breve</italic> strain Yakult (YIT 12272), <italic toggle="yes">Lactococcus lactis</italic> YIT 2027, and <italic toggle="yes">Streptococcus thermophilus</italic> YIT 2021 (mixture) for 4&#xA0;weeks</td><td align="left">Enhancing stool consistency, defecation frequency, and feces quantity to maintain healthy skin</td><td align="left"><sup><xref rid="cit0237" ref-type="bibr">237</xref></sup></td></tr><tr><td align="left">110 volunteers (aged 41 and 59&#xA0;years)</td><td align="left"><italic toggle="yes">Lactobacillus plantarum</italic> HY7714 for 12 weeks</td><td align="left">Enhancing skin hydration, reduction of wrinkle depth, and overall skin shine and elasticity</td><td align="left"><sup><xref rid="cit0238" ref-type="bibr">238</xref></sup></td></tr><tr><td align="left">166 pregnant women</td><td align="left"><italic toggle="yes">Bifidobacterium breve</italic> M-16&#xA0;V and <italic toggle="yes">Bifidobacterium longum</italic> BB536 for 4&#xA0;weeks</td><td align="left">Reducing the risk of newborns eczema</td><td align="left"><sup><xref rid="cit0239" ref-type="bibr">239</xref></sup></td></tr><tr><td align="left">45 females (aged 18 to 35&#xA0;years)</td><td align="left"><italic toggle="yes">Lactobacillus acidophilus</italic>,<break/><italic toggle="yes">Lactobacillus delbrueckii</italic>, and <italic toggle="yes">Bifidobacterium bifidum</italic> (mixture) for 12 weeks</td><td align="left">Improving the total lesion for acne patients</td><td align="left"><sup><xref rid="cit0240" ref-type="bibr">240</xref></sup></td></tr><tr><td align="left">26 male and female (aged 18&#x2013;60&#xA0;years)</td><td align="left"><italic toggle="yes">Bifidobacterium infantis 35624</italic> for 6&#x2012;8&#xA0;weeks</td><td align="left">Improving the CRP levels in psoriasis patients</td><td align="left"><sup><xref rid="cit0170" ref-type="bibr">170</xref></sup></td></tr><tr><td align="left">30 women (aged 30&#x2013;48&#xA0;years)</td><td align="left"><italic toggle="yes">L. lactis strain</italic> H61 (60 mg), daily for 8&#xA0;weeks</td><td align="left">Improving hair follicles and skin hydration</td><td align="left"><sup><xref rid="cit0241" ref-type="bibr">241</xref></sup></td></tr><tr><td align="left">A woman (aged 47&#xA0;years)</td><td align="left"><italic toggle="yes">Lactobacillus sporogenes</italic> and biotin (mixture)</td><td align="left">Reducing the risk of psoriasis</td><td align="left"><sup><xref rid="cit0242" ref-type="bibr">242</xref></sup></td></tr><tr><td align="left">20 children (aged 4&#x2013;15&#xA0;years)</td><td align="left"><italic toggle="yes">L. acidophilus</italic> L-92 strain for 8&#xA0;weeks</td><td align="left">Effective as Serum Markers of Atopic Dermatitis in Children</td><td align="left"><sup><xref rid="cit0243" ref-type="bibr">243</xref></sup></td></tr><tr><td align="left">56 Patients (aged 18 to 30&#xA0;years)</td><td align="left"><italic toggle="yes">L. bulgaricus</italic> and <italic toggle="yes">Streptococcus thermophilus</italic><break/>for 12 weeks</td><td align="left">Reducing the severity of acne vulgaris by selectively lowering TGs in skin surface lipids.</td><td align="left"><sup><xref rid="cit0244" ref-type="bibr">244</xref></sup></td></tr><tr><td align="left">66 female volunteers (aged 35&#x2013;45&#xA0;years)</td><td align="left"><italic toggle="yes">Bifidobacterium longum</italic>, twice daily for 2&#xA0;months</td><td align="left">Improving skin hydration and physical aggression</td><td align="left"><sup><xref rid="cit0245" ref-type="bibr">245</xref></sup></td></tr><tr><td align="left">70 patients (12&#xA0;years of age or older)</td><td align="left"><italic toggle="yes">Enterococcus faecalis</italic> SL-5 for 8&#xA0;weeks</td><td align="left">Improving the severity of acne</td><td align="left"><sup><xref rid="cit0246" ref-type="bibr">246</xref></sup></td></tr><tr><td align="left">474 patients</td><td align="left"><italic toggle="yes">Lactobacillus rhamnosus</italic> for 35&#xA0;weeks</td><td align="left">Reducing the risk of eczema</td><td align="left"><sup><xref rid="cit0247" ref-type="bibr">247</xref></sup></td></tr><tr><td align="left">59 patients</td><td align="left"><italic toggle="yes">Lactobacillus rhamnosus</italic> and <italic toggle="yes">Bifidobacterium</italic><break/><italic toggle="yes">lactis</italic> for 12 weeks</td><td align="left">Reducing the severity of AD according to the SCORAD index</td><td align="left"><sup><xref rid="cit0248" ref-type="bibr">248</xref></sup></td></tr><tr><td align="left">56 children (aged 6&#x2013;18&#xA0;months)</td><td align="left"><italic toggle="yes">Lactobacillus fermentum</italic> VRI-033 PCC for 8&#xA0;weeks</td><td align="left">Reducing the severity of AD according to the SCORAD index</td><td align="left"><sup><xref rid="cit0249" ref-type="bibr">249</xref></sup></td></tr><tr><td align="left">41 children (aged 1&#x2013;13&#xA0;years)</td><td align="left"><italic toggle="yes">Lactobacillus rhamnosus</italic> 19070<italic toggle="yes">&#x2013;2</italic> and <italic toggle="yes">Lactobacillus reuteri</italic> DSM 12246 for 6&#xA0;weeks</td><td align="left">Reducing the severity of atopic eczema</td><td align="left"><sup><xref rid="cit0250" ref-type="bibr">250</xref></sup></td></tr><tr><td align="left">159 pregnant<break/>women</td><td align="left"><italic toggle="yes">Lactobacillus rhamnosus</italic> strain GG for 4&#xA0;weeks</td><td align="left">Reducing the severity of atopic eczema</td><td align="left"><sup><xref rid="cit0251" ref-type="bibr">251</xref></sup></td></tr><tr><td align="left">159 patients</td><td align="left"><italic toggle="yes">Lactobacillus</italic> GG for 4&#xA0;weeks</td><td align="left">Reducing the severity of atopic eczema in children</td><td align="left"><sup><xref rid="cit0252" ref-type="bibr">252</xref></sup></td></tr><tr><td align="left">27 infants</td><td align="left"><italic toggle="yes">Bifidobacterium lactis</italic> Bb-12 or <italic toggle="yes">Lactobacillus</italic> strain GG (ATCC 53103)</td><td align="left">Reducing the severity of atopic eczema</td><td align="left"><sup><xref rid="cit0253" ref-type="bibr">253</xref></sup></td></tr></tbody></table></table-wrap></p>
      </sec>
      <sec disp-level="2" id="s0002-s2008">
        <title>Psoriasis</title>
      </sec>
      <sec disp-level="2" id="s0002-s2009">
        <p>Psoriasis is a systemic autoimmune condition associated with improper activation of immune-mediated pathways that drive the immune cells to attack self-skin cells, subsequently resulting in increased levels of pro-inflammatory cytokines. Inflammatory bowel disease (IBD), a second known comorbidity of psoriasis, is associated with the gut microbiome through development of pro-inflammatory Th17 cells.<sup><xref rid="cit0005" ref-type="bibr">5</xref>,<xref rid="cit0157" ref-type="bibr">157</xref></sup> A reduction in the abundance of potentially beneficial microbes in psoriasis patients could alter balance of immune system, thus affecting skin health.<sup><xref rid="cit0158" ref-type="bibr">158</xref>,<xref rid="cit0159" ref-type="bibr">159</xref></sup> Specifically, psoriasis patients have reduced numbers of Bacteroidetes (including the <italic toggle="yes">Bacteroides</italic> genus), Proteobacteria, and Actinobacteria along with relatively low amounts of <italic toggle="yes">Akkermansia muciniphila</italic><sup><xref rid="cit0015" ref-type="bibr">15</xref>,<xref rid="cit0160" ref-type="bibr">160</xref>,<xref rid="cit0161" ref-type="bibr">161</xref></sup> and a lower prevalence of the phylum Firmicutes.<sup><xref rid="cit0162" ref-type="bibr">162</xref></sup> A reduced abundance of <italic toggle="yes">Akkermansia</italic> and <italic toggle="yes">Ruminoccocus</italic> was also observed in patients with psoriasis, psoriatic arthritis (PsA), and IBD.<sup><xref rid="cit0159" ref-type="bibr">159</xref>,<xref rid="cit0160" ref-type="bibr">160</xref>,<xref rid="cit0163" ref-type="bibr">163</xref></sup></p>
        <p>Biomarkers of a damaged intestinal barrier, such as elevated levels of claudin-3 and intestinal fatty acid-binding protein, have been observed among psoriasis patients.<sup><xref rid="cit0015" ref-type="bibr">15</xref></sup> Furthermore, microbial production of TMAO upon utilization of choline can lead to psoriasis.<sup><xref rid="cit0106" ref-type="bibr">106</xref>,<xref rid="cit0124" ref-type="bibr">124</xref></sup> Several studies have shown that <italic toggle="yes">Bacteroides</italic> produces polysaccharide A, activates Tregs and promotes the anti-inflammatory response.<sup><xref rid="cit0158" ref-type="bibr">158</xref>,<xref rid="cit0164" ref-type="bibr">164&#x2013;166</xref></sup> Thus, a remarkable reduction in <italic toggle="yes">Bacteroides</italic> count in psoriasis could lead to immune alteration and pro-inflammatory response.<sup><xref rid="cit0158" ref-type="bibr">158</xref></sup> As the natural colonizers of the mucin layer in the human gut, <italic toggle="yes">Akkermansia muciniphila</italic> and <italic toggle="yes">Ruminoccocus</italic> prevent pathogen colonization by competitive inhibition.<sup><xref rid="cit0157" ref-type="bibr">157</xref>,<xref rid="cit0159" ref-type="bibr">159</xref>,<xref rid="cit0167" ref-type="bibr">167</xref>,<xref rid="cit0168" ref-type="bibr">168</xref></sup> Moreover, <italic toggle="yes">Bacteroides, Akkermansia muciniphila</italic> and <italic toggle="yes">Ruminoccocus</italic> produce SCFAs.<sup><xref rid="cit0126" ref-type="bibr">126</xref></sup> Therefore, the reduction of these beneficial microbes results in the impairment of the gut barrier function, promoting bacterial translocation from the gut into the systemic circulation in psoriasis patients.<sup><xref rid="cit0126" ref-type="bibr">126</xref>,<xref rid="cit0156" ref-type="bibr">156</xref>,<xref rid="cit0166" ref-type="bibr">166</xref></sup></p>
        <p>Oral administration of antibiotics, prebiotics, probiotics, and newly developed fecal transplantation are promising therapeutic methods for psoriasis.<sup><xref rid="cit0169" ref-type="bibr">169</xref></sup> Probiotics have been shown to improve the disease course of psoriasis by increasing TNF-&#x3B1; (tumor necrosis factor alpha) production by epithelial cells, by improving the barrier function, and by regulating the NF-k&#x3B2; (Nuclear factor kappa B) pathway that affects the development of psoriasis pathogenesis.<sup><xref rid="cit0169" ref-type="bibr">169</xref></sup> A study by Groeger and colleagues in 2013 found that <italic toggle="yes">Bifidobacterium infantis</italic> 35624 supplementation significantly decreased plasma levels of TNF-&#x3B1;, IL-6, and C-reactive protein (CRP) (the markers of inflammation in the body) among psoriasis sufferers.<sup><xref rid="cit0170" ref-type="bibr">170</xref></sup> Although studies have shown that probiotic treatments lead to a significant change in skin inflammation, there is still no evidence to support their use in the treatment of psoriasis. Therefore, further research is needed in this field.<sup><xref rid="cit0171" ref-type="bibr">171</xref></sup></p>
      </sec>
      <sec disp-level="2" id="s0002-s2010">
        <title>Atopic dermatitis (eczema)</title>
        <p>Several investigations on the role of gut microbiome in the pathogenesis of atopic dermatitis (AD) in infants and children suggest that infants with limited heterogeneity in the gut microbiome develop AD later in life.<sup><xref rid="cit0005" ref-type="bibr">5</xref>,<xref rid="cit0172" ref-type="bibr">172&#x2013;175</xref></sup> This is contradicting to other results, which suggest that gut microbial diversity facilitates AD. For example, a lower abundance of <italic toggle="yes">Bifidobacterium</italic> in the gut was observed in patients with AD compared to healthy controls.<sup><xref rid="cit0015" ref-type="bibr">15</xref>,<xref rid="cit0176" ref-type="bibr">176</xref>,<xref rid="cit0177" ref-type="bibr">177</xref></sup> However, alteration of gut microbial composition alone cannot promote the development of AD. Interaction of specific microbes with the immune system, together with other external factors, such as diet, could better explain the pathogenesis of AD. The immunopathology behind AD prognosis is linked with an imbalance of Th1 and Th2. The effector skin-resident dendritic cells of AD patients travel to the local lymph node where they activate the na&#xEF;ve T lymphocytes and induce their differentiation into effector Th2 subtype of effector T lymphocytes.<sup><xref rid="cit0223" ref-type="bibr">223</xref></sup> Once activated and recruited back to the skin, Th2s substantially produce inflammatory cytokines, such as IL-4, IL-5, and IL-13, which ultimately causes enhanced production of IgE, commonly found in AD patient.<sup><xref rid="cit0178" ref-type="bibr">178</xref>,<xref rid="cit0223" ref-type="bibr">223</xref></sup></p>
        <p>Two metagenomic studies conducted in South Korea analyzed fecal samples of patients with AD and revealed a decreased abundance in <italic toggle="yes">Faecalibacterium prausnitzii</italic> along with a significant reduction in SCFA production when compared with healthy controls.<sup><xref rid="cit0002" ref-type="bibr">2</xref>,<xref rid="cit0179" ref-type="bibr">179</xref>,<xref rid="cit0180" ref-type="bibr">180</xref></sup> According to a study, dysbiosis of <italic toggle="yes">F. prausnitzii</italic> in patients with AD was associated with an increased expression of a variety of nutrients. These nutrients, such as the mucin components GalNAc and L-fucose, are released from damaged gut epithelium, indicating a leaky gut and dysregulation of inflammation of the gut epithelium. Increased gut permeability was identified due to damaged gut epithelium, allowing various toxins, food residues, and pathogens to access blood circulation. The metabolites and toxins ultimately paved their way to the skin and induced Th2-type immune responses by releasing pro-inflammatory cytokines, which underlies the prognosis of AD.<sup><xref rid="cit0180" ref-type="bibr">180</xref></sup></p>
        <p>Zheng et al.<sup><xref rid="cit0181" ref-type="bibr">181</xref></sup> demonstrated that an increased abundance of <italic toggle="yes">Akkermansia muciniphila</italic> in infants with AD is associated with intestinal barrier dysfunction and skin lesion deterioration.<sup><xref rid="cit0015" ref-type="bibr">15</xref>,<xref rid="cit0181" ref-type="bibr">181</xref></sup> In addition to, or potentially mediated by the gut microbiome, diet may also impact AD. For example, a gluten-containing diet can impair the intestinal barrier, causing leaky gut, and gluten sensitivity is associated with gut dysbiosis.<sup><xref rid="cit0135" ref-type="bibr">135</xref>,<xref rid="cit0182" ref-type="bibr">182</xref>,<xref rid="cit0183" ref-type="bibr">183</xref></sup> According to a recent study, probiotic lactobacilli and enterococci of human origin can help to improve gut microbiome dysbiosis, and hence could be used as a treatment for disorders involving low SCFA synthesis in the gut.<sup><xref rid="cit0184" ref-type="bibr">184</xref></sup> Furthermore, Fecal microbiota transplant (FMT) could be a potential therapeutic option for AD.<sup><xref rid="cit0185" ref-type="bibr">185</xref></sup> However, research-oriented studies in this section are required to gain a better insight for future therapeutic interventions.</p>
      </sec>
      <sec disp-level="2" id="s0002-s2011">
        <title>Acne vulgaris</title>
        <p>Acne vulgaris is identified by inflammatory skin lesions (papules and pustules), non&#x2010;inflammatory comedones, or a combination of the two.<sup><xref rid="cit0015" ref-type="bibr">15</xref>,<xref rid="cit0135" ref-type="bibr">135</xref></sup> Several studies have indicated a correlation of gut dysbiosis with acne vulgaris. A recent investigation revealed a significant reduction in the prevalence of <italic toggle="yes">Actinobacteria, Bifidobacterium, Butyricicoccus, Coprobacillus</italic>, and <italic toggle="yes">Lactobacillus</italic> species along with an increased abundance of Proteobacteria in persons with acne vulgaris.<sup><xref rid="cit0015" ref-type="bibr">15</xref></sup> According to a hypothesis, sterol regulatory element-binding protein 1 (SREBP-1), sebum fatty acid, and sebum triglyceride become stimulated by nutrient signaling disruption and lead to flourishment of <italic toggle="yes">Propionibacterium acnes</italic>.<sup><xref rid="cit0186" ref-type="bibr">186</xref></sup> In addition to the gut microbiome, various metabolic pathways also influence the pathophysiology of acne vulgaris, such as the mTOR pathway, which becomes activated by high glycemic load. The high glycemic load is the sole contributor to increased insulin/insulin-like growth factor (IGF-1) signaling, enhancing the cytoplasmic expression of FoxO1 (Forkhead box transcription factor O1). FoxO1 then stimulates the mammalian target of rapamycin complex 1 (mTORC1), which ultimately leads to acne development.<sup><xref rid="cit0002" ref-type="bibr">2</xref></sup></p>
        <p>Besides the mTOR pathway, high-fat diet has an influence on acne development.<sup><xref rid="cit0187" ref-type="bibr">187</xref></sup> Guo et al. found that there is a lower release rate of AMPs in the small intestine of mice due to high-fat diet, which promotes growth of Firmicutes than Bacteroidetes, resulting in dysbiosis and alteration of serological cytokine levels that promote inflammation.<sup><xref rid="cit0188" ref-type="bibr">188</xref></sup> Several acne patients have also been found to develop Hyperchlorhydria (low level of stomach acid). Low acidity levels allow colonic bacteria to migrate to the distal region of the small intestine, creating conditions for intestinal dysbiosis and growth of small intestinal bacteria, which can increase intestinal permeability and promote inflammation of the skin.<sup><xref rid="cit0189" ref-type="bibr">189</xref></sup></p>
        <p>Noureldein &amp; Eid<sup><xref rid="cit0190" ref-type="bibr">190</xref></sup> demonstrated that the inhibition of mTORC1 together with changes in the gut microbiome improve the level of glucose tolerance and reduce hyperinsulinemia. Supporting this hypothesis, a reduced level of acne lesion was found in patients supplied with a low glycemic load diet for 12 weeks.<sup><xref rid="cit0191" ref-type="bibr">191</xref></sup> Also, probiotics may reduce acne inflammation by reducing levels of inflammatory cytokines, by increasing CD8 cell recruitment, by suppressing IL&#x2212;1&#x3B1;, and by activating Tregs.<sup><xref rid="cit0112" ref-type="bibr">112</xref>,<xref rid="cit0192" ref-type="bibr">192</xref></sup></p>
      </sec>
      <sec disp-level="2" id="s0002-s2012">
        <title>Rosacea</title>
        <p>Rosacea is a common dermatological condition that is characterized by pustules, persistent erythema, excessive fibrous tissue proliferation, papules, telangiectasia, and periocular changes. The coexistence of several gastrointestinal comorbidities with rosacea has been observed, which connects the condition with altered gut microbiome.<sup><xref rid="cit0015" ref-type="bibr">15</xref>,<xref rid="cit0107" ref-type="bibr">107</xref>,<xref rid="cit0161" ref-type="bibr">161</xref></sup> Moreover, <italic toggle="yes">H. pylori</italic> infection, IBD, and small intestinal bacterial overgrowth (SIBO) are potentially associated with the pathogenesis of rosacea.<sup><xref rid="cit0015" ref-type="bibr">15</xref>,<xref rid="cit0135" ref-type="bibr">135</xref>,<xref rid="cit0161" ref-type="bibr">161</xref></sup> The crosstalk between the immune system and the gut-associated diseases further demonstrates the link between gut and rosacea. According to reports, the role of <italic toggle="yes">H. pylori</italic> in rosacea pathogenesis is associated with several immune-pathological and inflammatory mediators and toxic factors.<sup><xref rid="cit0193" ref-type="bibr">193&#x2013;195</xref></sup> For example, <italic toggle="yes">H. pylori</italic> can substantially increase ROS generation (Reactive oxygen species), which has an inflammatory effect on the gut. Among the ROS, NO (nitric oxide) causes inflammation of the gut mucosa and alters the skin physiological processes, including vasodilation, inflammation and immunomodulation, ultimately resulting in the clinical manifestations associated with rosacea.<sup><xref rid="cit0194" ref-type="bibr">194</xref></sup> Another mechanism justifying the role of <italic toggle="yes">H. pylori</italic> in rosacea development is the production of a cytotoxin, which induces the production of pro-inflammatory cytokines such as TNF-&#x3B1; and IL-8. As a result of these inflammatory cytokine releases, inflammation of gastric mucosa and clinical manifestation of rosacea are seen.<sup><xref rid="cit0193" ref-type="bibr">193</xref>,<xref rid="cit0194" ref-type="bibr">194</xref></sup></p>
        <p>The eradication of <italic toggle="yes">H. pylori</italic> reduces rosacea symptoms as well as associated gastrointestinal issues.<sup><xref rid="cit0196" ref-type="bibr">196</xref></sup>
<italic toggle="yes">Bacillus subtilis</italic>-3 is effective against <italic toggle="yes">H. pylori</italic>, allowing spore colonization of the gastrointestinal system and subsequent microbiome modification by permitting passage over the gastric barrier.<sup><xref rid="cit0197" ref-type="bibr">197</xref></sup> Many studies have shown that probiotics can be used to treat chronic inflammatory rosacea, which could be used as an additional therapy in patients.<sup><xref rid="cit0198" ref-type="bibr">198</xref>,<xref rid="cit0199" ref-type="bibr">199</xref></sup></p>
      </sec>
      <sec disp-level="2" id="s0002-s2013">
        <title>Alopecia areata (AA)</title>
        <p>AA, or spot baldness, is an autoimmune disorder in which the hair-loss pattern is in either a limited or all areas of the body. AA has no age restriction.<sup><xref rid="cit0015" ref-type="bibr">15</xref></sup> AA is an auto-immune disease where the auto-reactive T lymphocyte interacts with a follicular auto-antigen presented by perifollicular or follicular cell. Their interaction gives rise to activation and induction of the T Lymphocytes, especially Th1, to produce pro-inflammatory cytokines (such as IFN-&#x3B3;). IFN-&#x3B3; disrupts the anagen growth phase, ultimately resulting in hair loss and other manifestations of AA.<sup><xref rid="cit0200" ref-type="bibr">200</xref>,<xref rid="cit0201" ref-type="bibr">201</xref></sup></p>
        <p>When compared with a healthy population, a high proportion of persons with AA also exhibit ulcerative colitis, indicating an association of the gut with AA.<sup><xref rid="cit0015" ref-type="bibr">15</xref>,<xref rid="cit0200" ref-type="bibr">200</xref>,<xref rid="cit0202" ref-type="bibr">202</xref></sup> The driving force behind this association is accumulation of auto-reactive T lymphocytes that gain tolerance against apoptotic cell death, causing prolonged chronic inflammation and hair loss due to inflammatory cytokine (IFN-&#x3B3; and IL-2) production by the autoreactive Th1 cells.<sup><xref rid="cit0200" ref-type="bibr">200</xref></sup></p>
        <p>FMT is thought to be a safe and effective way to reestablish a healthy gut microbial ecosystem by delivering beneficial bacteria and nutrients directly or indirectly.<sup><xref rid="cit0203" ref-type="bibr">203</xref></sup> FMT could possibly be used to treat alopecia areata by restoring the homeostasis of the gut flora.<sup><xref rid="cit0204" ref-type="bibr">204</xref></sup></p>
      </sec>
      <sec disp-level="2" id="s0002-s2014">
        <title>Hidradenitis suppurativa</title>
        <p>HS is a chronic disorder of the skin characterized by inflammation of hair follicles in intertriginous areas.<sup><xref rid="cit0015" ref-type="bibr">15</xref></sup> The mechanism underlying this chronic disorder needs to be deeply researched, as very little evidence and studies are available for inferring correlation with the disease pathogenesis and gut microbiome. Although the pathogenesis of HS is not yet clear, follicular occlusion syndrome, disturbance of the inflammatory cytokines, such as TNF-&#x3B1;, IL-1&#xDF; and IL-17, and fluctuation in the microbial composition are known to be crucial.<sup><xref rid="cit0205" ref-type="bibr">205&#x2013;210</xref></sup> The possible linkage between HS pathology and altered gut microbiome is supported by some features that are found in both HS and acne vulgaris, such as the coexistence of IBD and metabolic syndrome, and a negative association with a high-sugar diet.<sup><xref rid="cit0015" ref-type="bibr">15</xref>,<xref rid="cit0211" ref-type="bibr">211</xref>,<xref rid="cit0212" ref-type="bibr">212</xref></sup> IBD was observed at high frequencies in patients with HS when compared with healthy controls. Persons with HS also had a significant reduction in <italic toggle="yes">Faecalibacterium prausnitzii</italic> and increased abundance of <italic toggle="yes">E. coli</italic> in their gut.<sup><xref rid="cit0015" ref-type="bibr">15</xref>,<xref rid="cit0213" ref-type="bibr">213</xref>,<xref rid="cit0214" ref-type="bibr">214</xref></sup></p>
        <p>Gut microbial dysbiosis can potentially induce HS by influencing skin microbes through mediating systemic inflammatory pathways.<sup><xref rid="cit0002" ref-type="bibr">2</xref>,<xref rid="cit0215" ref-type="bibr">215</xref></sup> According to an interesting hypothesis, colonic dysbiosis resulting from high-fat diet results in inflammatory cytokine (e.g., TNF-&#x3B1;, IL-1&#x3B2;, and IL-17) elevation, and ultimately in formation of HS lesion by enhancing matrix metalloproteinase levels.<sup><xref rid="cit0215" ref-type="bibr">215</xref></sup> Probiotics are considered an effective option in treating HS for restoring a healthy cutaneous microbiome, as they are capable of replenishing the abundance of <italic toggle="yes">Cutibacterium</italic> spp., <italic toggle="yes">Corynebacterium</italic>, and <italic toggle="yes">Staphylococcus</italic> within the communities.<sup><xref rid="cit0216" ref-type="bibr">216</xref></sup> Avoiding a high-fat diet can be a great secondary preventive measure for HS.<sup><xref rid="cit0217" ref-type="bibr">217</xref></sup> However, finding the potential primary preventive measure (e.g., microbial marker) for HS is still under rigorous research.</p>
      </sec>
    </sec>
    <sec disp-level="1" id="s0003">
      <title>Conclusion and future prospective</title>
      <p>Understanding the relationship between gut and skin microbial communities is an emerging area of research. A number of findings we have summarized here provides sufficient evidence for the existence of a skin&#x2013;gut axis. Although limited research is available on the pathobiological drivers on the gut-skin axis in disease, our review has provided a brief understanding on the linkage between the gut microbiome with skin diseases and indicated direction of potential future studies. Whereas specific skin diseases have been connected with gut health and the balance of microbiome within the gut, the exact mechanisms of influencing skin by intestinal microorganisms are to be elucidated. Besides acting through the immune system, catabolic products of diet and microbial compounds can impact the gut epithelium by altering gut physiology, leading to a variety of secretory products that circulate throughout the body and enter the skin. Skin commensal microbiome can be affected by the bioactive compounds, such as neurotransmitters, hormones, and SCFAs, which are the end-products of gut microbial metabolism. Ingested compounds and chemicals can thus have an immediate impact on the skin appearance and activity. However, the mechanisms behind this interaction are multifactorial and currently mainly based on theory. Further studies that can detail the fate of specific compounds (e.g., by labeling), being transferred from the intestine to the skin and their mechanism of action on skin cells and/or microbiome would be needed to positively prove such connection. For example, metabolites, such as ceramide,<sup><xref rid="cit0218" ref-type="bibr">218&#x2013;227</xref></sup> have been radioactively labeled prior to oral consumption and tracked on the skin of mice. Similar labeling studies on microbial products, such as SCFAs, would provide strong evidence toward direct effects of gut microbiome on the skin.</p>
      <p>Another line of research having many promising prospects on the gut-skin axis are dietary supplements promoting health of gut microbiome, including pre- and probiotics. This research area has been massively studied in the past due to many beneficial health effects of fermented foods. In our review, we have listed several connections of probiotics with the skin condition, for example, <italic toggle="yes">Lactobacillus reuteri</italic>, which improves epidermal thickness and increased folliculogenesis after ingestion by mice.<sup><xref rid="cit0003" ref-type="bibr">3</xref></sup> Further studies linking probiotics with skin would likely provide new significant knowledge on the importance of specific members of the gut microbial community in skin health. Linking together studies on probiotics and tracking of specific microbial products from gut to the skin could reveal exciting new information on the gut-skin axis in the future.</p>
    </sec>
  </body>
  <back>
    <sec disp-level="1" id="s0004">
      <title>Abbreviations</title>
      <p>
<def-list><def-item><term>AA</term><def><p>Alopecia areata</p></def></def-item><def-item><term>AD</term><def><p>Atopic dermatitis</p></def></def-item><def-item><term>AhR</term><def><p>Aryl hydrocarbon receptor</p></def></def-item><def-item><term>AMP</term><def><p>Antimicrobial peptides</p></def></def-item><def-item><term>COL1A1</term><def><p>Collagen type 1 alpha 1</p></def></def-item><def-item><term>COL1A2</term><def><p>Collagen type 1 alpha 2</p></def></def-item><def-item><term>CRP</term><def><p>C-reactive protein</p></def></def-item><def-item><term>CX3CR1</term><def><p>C-X3-C Motif Chemokine Receptor 1</p></def></def-item><def-item><term>DC</term><def><p>Dendritic cell</p></def></def-item><def-item><term>FoxO1</term><def><p>Forkhead box transcription factor O1</p></def></def-item><def-item><term>Foxp3</term><def><p>Forkhead box protein P3</p></def></def-item><def-item><term>FMT</term><def><p>Fecal microbiota transplant</p></def></def-item><def-item><term>GalNAc</term><def><p>N-Acetylgalactosamine</p></def></def-item><def-item><term>GABA</term><def><p>Gamma-aminobutyric acid</p></def></def-item><def-item><term>GALTs</term><def><p>Gut-associated lymphoid tissues</p></def></def-item><def-item><term>GI</term><def><p>Gastrointestinal</p></def></def-item><def-item><term>GM-CSF</term><def><p>Granulocyte-macrophage colony-stimulating factor</p></def></def-item><def-item><term>GOS</term><def><p>Galacto-oligosaccharides</p></def></def-item><def-item><term>HS</term><def><p>Hidradenitis suppurativa</p></def></def-item><def-item><term>HMO</term><def><p>Human milk oligosaccharide</p></def></def-item><def-item><term>IFN</term><def><p>Interferon</p></def></def-item><def-item><term>IBD</term><def><p>Inflammatory bowel disease</p></def></def-item><def-item><term>IEC</term><def><p>Intestinal epithelial cell</p></def></def-item><def-item><term>IgA</term><def><p>Immunoglobulin A</p></def></def-item><def-item><term>IgE</term><def><p>Immunoglobulin E</p></def></def-item><def-item><term>IGF</term><def><p>Insulin-like growth factor</p></def></def-item><def-item><term>IMID</term><def><p>Immune-mediated inflammatory diseases</p></def></def-item><def-item><term>IL-10</term><def><p>Interleukin 10</p></def></def-item><def-item><term>ILCs</term><def><p>Innate lymphoid cells</p></def></def-item><def-item><term>ILFs</term><def><p>Isolated lymphoid follicles&#xA0;</p></def></def-item><def-item><term>IL</term><def><p>Interleukin</p></def></def-item><def-item><term>IS</term><def><p>Indoxyl sulfate</p></def></def-item><def-item><term>ISAPP</term><def><p>International Scientific Association for Probiotics and Prebiotics</p></def></def-item><def-item><term>MAIT</term><def><p>Mucosal-associated invariant T cells</p></def></def-item><def-item><term>MALTs</term><def><p>Mucosa-associated lymphoid tissues</p></def></def-item><def-item><term>LTi</term><def><p>Lymphoid tissue inducer</p></def></def-item><def-item><term>MHC II</term><def><p>Major histocompatibility complex II</p></def></def-item><def-item><term>mLN</term><def><p>Mediastinal lymph node</p></def></def-item><def-item><term>MMP</term><def><p>Matrix metalloproteinase</p></def></def-item><def-item><term>MR1</term><def><p>Major histocompatibility complex class I-related gene protein</p></def></def-item><def-item><term>mTOR</term><def><p>Mammalian target of rapamycin</p></def></def-item><def-item><term>mTORC1</term><def><p>Mammalian target of rapamycin complex 1</p></def></def-item><def-item><term>NF-k&#x3B2;</term><def><p>Nuclear factor kappa B</p></def></def-item><def-item><term>NK</term><def><p>Natural Killer cells</p></def></def-item><def-item><term>NO</term><def><p>Nitric oxide</p></def></def-item><def-item><term>NLR</term><def><p>NOD like receptor</p></def></def-item><def-item><term>NOD</term><def><p>Nucleotide oligomerization domain</p></def></def-item><def-item><term>PRRs</term><def><p>Pattern-recognition receptors</p></def></def-item><def-item><term>PAMPs</term><def><p>Pathogen-associated molecular patterns</p></def></def-item><def-item><term>RegIII</term><def><p>Regenerating gene III</p></def></def-item><def-item><term>RIG</term><def><p>Retinoic acid-inducible gene I</p></def></def-item><def-item><term>RLR</term><def><p>RIG-like receptor</p></def></def-item><def-item><term>ROS</term><def><p>Reactive oxygen species</p></def></def-item><def-item><term>SIBO</term><def><p>Small intestinal bacterial overgrowth</p></def></def-item><def-item><term>SCFA</term><def><p>Short chain fatty acid</p></def></def-item><def-item><term>SREBP-1</term><def><p>Sterol regulatory element-binding protein 1</p></def></def-item><def-item><term>SIRs</term><def><p>Systemic inflammatory response markers</p></def></def-item><def-item><term>Tregs</term><def><p>T regulatory cells</p></def></def-item><def-item><term>TEWL or TWL</term><def><p>Trans-epidermal water loss</p></def></def-item><def-item><term>TLR</term><def><p>Toll like receptor</p></def></def-item><def-item><term>TMAO</term><def><p>Trimethylamine N-oxide</p></def></def-item><def-item><term>TGF-&#x3B2;</term><def><p>Tumor growth factor beta</p></def></def-item><def-item><term>TNF-&#x3B1;</term><def><p>Tumor necrosis factor alpha</p></def></def-item><def-item><term>TSLP</term><def><p>Thymic stromal lymphopoietin</p></def></def-item><def-item><term>Th1</term><def><p>T helper cell type 1</p></def></def-item><def-item><term>Th2</term><def><p>T helper cell type 2</p></def></def-item></def-list></p>
    </sec>
    <sec sec-type="COI-statement" disp-level="1" id="s0005">
      <title>Disclosure statement</title>
      <p>No potential conflict of interest was reported by the authors.</p>
    </sec>
    <sec disp-level="1" id="s0006">
      <title>Author contributions</title>
      <p>M.R.M designed and supervised the study. M.R.M, S.A, S.K.T, I.Z.E, M.S.H, S.B, L.M, S.A and M.R.H collected necessary data and participated in the writing manuscript. A.M.P &amp; M.A reviewed the draft thoroughly and A.M.P also revised the final manuscript for further changes in format. M.R.M also acted as corresponding author. All authors declared no objection for submitting the final manuscript.</p>
    </sec>
    <ref-list>
      <title>References</title>
      <ref id="cit0001">
        <label>1.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Coates</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Lee</surname>
<given-names>MJ</given-names></string-name>, <string-name><surname>Norton</surname>
<given-names>D</given-names></string-name>, <string-name><surname>MacLeod</surname>
<given-names>AS</given-names></string-name>, <string-name><surname>Norton</surname>
<given-names>D</given-names></string-name>, <string-name><surname>MacLeod</surname>
<given-names>AS</given-names></string-name>, <string-name><surname>MacLeod</surname>
<given-names>AS.</given-names></string-name></person-group>
<article-title>The skin and intestinal microbiota and their specific innate immune systems</article-title>. <source>Front Immunol</source>. <year>2019</year>;<volume>10</volume>:<fpage>10</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fimmu.2019.02950</pub-id>.<pub-id pub-id-type="pmid">30723470</pub-id></mixed-citation>
      </ref>
      <ref id="cit0002">
        <label>2.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Salem</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Ramser</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Isham</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Ghannoum</surname>
<given-names>MA</given-names></string-name></person-group>. <article-title>The gut microbiome as a major regulator of the gut-skin axis</article-title>. <source>Front Microbiol</source>. <year>2018</year>;<volume>9</volume>:<fpage>1459</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fmicb.2018.01459</pub-id>.<pub-id pub-id-type="pmid">30042740</pub-id></mixed-citation>
      </ref>
      <ref id="cit0003">
        <label>3.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>O&#x2019;Neill</surname>
<given-names>CA</given-names></string-name>, <string-name><surname>Monteleone</surname>
<given-names>G</given-names></string-name>, <string-name><surname>McLaughlin</surname>
<given-names>JT</given-names></string-name>, <string-name><surname>Paus</surname>
<given-names>R</given-names></string-name></person-group>. <article-title>The gut-skin axis in health and disease: a paradigm with therapeutic implications</article-title>. <source>BioEssays</source>. <year>2016</year>;<volume>38</volume>(<issue>11</issue>):<fpage>1167</fpage>&#x2013;<lpage>29</lpage>. doi:<pub-id pub-id-type="doi">10.1002/bies.201600008</pub-id>.<pub-id pub-id-type="pmid">27554239</pub-id></mixed-citation>
      </ref>
      <ref id="cit0004">
        <label>4.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hsu</surname>
<given-names>DK</given-names></string-name>, <string-name><surname>Fung</surname>
<given-names>MA</given-names></string-name>, <string-name><surname>Chen</surname>
<given-names>HL</given-names></string-name></person-group>. <article-title>Role of skin and gut microbiota in the pathogenesis of psoriasis, an inflammatory skin disease</article-title>. <source>Med Microecol</source>. <year>2020</year>;<volume>4</volume>:<fpage>100016</fpage>. doi:<pub-id pub-id-type="doi">10.1016/j.medmic.2020.100016</pub-id>.</mixed-citation>
      </ref>
      <ref id="cit0005">
        <label>5.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ellis</surname>
<given-names>SR</given-names></string-name>, <string-name><surname>Nguyen</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Vaughn</surname>
<given-names>AR</given-names></string-name>, <string-name><surname>Notay</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Burney</surname>
<given-names>WA</given-names></string-name>, <string-name><surname>Sandhu</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Sivamani</surname>
<given-names>RK</given-names></string-name></person-group>. <article-title>The skin and gut microbiome and its role in common dermatologic conditions</article-title>. <source>Microorganisms</source>. <year>2019</year>;<volume>7</volume>(<issue>11</issue>):<fpage>550</fpage>. doi:<pub-id pub-id-type="doi">10.3390/microorganisms7110550</pub-id>.</mixed-citation>
      </ref>
      <ref id="cit0006">
        <label>6.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Guarner</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Khan</surname>
<given-names>AG</given-names></string-name>, <string-name><surname>Garisch</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Eliakim</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Gangl</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Thomson</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Krabshuis</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Lemair</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Kaufmann</surname>
<given-names>P</given-names></string-name>, <string-name><surname>de Paula</surname>
<given-names>JA</given-names></string-name>, et al</person-group>. <article-title>World gastroenterology organisation global guidelines</article-title>. <source>J Clin Gastroenterol</source>. <year>2012</year>;<volume>46</volume>(<issue>6</issue>):<fpage>468</fpage>&#x2013;<lpage>481</lpage>. doi:<pub-id pub-id-type="doi">10.1097/mcg.0b013e3182549092</pub-id>.<pub-id pub-id-type="pmid">22688142</pub-id></mixed-citation>
      </ref>
      <ref id="cit0007">
        <label>7.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Renz</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Brandtzaeg</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Hornef</surname>
<given-names>M</given-names></string-name></person-group>. <article-title>The impact of perinatal immune development on mucosal homeostasis and chronic inflammation</article-title>. <source>Nat Rev Immunol</source>. <year>2011</year>;<volume>12</volume>(<issue>1</issue>):<fpage>9</fpage>&#x2013;<lpage>23</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nri3112</pub-id>.<pub-id pub-id-type="pmid">22158411</pub-id></mixed-citation>
      </ref>
      <ref id="cit0008">
        <label>8.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Malard</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Dore</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Gaugler</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Mohty</surname>
<given-names>M</given-names></string-name></person-group>. <article-title>Introduction to host microbiome symbiosis in health and disease</article-title>. <source>Mucosal Immunol</source>. <year>2020</year>;<volume>14</volume>(<issue>3</issue>):<fpage>547</fpage>&#x2013;<lpage>554</lpage>. doi:<pub-id pub-id-type="doi">10.1038/s41385-020-00365-4</pub-id>.<pub-id pub-id-type="pmid">33299088</pub-id></mixed-citation>
      </ref>
      <ref id="cit0009">
        <label>9.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Shen</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Obin</surname>
<given-names>MS</given-names></string-name>, <string-name><surname>Zhao</surname>
<given-names>L</given-names></string-name></person-group>. <article-title>The gut microbiota, obesity and insulin resistance</article-title>. <source>Mol Aspects Med</source>. <year>2013</year>;<volume>34</volume>(<issue>1</issue>):<fpage>39</fpage>&#x2013;<lpage>58</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.mam.2012.11.001</pub-id>.<pub-id pub-id-type="pmid">23159341</pub-id></mixed-citation>
      </ref>
      <ref id="cit0010">
        <label>10.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Weng</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Walker</surname>
<given-names>WA</given-names></string-name></person-group>. <article-title>The role of gut microbiota in programming the immune phenotype</article-title>. <source>J Dev Orig Health Dis</source>. <year>2013</year>;<volume>4</volume>(<issue>3</issue>):<fpage>203</fpage>&#x2013;<lpage>214</lpage>. doi:<pub-id pub-id-type="doi">10.1017/s2040174412000712</pub-id>.<pub-id pub-id-type="pmid">24353893</pub-id></mixed-citation>
      </ref>
      <ref id="cit0011">
        <label>11.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Roland</surname>
<given-names>MM</given-names></string-name>, <string-name><surname>Mohammed</surname>
<given-names>AD</given-names></string-name>, <string-name><surname>Kubinak</surname>
<given-names>JL</given-names></string-name></person-group>. <article-title>How MHCII signaling promotes benign host-microbiota interactions</article-title>. <source>PLoS Pathog</source>. <year>2020</year>;<volume>16</volume>(<issue>6</issue>):<fpage>e1008558</fpage>. <comment>Public Library of Science</comment>. doi:<pub-id pub-id-type="doi">10.1371/journal.ppat.1008558</pub-id>.<pub-id pub-id-type="pmid">32598378</pub-id></mixed-citation>
      </ref>
      <ref id="cit0012">
        <label>12.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Parfrey</surname>
<given-names>LW</given-names></string-name>, <string-name><surname>Jirk&#x16F;</surname>
<given-names>M</given-names></string-name>, <string-name><surname>&#x160;&#xED;ma</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Jaloveck&#xE1;</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Sak</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Grigore</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Pomajb&#xED;kov&#xE1;</surname>
<given-names>KJ</given-names></string-name></person-group>. <article-title>A benign helminth alters the host immune system and the gut microbiota in a rat model system</article-title>. <source>PLoS ONE</source> . <year>2017</year>:<page-range>12(8)</page-range>. doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0182205</pub-id>.</mixed-citation>
      </ref>
      <ref id="cit0013">
        <label>13.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Pascal</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Perez-Gordo</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Caballero</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Escribese</surname>
<given-names>MM</given-names></string-name>, <string-name><surname>Lopez Longo</surname>
<given-names>MN</given-names></string-name>, <string-name><surname>Luengo</surname>
<given-names>O</given-names></string-name>, <string-name><surname>Manso</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Matheu</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Seoane</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Zamorano</surname>
<given-names>M</given-names></string-name>, et al</person-group>. <article-title>Microbiome and allergic diseases</article-title>. <source>Front Immunol</source>. <year>2018</year>;<volume>9</volume>:<fpage>1584</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fimmu.2018.01584</pub-id>.<pub-id pub-id-type="pmid">30065721</pub-id></mixed-citation>
      </ref>
      <ref id="cit0014">
        <label>14.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Holscher</surname>
<given-names>HD</given-names></string-name></person-group>. <article-title>Dietary fiber and prebiotics and the gastrointestinal microbiota</article-title>. <source>Gut Microbes</source>. <year>2017</year>;<volume>8</volume>(<issue>2</issue>):<fpage>172</fpage>&#x2013;<lpage>184</lpage>. doi:<pub-id pub-id-type="doi">10.1080/19490976.2017.1290756</pub-id>.<pub-id pub-id-type="pmid">28165863</pub-id></mixed-citation>
      </ref>
      <ref id="cit0015">
        <label>15.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Polkowska&#x2010;Pruszy&#x144;ska</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Gerkowicz</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Krasowska</surname>
<given-names>D</given-names></string-name></person-group>. <article-title>The gut microbiome alterations in allergic and inflammatory skin diseases &#x2013; an update</article-title>. <source>J EurAcad Dermatol Venereol</source>. <year>2019</year>;<volume>34</volume>(<issue>3</issue>):<fpage>455</fpage>&#x2013;<lpage>464</lpage>. doi:<pub-id pub-id-type="doi">10.1111/jdv.15951</pub-id>.</mixed-citation>
      </ref>
      <ref id="cit0016">
        <label>16.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>De Pessemier</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Grine</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Debaere</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Maes</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Paetzold</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Callewaert</surname>
<given-names>C</given-names></string-name></person-group>. <article-title>Gut&#x2013;skin axis: current knowledge of the interrelationship between microbial dysbiosis and skin conditions</article-title>. <source>Microorganisms</source>. <year>2021</year>;<volume>9</volume>(<issue>2</issue>):<fpage>353</fpage>. doi:<pub-id pub-id-type="doi">10.3390/microorganisms9020353</pub-id>.<pub-id pub-id-type="pmid">33670115</pub-id></mixed-citation>
      </ref>
      <ref id="cit0017">
        <label>17.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Page</surname>
<given-names>MJ</given-names></string-name>, <string-name><surname>McKenzie</surname>
<given-names>JE</given-names></string-name>, <string-name><surname>Bossuyt</surname>
<given-names>PM</given-names></string-name>, <string-name><surname>Boutron</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Hoffmann</surname>
<given-names>TC</given-names></string-name>, <string-name><surname>Mulrow</surname>
<given-names>CD</given-names></string-name>, <string-name><surname>Shamseer</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Tetzlaff</surname>
<given-names>JM</given-names></string-name>, <string-name><surname>Akl</surname>
<given-names>EA</given-names></string-name>, <string-name><surname>Brennan</surname>
<given-names>SE</given-names></string-name>, et al</person-group>. <article-title>The PRISMA 2020 statement: an updated guideline for reporting systematic reviews</article-title>. <source>BMJ</source>. <year>2021</year>:<volume>71</volume>. doi:<pub-id pub-id-type="doi">10.1136/bmj.n71</pub-id>.</mixed-citation>
      </ref>
      <ref id="cit0018">
        <label>18.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Godoy-Vitorino</surname>
<given-names>F</given-names></string-name></person-group>. <article-title>Human microbial ecology and the rising new medicine</article-title>. <source>Ann Transll Med</source>. <year>2019</year>;<volume>7</volume>(<issue>14</issue>):<fpage>342</fpage>. doi:<pub-id pub-id-type="doi">10.21037/atm.2019.06.56</pub-id>.</mixed-citation>
      </ref>
      <ref id="cit0019">
        <label>19.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Uhr</surname>
<given-names>GT</given-names></string-name>, <string-name><surname>Dohnalov&#xE1;</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Thaiss</surname>
<given-names>CA</given-names></string-name></person-group>. <article-title>The dimension of time in host-microbiome interactions</article-title>. <source>MSystems</source>. <year>2019</year>;<volume>4</volume>(<issue>1</issue>). doi:<pub-id pub-id-type="doi">10.1128/msystems.00216-18</pub-id>.</mixed-citation>
      </ref>
      <ref id="cit0020">
        <label>20.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Johnson</surname>
<given-names>CL</given-names></string-name>, <string-name><surname>Versalovic</surname>
<given-names>J</given-names></string-name></person-group>. <article-title>The human microbiome and its potential importance to pediatrics</article-title>. <source>Pediatrics</source>. <year>2012</year>;<volume>129</volume>(<issue>5</issue>):<fpage>950</fpage>&#x2013;<lpage>960</lpage>. doi:<pub-id pub-id-type="doi">10.1542/peds.2011-2736</pub-id>.<pub-id pub-id-type="pmid">22473366</pub-id></mixed-citation>
      </ref>
      <ref id="cit0021">
        <label>21.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Fredricks</surname>
<given-names>DN</given-names></string-name></person-group>. <article-title>Microbial ecology of human skin in health and disease</article-title>. <source>J Invest Dermatol Symp Proc</source>. <year>2001</year>;<volume>6</volume>(<issue>3</issue>):<fpage>167</fpage>&#x2013;<lpage>169</lpage>. doi:<pub-id pub-id-type="doi">10.1046/j.0022-202x.2001.00039.x</pub-id>.</mixed-citation>
      </ref>
      <ref id="cit0022">
        <label>22.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gallo</surname>
<given-names>RL</given-names></string-name></person-group>. <article-title>Human skin is the largest epithelial surface for interaction with microbes</article-title>. <source>J Invest Dermatol</source>. <year>2017</year>;<volume>137</volume>(<issue>6</issue>):<fpage>1213</fpage>&#x2013;<lpage>1214</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jid.2016.11.045</pub-id>.<pub-id pub-id-type="pmid">28395897</pub-id></mixed-citation>
      </ref>
      <ref id="cit0023">
        <label>23.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Cundell</surname>
<given-names>AM</given-names></string-name></person-group>. <article-title>Microbial ecology of the human skin</article-title>. <source>Microb Ecol</source>. <year>2016</year>;<volume>76</volume>(<issue>1</issue>):<fpage>113</fpage>&#x2013;<lpage>120</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s00248-016-0789-6</pub-id>.<pub-id pub-id-type="pmid">27245597</pub-id></mixed-citation>
      </ref>
      <ref id="cit0024">
        <label>24.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chiller</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Selkin</surname>
<given-names>BA</given-names></string-name>, <string-name><surname>Murakawa</surname>
<given-names>GJ</given-names></string-name></person-group>. <article-title>Skin microflora and bacterial infections of the skin</article-title>. <source>J Invest Dermatol Symp Proc</source>. <year>2001</year>;<volume>6</volume>(<issue>3</issue>):<fpage>170</fpage>&#x2013;<lpage>174</lpage>. doi:<pub-id pub-id-type="doi">10.1046/j.0022-202x.2001.00043.x</pub-id>.</mixed-citation>
      </ref>
      <ref id="cit0025">
        <label>25.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Byrd</surname>
<given-names>AL</given-names></string-name>, <string-name><surname>Belkaid</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Segre</surname>
<given-names>JA</given-names></string-name></person-group>. <article-title>The human skin microbiome</article-title>. <source>Nat Rev Microbiol</source>. <year>2018</year>;<volume>16</volume>(<issue>3</issue>):<fpage>143</fpage>&#x2013;<lpage>155</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nrmicro.2017.157</pub-id>.<pub-id pub-id-type="pmid">29332945</pub-id></mixed-citation>
      </ref>
      <ref id="cit0026">
        <label>26.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Grice</surname>
<given-names>EA</given-names></string-name>, <string-name><surname>Segre</surname>
<given-names>JA</given-names></string-name></person-group>. <article-title>The skin microbiome</article-title>. <source>Nat Rev Microbiol</source>. <year>2011</year>;<volume>9</volume>(<issue>4</issue>):<fpage>244</fpage>&#x2013;<lpage>253</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nrmicro2537</pub-id>.<pub-id pub-id-type="pmid">21407241</pub-id></mixed-citation>
      </ref>
      <ref id="cit0027">
        <label>27.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Xu</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Knight</surname>
<given-names>R</given-names></string-name></person-group>. <article-title>Dietary effects on human gut microbiome diversity</article-title>. <source>Br J Nutr</source>. <year>2014</year>;<volume>113</volume>(<issue>S1</issue>):<fpage>S1</fpage>&#x2013;<lpage>S5</lpage>. doi:<pub-id pub-id-type="doi">10.1017/s0007114514004127</pub-id>.<pub-id pub-id-type="pmid">25498959</pub-id></mixed-citation>
      </ref>
      <ref id="cit0028">
        <label>28.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Valdes</surname>
<given-names>AM</given-names></string-name>, <string-name><surname>Walter</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Segal</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Spector</surname>
<given-names>TD</given-names></string-name></person-group>. <article-title>Role of the gut microbiota in nutrition and health</article-title>. <source>BMJ</source>. <year>2018</year>:<fpage>k2179</fpage>. doi:<pub-id pub-id-type="doi">10.1136/bmj.k2179</pub-id>.<pub-id pub-id-type="pmid">29899036</pub-id></mixed-citation>
      </ref>
      <ref id="cit0029">
        <label>29.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Grice</surname>
<given-names>EA</given-names></string-name>, <string-name><surname>Kong</surname>
<given-names>HH</given-names></string-name>, <string-name><surname>Conlan</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Deming</surname>
<given-names>CB</given-names></string-name>, <string-name><surname>Davis</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Young</surname>
<given-names>AC</given-names></string-name>, <string-name><surname>Bouffard</surname>
<given-names>GG</given-names></string-name>, <string-name><surname>Blakesley</surname>
<given-names>RW</given-names></string-name>, <string-name><surname>Murray</surname>
<given-names>PR</given-names></string-name>, <string-name><surname>Green</surname>
<given-names>ED</given-names></string-name>, et al</person-group>. <article-title>Topographical and temporal diversity of the human skin microbiome</article-title>. <source>Science</source>. <year>2009</year>;<volume>324</volume>(<issue>5931</issue>):<fpage>1190</fpage>&#x2013;<lpage>1192</lpage>. doi:<pub-id pub-id-type="doi">10.1126/science.1171700</pub-id>.<pub-id pub-id-type="pmid">19478181</pub-id></mixed-citation>
      </ref>
      <ref id="cit0030">
        <label>30.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hillman</surname>
<given-names>ET</given-names></string-name>, <string-name><surname>Lu</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Yao</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Nakatsu</surname>
<given-names>CH</given-names></string-name></person-group>. <article-title>Microbial ecology along the gastrointestinal tract</article-title>. <source>Microbes and Environ</source>. <year>2017</year>;<volume>32</volume>(<issue>4</issue>):<fpage>300</fpage>&#x2013;<lpage>313</lpage>. doi:<pub-id pub-id-type="doi">10.1264/jsme2.me17017</pub-id>.</mixed-citation>
      </ref>
      <ref id="cit0031">
        <label>31.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lau</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Srivatsav</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Rizwan</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Nashed</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Shen</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Akhtar</surname>
<given-names>M</given-names></string-name></person-group>. <article-title>Bridging the Gap between gut microbial dysbiosis and cardiovascular diseases</article-title>. <source>Nutrients</source>. <year>2017</year>;<volume>9</volume>(<issue>8</issue>):<fpage>859</fpage>. doi:<pub-id pub-id-type="doi">10.3390/nu9080859</pub-id>.</mixed-citation>
      </ref>
      <ref id="cit0032">
        <label>32.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bor</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Bedree</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Shi</surname>
<given-names>W</given-names></string-name>, <string-name><surname>McLean</surname>
<given-names>J</given-names></string-name>, <string-name><surname>He</surname>
<given-names>X</given-names></string-name></person-group>. <article-title>Saccharibacteria (TM7) in the human oral microbiome</article-title>. <source>J Dent Res</source>. <year>2019</year>;<volume>98</volume>(<issue>5</issue>):<fpage>500</fpage>&#x2013;<lpage>509</lpage>. doi:<pub-id pub-id-type="doi">10.1177/0022034519831671</pub-id>.<pub-id pub-id-type="pmid">30894042</pub-id></mixed-citation>
      </ref>
      <ref id="cit0033">
        <label>33.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hoffmann</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Dollive</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Grunberg</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Chen</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Wu</surname>
<given-names>GD</given-names></string-name>, <string-name><surname>Lewis</surname>
<given-names>JD</given-names></string-name>, <string-name><surname>Bushman</surname>
<given-names>FD</given-names></string-name></person-group>. <article-title>Archaea and fungi of the human gut microbiome: correlations with diet and bacterial residents</article-title>. <source>PLoS ONE</source>. <year>2013</year>;<volume>8</volume>(<issue>6</issue>):<fpage>e66019</fpage>. doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0066019</pub-id>.<pub-id pub-id-type="pmid">23799070</pub-id></mixed-citation>
      </ref>
      <ref id="cit0034">
        <label>34.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Honkanen</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Vuorela</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Muthas</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Orivuori</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Luopaj&#xE4;rvi</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Tejesvi</surname>
<given-names>MVG</given-names></string-name>, <string-name><surname>Lavrinienko</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Pirttil&#xE4;</surname>
<given-names>AM</given-names></string-name>, <string-name><surname>Fogarty</surname>
<given-names>CL</given-names></string-name>, <string-name><surname>H&#xE4;rk&#xF6;nen</surname>
<given-names>T</given-names></string-name>, et al</person-group>. <article-title>Fungal dysbiosis and intestinal inflammation in children with beta-cell autoimmunity</article-title>. <source>Front Immunol</source>. <year>2020</year>;<volume>11</volume>:<fpage>11</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fimmu.2020.00468</pub-id>.<pub-id pub-id-type="pmid">32082309</pub-id></mixed-citation>
      </ref>
      <ref id="cit0035">
        <label>35.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Dridi</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Raoult</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Drancourt</surname>
<given-names>M</given-names></string-name></person-group>. <article-title>Archaea as emerging organisms in complex human microbiomes</article-title>. <source>Anaerobe</source>. <year>2011</year>;<volume>17</volume>(<issue>2</issue>):<fpage>56</fpage>&#x2013;<lpage>63</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.anaerobe.2011.03.001</pub-id>.<pub-id pub-id-type="pmid">21420503</pub-id></mixed-citation>
      </ref>
      <ref id="cit0036">
        <label>36.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Camp</surname>
<given-names>JG</given-names></string-name>, <string-name><surname>Kanther</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Semova</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Rawls</surname>
<given-names>JF</given-names></string-name></person-group>. <article-title>Patterns and scales in gastrointestinal microbial ecology</article-title>. <source>Gastroenterology</source>. <year>2009</year>;<volume>136</volume>(<issue>6</issue>):<fpage>1989</fpage>&#x2013;<lpage>2002</lpage>. doi:<pub-id pub-id-type="doi">10.1053/j.gastro.2009.02.075</pub-id>.<pub-id pub-id-type="pmid">19457423</pub-id></mixed-citation>
      </ref>
      <ref id="cit0037">
        <label>37.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hansen</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Scott</surname>
<given-names>KP</given-names></string-name>, <string-name><surname>Khan</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Martin</surname>
<given-names>JC</given-names></string-name>, <string-name><surname>Berry</surname>
<given-names>SH</given-names></string-name>, <string-name><surname>Stevenson</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Okpapi</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Munro</surname>
<given-names>MJ</given-names></string-name>, <string-name><surname>Hold</surname>
<given-names>GL</given-names></string-name></person-group>. <article-title>First-pass meconium samples from healthy term vaginally-delivered neonates: an analysis of the microbiota</article-title>. <source>PLOS ONE</source>. <year>2015</year>;<volume>10</volume>(<issue>7</issue>):<fpage>e0133320</fpage>. doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0133320</pub-id>.<pub-id pub-id-type="pmid">26218283</pub-id></mixed-citation>
      </ref>
      <ref id="cit0038">
        <label>38.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Jim&#xE9;nez</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Mar&#xED;n</surname>
<given-names>ML</given-names></string-name>, <string-name><surname>Mart&#xED;n</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Odriozola</surname>
<given-names>JM</given-names></string-name>, <string-name><surname>Olivares</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Xaus</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Fern&#xE1;ndez</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Rodr&#xED;guez</surname>
<given-names>JM</given-names></string-name></person-group>. <article-title>Is meconium from healthy newborns actually sterile?</article-title>
<source>Res Microbiol</source>. <year>2008</year>;<volume>159</volume>(<issue>3</issue>):<fpage>187</fpage>&#x2013;<lpage>193</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.resmic.2007.12.007</pub-id>.<pub-id pub-id-type="pmid">18281199</pub-id></mixed-citation>
      </ref>
      <ref id="cit0039">
        <label>39.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tapiainen</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Paalanne</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Tejesvi</surname>
<given-names>MV</given-names></string-name>, <string-name><surname>Koivusaari</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Korpela</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Pokka</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Salo</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Kaukola</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Pirttil&#xE4;</surname>
<given-names>AM</given-names></string-name>, <string-name><surname>Uhari</surname>
<given-names>M</given-names></string-name>, et al</person-group>. <article-title>Maternal influence on the fetal microbiome in a population-based study of the first-pass meconium</article-title>. <source>Pediatr Res</source>. <year>2018</year>;<volume>84</volume>(<issue>3</issue>):<fpage>371</fpage>&#x2013;<lpage>379</lpage>. doi:<pub-id pub-id-type="doi">10.1038/pr.2018.29</pub-id>.<pub-id pub-id-type="pmid">29538354</pub-id></mixed-citation>
      </ref>
      <ref id="cit0040">
        <label>40.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yang</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Yao</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Cheng</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Xu</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Hou</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Wei</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Feng</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Yu</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Tong</surname>
<given-names>X</given-names></string-name>, et al</person-group>. <article-title>Comparison of meconium microbiome in dizygotic and monozygotic twins born by Caesarean section (CS)</article-title>. <source>Front Microbiol</source>. <year>2020</year>;<volume>11</volume>:<fpage>1139</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fmicb.2020.01139</pub-id>.<pub-id pub-id-type="pmid">32582089</pub-id></mixed-citation>
      </ref>
      <ref id="cit0041">
        <label>41.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sekirov</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Russell</surname>
<given-names>SL</given-names></string-name>, <string-name><surname>Caetano</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Antunes</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Finlay</surname>
<given-names>BB</given-names></string-name></person-group>. <article-title>Gut microbiota in health and disease</article-title>. <source>Physiol Rev</source>. <year>2010</year>;<volume>90</volume>(<issue>3</issue>):<fpage>859</fpage>&#x2013;<lpage>904</lpage>. doi:<pub-id pub-id-type="doi">10.1152/physrev.00045.2009</pub-id>.<pub-id pub-id-type="pmid">20664075</pub-id></mixed-citation>
      </ref>
      <ref id="cit0042">
        <label>42.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mueller</surname>
<given-names>NT</given-names></string-name>, <string-name><surname>Bakacs</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Combellick</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Grigoryan</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Dominguez-Bello</surname>
<given-names>MG</given-names></string-name></person-group>. <article-title>The infant microbiome development: mom matters</article-title>. <source>Trends Mol Med</source>. <year>2015</year>;<volume>21</volume>(<issue>2</issue>):<fpage>109</fpage>&#x2013;<lpage>117</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.molmed.2014.12.002</pub-id>.<pub-id pub-id-type="pmid">25578246</pub-id></mixed-citation>
      </ref>
      <ref id="cit0043">
        <label>43.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Rinninella</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Raoul</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Cintoni</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Franceschi</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Miggiano</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Gasbarrini</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Mele</surname>
<given-names>MC</given-names></string-name></person-group>. <article-title>What is the healthy gut microbiota composition? A changing ecosystem across age, environment, diet, and diseases</article-title>. <source>Microorganisms</source>. <year>2019</year>;<volume>7</volume>(<issue>1</issue>):<fpage>14</fpage>. doi:<pub-id pub-id-type="doi">10.3390/microorganisms7010014</pub-id>.</mixed-citation>
      </ref>
      <ref id="cit0044">
        <label>44.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Santacruz</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Collado</surname>
<given-names>MC</given-names></string-name>, <string-name><surname>Garc&#xED;a-Vald&#xE9;s</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Segura</surname>
<given-names>MT</given-names></string-name>, <string-name><surname>Mart&#xED;n-Lagos</surname>
<given-names>JA</given-names></string-name>, <string-name><surname>Anjos</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Mart&#xED;-Romero</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Lopez</surname>
<given-names>RM</given-names></string-name>, <string-name><surname>Florido</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Campoy</surname>
<given-names>C</given-names></string-name>, et al</person-group>. <article-title>Gut microbiota composition is associated with body weight, weight gain and biochemical parameters in pregnant women</article-title>. <source>Br J Nutr</source>. <year>2010</year>;<volume>104</volume>(<issue>1</issue>):<fpage>83</fpage>&#x2013;<lpage>92</lpage>. doi:<pub-id pub-id-type="doi">10.1017/s0007114510000176</pub-id>.<pub-id pub-id-type="pmid">20205964</pub-id></mixed-citation>
      </ref>
      <ref id="cit0045">
        <label>45.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Edwards</surname>
<given-names>SM</given-names></string-name>, <string-name><surname>Cunningham</surname>
<given-names>SA</given-names></string-name>, <string-name><surname>Dunlop</surname>
<given-names>AL</given-names></string-name>, <string-name><surname>Corwin</surname>
<given-names>EJ</given-names></string-name></person-group>. <article-title>The Maternal gut microbiome during pregnancy</article-title>. <source>MCN: Ame J Matern Child Nurs</source>. <year>2017</year>;<volume>42</volume>(<issue>6</issue>):<fpage>310</fpage>&#x2013;<lpage>317</lpage>. doi:<pub-id pub-id-type="doi">10.1097/nmc.0000000000000372</pub-id>.</mixed-citation>
      </ref>
      <ref id="cit0046">
        <label>46.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mayer</surname>
<given-names>EA</given-names></string-name>, <string-name><surname>Savidge</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Shulman</surname>
<given-names>RJ</given-names></string-name></person-group>. <article-title>Brain&#x2013;gut microbiome interactions and functional bowel disorders</article-title>. <source>Gastroenterology</source>. <year>2014</year>;<volume>146</volume>(<issue>6</issue>):<fpage>1500</fpage>&#x2013;<lpage>1512</lpage>. doi:<pub-id pub-id-type="doi">10.1053/j.gastro.2014.02.037</pub-id>.<pub-id pub-id-type="pmid">24583088</pub-id></mixed-citation>
      </ref>
      <ref id="cit0047">
        <label>47.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Boyle</surname>
<given-names>RJ</given-names></string-name>, <string-name><surname>Lahtinen</surname>
<given-names>SJ</given-names></string-name>, <string-name><surname>Tang</surname>
<given-names>MLK</given-names></string-name></person-group>. <article-title>Probiotics and Skin</article-title>. <source>Nutr Skin</source>. <year>2011</year>:<fpage>111</fpage>&#x2013;<lpage>127</lpage>. doi:<pub-id pub-id-type="doi">10.1007/978-1-4419-7967-4_8</pub-id>.</mixed-citation>
      </ref>
      <ref id="cit0048">
        <label>48.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kosiewicz</surname>
<given-names>MM</given-names></string-name>, <string-name><surname>Dryden</surname>
<given-names>GW</given-names></string-name>, <string-name><surname>Chhabra</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Alard</surname>
<given-names>P</given-names></string-name></person-group>. <article-title>Relationship between gut microbiota and development of T cell associated disease</article-title>. <source>FEBS Lett</source>. <year>2014</year>;<volume>588</volume>(<issue>22</issue>):<fpage>4195</fpage>&#x2013;<lpage>4206</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.febslet.2014.03.019</pub-id>.<pub-id pub-id-type="pmid">24681103</pub-id></mixed-citation>
      </ref>
      <ref id="cit0049">
        <label>49.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Brandtzaeg</surname>
<given-names>P</given-names></string-name></person-group>. <article-title>The gut as communicator between environment and host: immunological consequences</article-title>. <source>Eur J Pharmacol</source>. <year>2011</year>;<volume>668</volume>:<fpage>S16</fpage>&#x2013;<lpage>S32</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.ejphar.2011.07.006</pub-id>.<pub-id pub-id-type="pmid">21816150</pub-id></mixed-citation>
      </ref>
      <ref id="cit0050">
        <label>50.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Thursby</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Juge</surname>
<given-names>N</given-names></string-name></person-group>. <article-title>Introduction to the human gut microbiota</article-title>. <source>Biochem Jl</source>. <year>2017</year>;<volume>474</volume>(<issue>11</issue>):<fpage>1823</fpage>&#x2013;<lpage>1836</lpage>. doi:<pub-id pub-id-type="doi">10.1042/bcj20160510</pub-id>.<pub-id pub-id-type="pmid">28512250</pub-id></mixed-citation>
      </ref>
      <ref id="cit0051">
        <label>51.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Power</surname>
<given-names>SE</given-names></string-name>, <string-name><surname>O&#x2019;Toole</surname>
<given-names>PW</given-names></string-name>, <string-name><surname>Stanton</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Ross</surname>
<given-names>RP</given-names></string-name>, <string-name><surname>Fitzgerald</surname>
<given-names>GF</given-names></string-name></person-group>. <article-title>Intestinal microbiota, diet and health</article-title>. <source>Br J Nutr</source>. <year>2013</year>;<volume>111</volume>(<issue>3</issue>):<fpage>387</fpage>&#x2013;<lpage>402</lpage>. doi:<pub-id pub-id-type="doi">10.1017/s0007114513002560</pub-id>.<pub-id pub-id-type="pmid">23931069</pub-id></mixed-citation>
      </ref>
      <ref id="cit0052">
        <label>52.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Brandtzaeg</surname>
<given-names>P</given-names></string-name></person-group>. <article-title>Mucosal immunity: induction, dissemination, and effector functions</article-title>. <source>Scand J Immunol</source>. <year>2009</year>;<volume>70</volume>(<issue>6</issue>):<fpage>505</fpage>&#x2013;<lpage>515</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1365-3083.2009.02319.x</pub-id>.<pub-id pub-id-type="pmid">19906191</pub-id></mixed-citation>
      </ref>
      <ref id="cit0053">
        <label>53.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Corth&#xE9;sy</surname>
<given-names>B</given-names></string-name></person-group>. <article-title>Role of secretory immunoglobulin A and secretory component in the protection of mucosal surfaces</article-title>. <source>Future Microbiol</source>. <year>2010</year>;<volume>5</volume>(<issue>5</issue>):<fpage>817</fpage>&#x2013;<lpage>829</lpage>. doi:<pub-id pub-id-type="doi">10.2217/fmb.10.39</pub-id>.<pub-id pub-id-type="pmid">20441552</pub-id></mixed-citation>
      </ref>
      <ref id="cit0054">
        <label>54.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Canny</surname>
<given-names>GO</given-names></string-name>, <string-name><surname>McCormick</surname>
<given-names>BA</given-names></string-name></person-group>. <article-title>Bacteria in the intestine, helpful residents or enemies from within?</article-title>
<source>Infect Immun</source>. <year>2008</year>;<volume>76</volume>(<issue>8</issue>):<fpage>3360</fpage>&#x2013;<lpage>3373</lpage>. doi:<pub-id pub-id-type="doi">10.1128/iai.00187-08</pub-id>.<pub-id pub-id-type="pmid">18474643</pub-id></mixed-citation>
      </ref>
      <ref id="cit0055">
        <label>55.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Jiao</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Wu</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Huntington</surname>
<given-names>ND</given-names></string-name>, and <string-name><surname>Zhang</surname>
<given-names>X</given-names></string-name></person-group>. <article-title>Crosstalk between gut microbiota and innate immunity and its implication in autoimmune diseases</article-title>. <source>Front Immunol</source>. <year>2020</year>:<fpage>11</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fimmu.2020.00282</pub-id>.<pub-id pub-id-type="pmid">32082309</pub-id></mixed-citation>
      </ref>
      <ref id="cit0056">
        <label>56.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zheng</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Liwinski</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Elinav</surname>
<given-names>E</given-names></string-name></person-group>. <article-title>Interaction between microbiota and immunity in health and disease</article-title>. <source>Cell Res</source>. <year>2020</year>;<volume>30</volume>(<issue>6</issue>):<fpage>492</fpage>&#x2013;<lpage>506</lpage>. doi:<pub-id pub-id-type="doi">10.1038/s41422-020-0332-7</pub-id>.<pub-id pub-id-type="pmid">32433595</pub-id></mixed-citation>
      </ref>
      <ref id="cit0057">
        <label>57.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Belkaid</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Hand</surname>
<given-names>T</given-names></string-name></person-group>. <article-title>Role of the microbiota in immunity and inflammation</article-title>. <source>Cell</source>. <year>2014</year>;<volume>157</volume>(<issue>1</issue>):<fpage>121</fpage>&#x2013;<lpage>141</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cell.2014.03.011</pub-id>.<pub-id pub-id-type="pmid">24679531</pub-id></mixed-citation>
      </ref>
      <ref id="cit0058">
        <label>58.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hinks</surname>
<given-names>TSC</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>XW</given-names></string-name></person-group>. <article-title>MAIT cell activation and functions</article-title>. <source>Front Immunol</source>. <year>2020</year>;<volume>11</volume>:<fpage>11</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fimmu.2020.01014</pub-id>.<pub-id pub-id-type="pmid">32082309</pub-id></mixed-citation>
      </ref>
      <ref id="cit0059">
        <label>59.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Macpherson</surname>
<given-names>AJ</given-names></string-name>, <string-name><surname>Slack</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Geuking</surname>
<given-names>MB</given-names></string-name>, <string-name><surname>McCoy</surname>
<given-names>KD</given-names></string-name></person-group>. <article-title>The mucosal firewalls against commensal intestinal microbes</article-title>. <source>Semin Immunopathol</source>. <year>2009</year>;<volume>31</volume>(<issue>2</issue>):<fpage>145</fpage>&#x2013;<lpage>149</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s00281-009-0174-3</pub-id>.<pub-id pub-id-type="pmid">19707762</pub-id></mixed-citation>
      </ref>
      <ref id="cit0060">
        <label>60.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Dillon</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Lo</surname>
<given-names>DD</given-names></string-name></person-group>. <article-title>M cells: intelligent engineering of mucosal immune surveillance</article-title>. <source>Front Immunol</source>. <year>2019</year>;<volume>10</volume>:<fpage>10</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fimmu.2019.01499</pub-id>.<pub-id pub-id-type="pmid">30723470</pub-id></mixed-citation>
      </ref>
      <ref id="cit0061">
        <label>61.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mabbott</surname>
<given-names>NA</given-names></string-name>, <string-name><surname>Donaldson</surname>
<given-names>DS</given-names></string-name>, <string-name><surname>Ohno</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Williams</surname>
<given-names>IR</given-names></string-name>, <string-name><surname>Mahajan</surname>
<given-names>A</given-names></string-name></person-group>. <article-title>Microfold (M) cells: important immunosurveillance posts in the intestinal epithelium</article-title>. <source>Mucosal Immunol</source>. <year>2013</year>;<volume>6</volume>(<issue>4</issue>):<fpage>666</fpage>&#x2013;<lpage>677</lpage>. doi:<pub-id pub-id-type="doi">10.1038/mi.2013.30</pub-id>.<pub-id pub-id-type="pmid">23695511</pub-id></mixed-citation>
      </ref>
      <ref id="cit0062">
        <label>62.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>M&#xF6;rbe</surname>
<given-names>UM</given-names></string-name>, <string-name><surname>J&#xF8;rgensen</surname>
<given-names>PB</given-names></string-name>, <string-name><surname>Fenton</surname>
<given-names>TM</given-names></string-name>, <string-name><surname>von Burg</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Riis</surname>
<given-names>LB</given-names></string-name>, <string-name><surname>Spencer</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Agace</surname>
<given-names>WW</given-names></string-name></person-group>. <article-title>Human gut-associated lymphoid tissues (GALT); diversity, structure, and function</article-title>. <source>Mucosal Immunol</source>. <year>2021</year>;<volume>14</volume>(<issue>4</issue>):<fpage>793</fpage>&#x2013;<lpage>802</lpage>. doi:<pub-id pub-id-type="doi">10.1038/s41385-021-00389-4</pub-id>.<pub-id pub-id-type="pmid">33753873</pub-id></mixed-citation>
      </ref>
      <ref id="cit0063">
        <label>63.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Brandtzaeg</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Kiyono</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Pabst</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Russell</surname>
<given-names>MW</given-names></string-name></person-group>. <article-title>Terminology: nomenclature of mucosa-associated lymphoid tissue</article-title>. <source>Mucosal Immunol</source>. <year>2007</year>;<volume>1</volume>(<issue>1</issue>):<fpage>31</fpage>&#x2013;<lpage>37</lpage>. doi:<pub-id pub-id-type="doi">10.1038/mi.2007.9</pub-id>.</mixed-citation>
      </ref>
      <ref id="cit0064">
        <label>64.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Layhadi</surname>
<given-names>JA</given-names></string-name>, <string-name><surname>Shamji</surname>
<given-names>MH</given-names></string-name></person-group>. <article-title>Uncovering the immunological properties of isolated lymphoid follicles</article-title>. <source>Allergy</source>. <year>2020</year>;<volume>76</volume>(<issue>4</issue>):<fpage>1292</fpage>&#x2013;<lpage>1293</lpage>. doi:<pub-id pub-id-type="doi">10.1111/all.14598</pub-id>.<pub-id pub-id-type="pmid">32969038</pub-id></mixed-citation>
      </ref>
      <ref id="cit0065">
        <label>65.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gubatan</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Holman</surname>
<given-names>DR</given-names></string-name>, <string-name><surname>Puntasecca</surname>
<given-names>CJ</given-names></string-name>, <string-name><surname>Polevoi</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Rubin</surname>
<given-names>SJ</given-names></string-name>, <string-name><surname>Rogalla</surname>
<given-names>S</given-names></string-name></person-group>. <article-title>Antimicrobial peptides and the gut microbiome in inflammatory bowel disease</article-title>. <source>World J Gastroenterol</source>. <year>2021</year>;<volume>27</volume>(<issue>43</issue>):<fpage>7402</fpage>&#x2013;<lpage>7422</lpage>. doi:<pub-id pub-id-type="doi">10.3748/wjg.v27.i43.7402</pub-id>.<pub-id pub-id-type="pmid">34887639</pub-id></mixed-citation>
      </ref>
      <ref id="cit0066">
        <label>66.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Grigat</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Soruri</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Forssmann</surname>
<given-names>U</given-names></string-name>, <string-name><surname>Riggert</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Zwirner</surname>
<given-names>J</given-names></string-name></person-group>. <article-title>Chemoattraction of macrophages, T Lymphocytes, and mast cells is evolutionarily conserved within the human &#x3B1;-defensin family</article-title>. <source>J Immunol</source>. <year>2007</year>;<volume>179</volume>(<issue>6</issue>):<fpage>3958</fpage>&#x2013;<lpage>3965</lpage>. doi:<pub-id pub-id-type="doi">10.4049/jimmunol.179.6.3958</pub-id>.<pub-id pub-id-type="pmid">17785833</pub-id></mixed-citation>
      </ref>
      <ref id="cit0067">
        <label>67.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lunjani</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Ahearn-Ford</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Dube</surname>
<given-names>FS</given-names></string-name>, <string-name><surname>Hlela</surname>
<given-names>C</given-names></string-name>, <string-name><surname>O&#x2019;Mahony</surname>
<given-names>L</given-names></string-name></person-group>. <article-title>Mechanisms of microbe-immune system dialogue within the skin</article-title>. <source>Genes Immun</source>. <year>2021</year>;<volume>22</volume>(<issue>5&#x2013;6</issue>):<fpage>276</fpage>&#x2013;<lpage>288</lpage>. doi:<pub-id pub-id-type="doi">10.1038/s41435-021-00133-9</pub-id>.<pub-id pub-id-type="pmid">33993202</pub-id></mixed-citation>
      </ref>
      <ref id="cit0068">
        <label>68.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kawai</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Akira</surname>
<given-names>S</given-names></string-name></person-group>. <article-title>The roles of TLRs, RLRs and NLRs in pathogen recognition</article-title>. <source>Int Immunol</source>. <year>2009</year>;<volume>21</volume>(<issue>4</issue>):<fpage>317</fpage>&#x2013;<lpage>337</lpage>. doi:<pub-id pub-id-type="doi">10.1093/intimm/dxp017</pub-id>.<pub-id pub-id-type="pmid">19246554</pub-id></mixed-citation>
      </ref>
      <ref id="cit0069">
        <label>69.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Asquith</surname>
<given-names>MJ</given-names></string-name>, <string-name><surname>Boulard</surname>
<given-names>O</given-names></string-name>, <string-name><surname>Powrie</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Maloy</surname>
<given-names>KJ</given-names></string-name></person-group>. <article-title>Pathogenic and protective roles of MyD88 in Leukocytes and epithelial cells in mouse models of inflammatory bowel disease</article-title>. <source>Gastroenterology</source>. <year>2010</year>;<volume>139</volume>(<issue>2</issue>):<fpage>519</fpage>&#x2013;<lpage>529.e2</lpage>. doi:<pub-id pub-id-type="doi">10.1053/j.gastro.2010.04.045</pub-id>.<pub-id pub-id-type="pmid">20433840</pub-id></mixed-citation>
      </ref>
      <ref id="cit0070">
        <label>70.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Huang</surname>
<given-names>YJ</given-names></string-name>, <string-name><surname>Marsland</surname>
<given-names>BJ</given-names></string-name>, <string-name><surname>Bunyavanich</surname>
<given-names>S</given-names></string-name>, <string-name><surname>O&#x2019;Mahony</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Leung</surname>
<given-names>DY</given-names></string-name>, <string-name><surname>Muraro</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Fleisher</surname>
<given-names>TA</given-names></string-name></person-group>. <article-title>The microbiome in allergic disease: current understanding and future opportunities&#x2014;2017 PRACTALL document of the American academy of allergy, Asthma &amp; immunology and the European academy of allergy and clinical immunology</article-title>. <source>J Allergy Clin Immunol</source>. <year>2017</year>;<volume>139</volume>(<issue>4</issue>):<fpage>1099</fpage>&#x2013;<lpage>1110</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jaci.2017.02.007</pub-id>.<pub-id pub-id-type="pmid">28257972</pub-id></mixed-citation>
      </ref>
      <ref id="cit0071">
        <label>71.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Rizzello</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Bonaccorsi</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Dongarr&#xE0;</surname>
<given-names>ML</given-names></string-name>, <string-name><surname>Fink</surname>
<given-names>LN</given-names></string-name>, <string-name><surname>Ferlazzo</surname>
<given-names>G</given-names></string-name></person-group>. <article-title>Role of Natural Killer and Dendritic Cell Crosstalk in Immunomodulation by Commensal Bacteria Probiotics</article-title>. <source>J Biomed Biotechnol</source>. <year>2011</year>;<volume>2011</volume>:<fpage>1</fpage>&#x2013;<lpage>10</lpage>. doi:<pub-id pub-id-type="doi">10.1155/2011/473097</pub-id>.</mixed-citation>
      </ref>
      <ref id="cit0072">
        <label>72.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Klose</surname>
<given-names>CSN</given-names></string-name>, <string-name><surname>Artis</surname>
<given-names>D</given-names></string-name></person-group>. <article-title>Innate lymphoid cells as regulators of immunity, inflammation and tissue homeostasis</article-title>. <source>Nat Immunol</source>. <year>2016</year>;<volume>17</volume>(<issue>7</issue>):<fpage>765</fpage>&#x2013;<lpage>774</lpage>. doi:<pub-id pub-id-type="doi">10.1038/ni.3489</pub-id>.<pub-id pub-id-type="pmid">27328006</pub-id></mixed-citation>
      </ref>
      <ref id="cit0073">
        <label>73.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Withers</surname>
<given-names>DR</given-names></string-name>, <string-name><surname>Hepworth</surname>
<given-names>MR</given-names></string-name></person-group>. <article-title>Group 3 innate lymphoid cells: communications hubs of the intestinal immune system</article-title>. <source>Front Immunol</source>. <year>2017</year>;<volume>8</volume>:<fpage>1298</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fimmu.2017.01298</pub-id>.<pub-id pub-id-type="pmid">29085366</pub-id></mixed-citation>
      </ref>
      <ref id="cit0074">
        <label>74.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kobayashi</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Ricardo-Gonzalez</surname>
<given-names>RR</given-names></string-name>, <string-name><surname>Moro</surname>
<given-names>K</given-names></string-name></person-group>. <article-title>Skin-resident innate lymphoid cells &#x2013; cutaneous innate guardians and regulators</article-title>. <source>Trends Immunol</source>. <year>2020</year>;<volume>41</volume>(<issue>2</issue>):<fpage>100</fpage>&#x2013;<lpage>112</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.it.2019.12.004</pub-id>.<pub-id pub-id-type="pmid">31948873</pub-id></mixed-citation>
      </ref>
      <ref id="cit0075">
        <label>75.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zheng</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Zhu</surname>
<given-names>J</given-names></string-name></person-group>. <article-title>Innate lymphoid cells and intestinal inflammatory disorders</article-title>. <source>Int J Mol Sci</source>. <year>2022</year>;<volume>23</volume>(<issue>3</issue>):<fpage>1856</fpage>. doi:<pub-id pub-id-type="doi">10.3390/ijms23031856</pub-id>.<pub-id pub-id-type="pmid">35163778</pub-id></mixed-citation>
      </ref>
      <ref id="cit0076">
        <label>76.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Legoux</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Salou</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Lantz</surname>
<given-names>O</given-names></string-name></person-group>. <article-title>MAIT cell development and functions: the microbial connection</article-title>. <source>Immunity</source>
<comment><italic toggle="yes">ScienceDirect</italic></comment>. <year>2020</year>
<month>October</month>
<day>13</day>;<volume>53</volume>(<issue>4</issue>):<fpage>710</fpage>&#x2013;<lpage>723</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.immuni.2020.09.009</pub-id>.<pub-id pub-id-type="pmid">33053329</pub-id></mixed-citation>
      </ref>
      <ref id="cit0077">
        <label>77.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gebru</surname>
<given-names>YA</given-names></string-name>, <string-name><surname>Choi</surname>
<given-names>MR</given-names></string-name>, <string-name><surname>Raja</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Gupta</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Sharma</surname>
<given-names>SP</given-names></string-name>, <string-name><surname>Choi</surname>
<given-names>YR</given-names></string-name>, <string-name><surname>Kim</surname>
<given-names>HS</given-names></string-name>, <string-name><surname>Yoon</surname>
<given-names>SJ</given-names></string-name>, <string-name><surname>Kim</surname>
<given-names>DJ</given-names></string-name>, <string-name><surname>Suk</surname>
<given-names>KT</given-names></string-name></person-group>. <article-title>Pathophysiological roles of mucosal-associated invariant t cells in the context of gut microbiota-liver axis</article-title>. <source>Microorganisms</source>. <year>2021</year>;<volume>9</volume>(<issue>2</issue>):<fpage>296</fpage>. doi:<pub-id pub-id-type="doi">10.3390/microorganisms9020296</pub-id>.<pub-id pub-id-type="pmid">33535703</pub-id></mixed-citation>
      </ref>
      <ref id="cit0078">
        <label>78.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Vojvodic</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Peric-Hajzler</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Matovic</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Vojvodic</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Vlaskovic-Jovicevic</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Sijan</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Dimitrijevic</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Stepic</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Wollina</surname>
<given-names>U</given-names></string-name>, <string-name><surname>Badr</surname>
<given-names>BAE</given-names></string-name>, et al</person-group>. <article-title>Gut microbiota and the alteration of immune balance in skin diseases: from nutraceuticals to fecal transplantation</article-title>. <source>Open Access Macedonian J Med Sci</source>. <year>2019</year>;<volume>7</volume>(<issue>18</issue>):<fpage>3034</fpage>&#x2013;<lpage>3038</lpage>. doi:<pub-id pub-id-type="doi">10.3889/oamjms.2019.827</pub-id>.</mixed-citation>
      </ref>
      <ref id="cit0079">
        <label>79.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>LeBlanc</surname>
<given-names>JG</given-names></string-name>, <string-name><surname>Milani</surname>
<given-names>C</given-names></string-name>, <string-name><surname>de Giori</surname>
<given-names>GS</given-names></string-name>, <string-name><surname>Sesma</surname>
<given-names>F</given-names></string-name>, <string-name><surname>van Sinderen</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Ventura</surname>
<given-names>M</given-names></string-name></person-group>. <article-title>Bacteria as vitamin suppliers to their host: a gut microbiota perspective</article-title>. <source>Curr Opin Biotechnol</source>. <year>2013</year>;<volume>24</volume>(<issue>2</issue>):<fpage>160</fpage>&#x2013;<lpage>168</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.copbio.2012.08.005</pub-id>.<pub-id pub-id-type="pmid">22940212</pub-id></mixed-citation>
      </ref>
      <ref id="cit0080">
        <label>80.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Scott</surname>
<given-names>KP</given-names></string-name>, <string-name><surname>Gratz</surname>
<given-names>SW</given-names></string-name>, <string-name><surname>Sheridan</surname>
<given-names>PO</given-names></string-name>, <string-name><surname>Flint</surname>
<given-names>HJ</given-names></string-name>, <string-name><surname>Duncan</surname>
<given-names>SH</given-names></string-name></person-group>. <article-title>The influence of diet on the gut microbiota</article-title>. <source>Pharmacol Res</source>. <year>2013</year>;<volume>69</volume>(<issue>1</issue>):<fpage>52</fpage>&#x2013;<lpage>60</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.phrs.2012.10.020</pub-id>.<pub-id pub-id-type="pmid">23147033</pub-id></mixed-citation>
      </ref>
      <ref id="cit0081">
        <label>81.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Belkaid</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Harrison</surname>
<given-names>OJ</given-names></string-name></person-group>. <article-title>Homeostatic immunity and the microbiota</article-title>. <source>Immunity</source>. <year>2017</year>;<volume>46</volume>(<issue>4</issue>):<fpage>562</fpage>&#x2013;<lpage>576</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.immuni.2017.04.008</pub-id>.<pub-id pub-id-type="pmid">28423337</pub-id></mixed-citation>
      </ref>
      <ref id="cit0082">
        <label>82.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Konrad</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Cong</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Duck</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Borlaza</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Elson</surname>
<given-names>CO</given-names></string-name></person-group>. <article-title>Tight mucosal compartmentation of the murine immune response to antigens of the enteric microbiota</article-title>. <source>Gastroenterology</source>. <year>2006</year>;<volume>130</volume>(<issue>7</issue>):<fpage>2050</fpage>&#x2013;<lpage>2059</lpage>. doi:<pub-id pub-id-type="doi">10.1053/j.gastro.2006.02.055</pub-id>.<pub-id pub-id-type="pmid">16762628</pub-id></mixed-citation>
      </ref>
      <ref id="cit0083">
        <label>83.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mowat</surname>
<given-names>AM</given-names></string-name></person-group>. <article-title>Anatomical basis of tolerance and immunity to intestinal antigens</article-title>. <source>Nat Rev Immunol</source>. <year>2003</year>;<volume>3</volume>(<issue>4</issue>):<fpage>331</fpage>&#x2013;<lpage>341</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nri1057</pub-id>.<pub-id pub-id-type="pmid">12669023</pub-id></mixed-citation>
      </ref>
      <ref id="cit0084">
        <label>84.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Macpherson</surname>
<given-names>AJ</given-names></string-name>, <string-name><surname>Uhr</surname>
<given-names>T</given-names></string-name></person-group>. <article-title>Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria</article-title>. <source>Sci (New York, N Y)</source>. <year>2004</year>;<volume>303</volume>(<issue>5664</issue>):<fpage>1662</fpage>&#x2013;<lpage>1665</lpage>. doi:<pub-id pub-id-type="doi">10.1126/science.1091334</pub-id>.</mixed-citation>
      </ref>
      <ref id="cit0085">
        <label>85.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Naik</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Bouladoux</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Linehan</surname>
<given-names>JL</given-names></string-name>, <string-name><surname>Han</surname>
<given-names>SJ</given-names></string-name>, <string-name><surname>Harrison</surname>
<given-names>OJ</given-names></string-name>, <string-name><surname>Wilhelm</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Conlan</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Himmelfarb</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Byrd</surname>
<given-names>AL</given-names></string-name>, <string-name><surname>Deming</surname>
<given-names>C</given-names></string-name>, et al</person-group>. <article-title>Commensal&#x2013;dendritic-cell interaction specifies a unique protective skin immune signature</article-title>. <source>Nature</source>. <year>2015</year>;<volume>520</volume>(<issue>7545</issue>):<fpage>104</fpage>&#x2013;<lpage>108</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nature14052</pub-id>.<pub-id pub-id-type="pmid">25539086</pub-id></mixed-citation>
      </ref>
      <ref id="cit0086">
        <label>86.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Goto</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Panea</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Nakato</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Cebula</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Lee</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Diez</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Laufer</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Ignatowicz</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Ivanov</surname>
<given-names>I</given-names></string-name></person-group>. <article-title>Segmented filamentous bacteria antigens presented by intestinal dendritic cells drive mucosal Th17 cell differentiation</article-title>. <source>Immunity</source>. <year>2014</year>;<volume>40</volume>(<issue>4</issue>):<fpage>594</fpage>&#x2013;<lpage>607</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.immuni.2014.03.005</pub-id>.<pub-id pub-id-type="pmid">24684957</pub-id></mixed-citation>
      </ref>
      <ref id="cit0087">
        <label>87.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Liang</surname>
<given-names>SC</given-names></string-name>, <string-name><surname>Tan</surname>
<given-names>XY</given-names></string-name>, <string-name><surname>Luxenberg</surname>
<given-names>DP</given-names></string-name>, <string-name><surname>Karim</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Dunussi-Joannopoulos</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Collins</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Fouser</surname>
<given-names>LA</given-names></string-name></person-group>. <article-title>Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides</article-title>. <source>J Exp Med</source>. <year>2006</year>;<volume>203</volume>(<issue>10</issue>):<fpage>2271</fpage>&#x2013;<lpage>2279</lpage>. doi:<pub-id pub-id-type="doi">10.1084/jem.20061308</pub-id>.<pub-id pub-id-type="pmid">16982811</pub-id></mixed-citation>
      </ref>
      <ref id="cit0088">
        <label>88.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kaetzel</surname>
<given-names>CS</given-names></string-name></person-group>. <article-title>Cooperativity among secretory IgA, the polymeric immunoglobulin receptor, and the gut microbiota promotes host&#x2013;microbial mutualism</article-title>. <source>Immunol Lett</source>. <year>2014</year>;<volume>162</volume>(<issue>2</issue>):<fpage>10</fpage>&#x2013;<lpage>21</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.imlet.2014.05.008</pub-id>.<pub-id pub-id-type="pmid">24877874</pub-id></mixed-citation>
      </ref>
      <ref id="cit0089">
        <label>89.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mantis</surname>
<given-names>NJ</given-names></string-name>, <string-name><surname>Rol</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Corth&#xE9;sy</surname>
<given-names>B</given-names></string-name></person-group>. <article-title>Secretory IgA&#x2019;s complex roles in immunity and mucosal homeostasis in the gut</article-title>. <source>Mucosal Immunol</source>. <year>2011</year>;<volume>4</volume>(<issue>6</issue>):<fpage>603</fpage>&#x2013;<lpage>611</lpage>. doi:<pub-id pub-id-type="doi">10.1038/mi.2011.41</pub-id>.<pub-id pub-id-type="pmid">21975936</pub-id></mixed-citation>
      </ref>
      <ref id="cit0090">
        <label>90.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Suzuki</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Maruya</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Kawamoto</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Sitnik</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Kitamura</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Agace</surname>
<given-names>WW</given-names></string-name>, <string-name><surname>Fagarasan</surname>
<given-names>S</given-names></string-name></person-group>. <article-title>The sensing of environmental stimuli by follicular dendritic cells promotes immunoglobulin A generation in the gut</article-title>. <source>Immunity</source>. <year>2010</year>;<volume>33</volume>(<issue>1</issue>):<fpage>71</fpage>&#x2013;<lpage>83</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.immuni.2010.07.003</pub-id>.<pub-id pub-id-type="pmid">20643338</pub-id></mixed-citation>
      </ref>
      <ref id="cit0091">
        <label>91.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wang</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Cho</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Suzuki</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Xu</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Green</surname>
<given-names>JA</given-names></string-name>, <string-name><surname>An</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Cyster</surname>
<given-names>JG</given-names></string-name></person-group>. <article-title>Follicular dendritic cells help establish follicle identity and promote B cell retention in germinal centers</article-title>. <source>J Exp Med</source>. <year>2011</year>;<volume>208</volume>(<issue>12</issue>):<fpage>2497</fpage>&#x2013;<lpage>2510</lpage>. doi:<pub-id pub-id-type="doi">10.1084/jem.20111449</pub-id>.<pub-id pub-id-type="pmid">22042977</pub-id></mixed-citation>
      </ref>
      <ref id="cit0092">
        <label>92.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lazar</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Ditu</surname>
<given-names>LM</given-names></string-name>, <string-name><surname>Pircalabioru</surname>
<given-names>GG</given-names></string-name>, <string-name><surname>Gheorghe</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Curutiu</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Holban</surname>
<given-names>AM</given-names></string-name>, <string-name><surname>Picu</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Petcu</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Chifiriuc</surname>
<given-names>MC</given-names></string-name></person-group>. <article-title>Aspects of gut microbiota and immune system interactions in infectious diseases, immunopathology, and cancer</article-title>. <source>Front Immunol</source>. <year>2018</year>;<volume>9</volume>:<fpage>1830</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fimmu.2018.01830</pub-id>.<pub-id pub-id-type="pmid">30158926</pub-id></mixed-citation>
      </ref>
      <ref id="cit0093">
        <label>93.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wu</surname>
<given-names>HJ</given-names></string-name>, <string-name><surname>Wu</surname>
<given-names>E</given-names></string-name></person-group>. <article-title>The role of gut microbiota in immune homeostasis and autoimmunity</article-title>. <source>Gut Microbes</source>. <year>2012</year>;<volume>3</volume>(<issue>1</issue>):<fpage>4</fpage>&#x2013;<lpage>14</lpage>. doi:<pub-id pub-id-type="doi">10.4161/gmic.19320</pub-id>.<pub-id pub-id-type="pmid">22356853</pub-id></mixed-citation>
      </ref>
      <ref id="cit0094">
        <label>94.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Arck</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Handjiski</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Hagen</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Pincus</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Bruenahl</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Bienenstock</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Paus</surname>
<given-names>R</given-names></string-name></person-group>. <article-title>Is there a &#x2018;gut-brain-skin axis&#x2019;?</article-title>
<source>Exp Dermatol</source>. <year>2010</year>;<volume>19</volume>(<issue>5</issue>):<fpage>401</fpage>&#x2013;<lpage>405</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1600-0625.2009.01060.x</pub-id>.<pub-id pub-id-type="pmid">20113345</pub-id></mixed-citation>
      </ref>
      <ref id="cit0095">
        <label>95.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lyte</surname>
<given-names>M</given-names></string-name></person-group>. <article-title>Microbial endocrinology and the microbiota-gut-brain axis</article-title>. <source>Adv Exp Med Biol</source>. <year>2014</year>:<fpage>3</fpage>&#x2013;<lpage>24</lpage>. doi:<pub-id pub-id-type="doi">10.1007/978-1-4939-0897-4_1</pub-id>.</mixed-citation>
      </ref>
      <ref id="cit0096">
        <label>96.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hokazono</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Omori</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Ono</surname>
<given-names>K</given-names></string-name></person-group>. <article-title>Effects of single and combined administration of fermented barley extract and &#x3B3;-aminobutyric acid on the development of atopic dermatitis in NC/Nga mice</article-title>. <source>Biosci Biotechnol Biochem</source>. <year>2010</year>;<volume>74</volume>(<issue>1</issue>):<fpage>135</fpage>&#x2013;<lpage>139</lpage>. doi:<pub-id pub-id-type="doi">10.1271/bbb.90653</pub-id>.<pub-id pub-id-type="pmid">20057128</pub-id></mixed-citation>
      </ref>
      <ref id="cit0097">
        <label>97.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Uehara</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Hokazono</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Sasaki</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Yoshioka</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Matsuo</surname>
<given-names>N</given-names></string-name></person-group>. <article-title>Effects of GABA on the expression of type I collagen gene in normal human dermal fibroblasts</article-title>. <source>Biosci Biotechnol Biochem</source>. <year>2017</year>;<volume>81</volume>(<issue>2</issue>):<fpage>376</fpage>&#x2013;<lpage>379</lpage>. doi:<pub-id pub-id-type="doi">10.1080/09168451.2016.1238296</pub-id>.<pub-id pub-id-type="pmid">27691923</pub-id></mixed-citation>
      </ref>
      <ref id="cit0098">
        <label>98.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Langan</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Lisztes</surname>
<given-names>E</given-names></string-name>, <string-name><surname>B&#xED;r&#xF3;</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Funk</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Kloepper</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Griffiths</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Paus</surname>
<given-names>R</given-names></string-name></person-group>. <article-title>Dopamine is a novel, direct inducer of catagen in human scalp hair folliclesin vitro</article-title>. <source>Bri J Dermatol</source>. <year>2012</year>;<volume>168</volume>(<issue>3</issue>):<fpage>520</fpage>&#x2013;<lpage>525</lpage>. doi:<pub-id pub-id-type="doi">10.1111/bjd.12113</pub-id>.</mixed-citation>
      </ref>
      <ref id="cit0099">
        <label>99.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ainonen</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Tejesvi</surname>
<given-names>MV</given-names></string-name>, <string-name><surname>Mahmud</surname>
<given-names>MR</given-names></string-name>, <string-name><surname>Paalanne</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Pokka</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Nelson</surname>
<given-names>KE</given-names></string-name>, <string-name><surname>Salo</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Renko</surname>
<given-names>M</given-names></string-name>, <string-name><surname>V&#xE4;nni</surname>
<given-names>P</given-names></string-name>, et al</person-group>. <article-title>Antibiotics at birth and later antibiotic courses: effects on gut microbiota</article-title>. <source>Pediatr Res</source>. <year>2021</year>;<volume>91</volume>(<issue>1</issue>):<fpage>154</fpage>&#x2013;<lpage>162</lpage>. doi:<pub-id pub-id-type="doi">10.1038/s41390-021-01494-7</pub-id>.<pub-id pub-id-type="pmid">33824448</pub-id></mixed-citation>
      </ref>
      <ref id="cit0100">
        <label>100.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Conlon</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Bird</surname>
<given-names>A</given-names></string-name></person-group>. <article-title>The impact of diet and lifestyle on gut microbiota and human health</article-title>. <source>Nutrients</source>. <year>2014</year>;<volume>7</volume>(<issue>1</issue>):<fpage>17</fpage>&#x2013;<lpage>44</lpage>. doi:<pub-id pub-id-type="doi">10.3390/nu7010017</pub-id>.<pub-id pub-id-type="pmid">25545101</pub-id></mixed-citation>
      </ref>
      <ref id="cit0101">
        <label>101.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Rodr&#xED;guez</surname>
<given-names>JM</given-names></string-name>, <string-name><surname>Murphy</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Stanton</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Ross</surname>
<given-names>RP</given-names></string-name>, <string-name><surname>Kober</surname>
<given-names>OI</given-names></string-name>, <string-name><surname>Juge</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Avershina</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Rudi</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Narbad</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Jenmalm</surname>
<given-names>MC</given-names></string-name>, et al</person-group>. <article-title>The composition of the gut microbiota throughout life, with an emphasis on early life</article-title>. <source>Microb Ecol Health Dis</source>. <year>2015</year>;<volume>26</volume>. doi:<pub-id pub-id-type="doi">10.3402/mehd.v26.26050</pub-id>.</mixed-citation>
      </ref>
      <ref id="cit0102">
        <label>102.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tojo</surname>
<given-names>R</given-names></string-name></person-group>. <article-title>Intestinal microbiota in health and disease: role of bifidobacteria in gut homeostasis</article-title>. <source>World J Gastroenterol</source>. <year>2014</year>;<volume>20</volume>(<issue>41</issue>):<fpage>15163</fpage>. doi:<pub-id pub-id-type="doi">10.3748/wjg.v20.i41.15163</pub-id>.<pub-id pub-id-type="pmid">25386066</pub-id></mixed-citation>
      </ref>
      <ref id="cit0103">
        <label>103.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Drake</surname>
<given-names>D</given-names></string-name></person-group>. <article-title>The gut microbiome&#x2010;skin axis</article-title>. <source>Skin Microbiome Handb</source>. <year>2020</year>:<fpage>33</fpage>&#x2013;<lpage>44</lpage>. doi:<pub-id pub-id-type="doi">10.1002/9781119593058.ch2</pub-id>.</mixed-citation>
      </ref>
      <ref id="cit0104">
        <label>104.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ramasamy</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Barnard</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Dawson</surname>
<given-names>TL</given-names>
<suffix>Jr</suffix></string-name>, <string-name><surname>Li</surname>
<given-names>H</given-names></string-name></person-group>. <article-title>The role of the skin microbiota in acne pathophysiology</article-title>. <source>Br J Dermatol</source>. <year>2019</year>;<volume>181</volume>(<issue>4</issue>):<fpage>691</fpage>&#x2013;<lpage>699</lpage>. doi:<pub-id pub-id-type="doi">10.1111/bjd.18230</pub-id>.<pub-id pub-id-type="pmid">31342510</pub-id></mixed-citation>
      </ref>
      <ref id="cit0105">
        <label>105.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Graf</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Di Cagno</surname>
<given-names>R</given-names></string-name>, <string-name><surname>F&#xE5;k</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Flint</surname>
<given-names>HJ</given-names></string-name>, <string-name><surname>Nyman</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Saarela</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Watzl</surname>
<given-names>B</given-names></string-name></person-group>. <article-title>Contribution of diet to the composition of the human gut microbiota</article-title>. <source>Microb Ecol Health Dis</source>. <year>2015</year>;<volume>26</volume>:<fpage>26164</fpage>. doi:<pub-id pub-id-type="doi">10.3402/mehd.v26.26164</pub-id>.<pub-id pub-id-type="pmid">25656825</pub-id></mixed-citation>
      </ref>
      <ref id="cit0106">
        <label>106.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Singh</surname>
<given-names>RK</given-names></string-name>, <string-name><surname>Chang</surname>
<given-names>HW</given-names></string-name>, <string-name><surname>Yan</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Lee</surname>
<given-names>KM</given-names></string-name>, <string-name><surname>Ucmak</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Wong</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Abrouk</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Farahnik</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Nakamura</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Zhu</surname>
<given-names>TH</given-names></string-name>, et al</person-group>. <article-title>Influence of diet on the gut microbiome and implications for human health</article-title>. <source>J Transl Med</source>. <year>2017</year>;<volume>15</volume>(<issue>1</issue>). doi:<pub-id pub-id-type="doi">10.1186/s12967-017-1175-y</pub-id>.</mixed-citation>
      </ref>
      <ref id="cit0107">
        <label>107.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Vaughn</surname>
<given-names>AR</given-names></string-name>, <string-name><surname>Notay</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Clark</surname>
<given-names>AK</given-names></string-name>, <string-name><surname>Sivamani</surname>
<given-names>RK</given-names></string-name></person-group>. <article-title>Skin-gut axis: the relationship between intestinal bacteria and skin health</article-title>. <source>World J Dermatol</source>. <year>2017</year>;<volume>6</volume>(<issue>4</issue>):<fpage>52</fpage>&#x2013;<lpage>58</lpage>. doi:<pub-id pub-id-type="doi">10.5314/wjd.v6.i4.52</pub-id>.</mixed-citation>
      </ref>
      <ref id="cit0108">
        <label>108.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Purchiaroni</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Tortora</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Gabrielli</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Bertucci</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Gigante</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Ianiro</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Ojetti</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Scarpellini</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Gasbarrini</surname>
<given-names>A</given-names></string-name></person-group>. <article-title>The role of intestinal microbiota and the immune system</article-title>. <source>Eur Rev Med Pharmacol Sci</source>. <year>2013</year>;<volume>17</volume>:<fpage>323</fpage>&#x2013;<lpage>333</lpage>.<pub-id pub-id-type="pmid">23426535</pub-id></mixed-citation>
      </ref>
      <ref id="cit0109">
        <label>109.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Madke</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Pradhan</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Kabra</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Singh</surname>
<given-names>A</given-names></string-name></person-group>. <article-title>Anti-inflammatory and immunomodulatory effects of antibiotics and their use in dermatology</article-title>. <source>Indian J Dermatol</source>. <year>2016</year>;<volume>61</volume>(<issue>5</issue>):<fpage>469</fpage>. doi:<pub-id pub-id-type="doi">10.4103/0019-5154.190105</pub-id>.<pub-id pub-id-type="pmid">27688434</pub-id></mixed-citation>
      </ref>
      <ref id="cit0110">
        <label>110.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ribeiro</surname>
<given-names>CFA</given-names></string-name>, <string-name><surname>Silveira</surname>
<given-names>GGDOS</given-names></string-name>, <string-name><surname>C&#xE2;ndido</surname>
<given-names>EDS</given-names></string-name>, <string-name><surname>Cardoso</surname>
<given-names>MH</given-names></string-name>, <string-name><surname>Esp&#xED;nola Carvalho</surname>
<given-names>CM</given-names></string-name>, <string-name><surname>Franco</surname>
<given-names>OL</given-names></string-name></person-group>. <article-title>Effects of antibiotic treatment on gut microbiota and how to overcome its negative impacts on human health</article-title>. <source>ACS Infect Dis</source>. <year>2020</year>;<volume>6</volume>(<issue>10</issue>):<fpage>2544</fpage>&#x2013;<lpage>2559</lpage>. doi:<pub-id pub-id-type="doi">10.1021/acsinfecdis.0c00036</pub-id>.<pub-id pub-id-type="pmid">32786282</pub-id></mixed-citation>
      </ref>
      <ref id="cit0111">
        <label>111.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sinha</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Lin</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Ferenczi</surname>
<given-names>K</given-names></string-name></person-group>. <article-title>The skin microbiome and the gut-skin axis</article-title>. <source>Clin Dermatol</source>. <year>2021</year>;<volume>39</volume>(<issue>5</issue>):<fpage>829</fpage>&#x2013;<lpage>839</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.clindermatol.2021.08.021</pub-id>.<pub-id pub-id-type="pmid">34785010</pub-id></mixed-citation>
      </ref>
      <ref id="cit0112">
        <label>112.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Baquerizo Nole</surname>
<given-names>KL</given-names></string-name>, <string-name><surname>Yim</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Keri</surname>
<given-names>JE</given-names></string-name></person-group>. <article-title>Probiotics and prebiotics in dermatology</article-title>. <source>J Am Acad Dermatol</source>. <year>2014</year>;<volume>71</volume>(<issue>4</issue>):<fpage>814</fpage>&#x2013;<lpage>821</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jaad.2014.04.050</pub-id>.<pub-id pub-id-type="pmid">24906613</pub-id></mixed-citation>
      </ref>
      <ref id="cit0113">
        <label>113.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Linares</surname>
<given-names>DM</given-names></string-name>, <string-name><surname>Ross</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Stanton</surname>
<given-names>C</given-names></string-name></person-group>. <article-title>Beneficial microbes: the pharmacy in the gut</article-title>. <source>Bioengineered</source>. <year>2015</year>;<volume>7</volume>(<issue>1</issue>):<fpage>11</fpage>&#x2013;<lpage>20</lpage>. doi:<pub-id pub-id-type="doi">10.1080/21655979.2015.1126015</pub-id>.</mixed-citation>
      </ref>
      <ref id="cit0114">
        <label>114.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kordy</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Gaufin</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Mwangi</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Cerini</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Lee</surname>
<given-names>DJ</given-names></string-name>, <string-name><surname>Adisetiyo</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Woodward</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Pannaraj</surname>
<given-names>PS</given-names></string-name>, <string-name><surname>Tobin</surname>
<given-names>NH</given-names></string-name>, et al</person-group>. <article-title>Contributions to human breast milk microbiome and enteromammary transfer of <italic toggle="yes">Bifidobacterium breve</italic></article-title>. <source>PLOS ONE</source>. <year>2020</year>;<volume>15</volume>(<issue>1</issue>):<fpage>e0219633</fpage>. doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0219633</pub-id>.<pub-id pub-id-type="pmid">31990909</pub-id></mixed-citation>
      </ref>
      <ref id="cit0115">
        <label>115.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Shamash</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Maurice</surname>
<given-names>CF</given-names></string-name></person-group>. <article-title>Phages in the infant gut: a framework for virome development during early life</article-title>. <source>ISME J Published</source>. <year>2021</year>. doi:<pub-id pub-id-type="doi">10.1038/s41396-021-01090-x</pub-id>.</mixed-citation>
      </ref>
      <ref id="cit0116">
        <label>116.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Duranti</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Lugli</surname>
<given-names>GA</given-names></string-name>, <string-name><surname>Mancabelli</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Armanini</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Turroni</surname>
<given-names>F</given-names></string-name>, <string-name><surname>James</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Ferretti</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Gorfer</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Ferrario</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Milani</surname>
<given-names>C</given-names></string-name>, et al</person-group>. <article-title>Maternal inheritance of bifidobacterial communities and bifidophages in infants through vertical transmission</article-title>. <source>Microbiome</source>. <year>2017</year>:<page-range>5(1)</page-range>. doi:<pub-id pub-id-type="doi">10.1186/s40168-017-0282-6</pub-id>.</mixed-citation>
      </ref>
      <ref id="cit0117">
        <label>117.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tanaka</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Nakayama</surname>
<given-names>J</given-names></string-name></person-group>. <article-title>Development of the gut microbiota in infancy and its impact on health in later life</article-title>. <source>Allergol Int</source>. <year>2017</year>;<volume>66</volume>(<issue>4</issue>):<fpage>515</fpage>&#x2013;<lpage>522</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.alit.2017.07.010</pub-id>.<pub-id pub-id-type="pmid">28826938</pub-id></mixed-citation>
      </ref>
      <ref id="cit0118">
        <label>118.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zeng</surname>
<given-names>MY</given-names></string-name>, <string-name><surname>Inohara</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Nu&#xF1;ez</surname>
<given-names>G</given-names></string-name></person-group>. <article-title>Mechanisms of inflammation-driven bacterial dysbiosis in the gut</article-title>. <source>Mucosal Immunol</source>. <year>2016</year>;<volume>10</volume>(<issue>1</issue>):<fpage>18</fpage>&#x2013;<lpage>26</lpage>. doi:<pub-id pub-id-type="doi">10.1038/mi.2016.75</pub-id>.<pub-id pub-id-type="pmid">27554295</pub-id></mixed-citation>
      </ref>
      <ref id="cit0119">
        <label>119.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>O&#x2019;Sullivan</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Farver</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Smilowitz</surname>
<given-names>JT</given-names></string-name></person-group>. <article-title>The influence of early infant-feeding practices on the intestinal microbiome and body composition in infants</article-title>. <source>Nutr Metab Insights</source>. <year>2015</year>;<volume>8</volume>(<issue>Suppl 1</issue>):<fpage>1</fpage>&#x2013;<lpage>9</lpage>. doi:<pub-id pub-id-type="doi">10.4137/NMI.S29530</pub-id>.</mixed-citation>
      </ref>
      <ref id="cit0120">
        <label>120.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Egawa</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Honda</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Kabashima</surname>
<given-names>K</given-names></string-name></person-group>. <article-title>SCFAs control skin immune responses via increasing tregs</article-title>. <source>J Invest Dermatol</source>. <year>2017</year>;<volume>137</volume>(<issue>4</issue>):<fpage>800</fpage>&#x2013;<lpage>801</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jid.2016.12.022</pub-id>.<pub-id pub-id-type="pmid">28340682</pub-id></mixed-citation>
      </ref>
      <ref id="cit0121">
        <label>121.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ge</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Tao</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Qiu</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Xu</surname>
<given-names>T</given-names></string-name></person-group>. <article-title>Effect of industrial trans-fatty acids-enriched diet on gut microbiota of C57BL/6 mice</article-title>. <source>Eur J Nutr</source>. <year>2019</year>;<volume>58</volume>(<issue>7</issue>):<fpage>2625</fpage>&#x2013;<lpage>2638</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s00394-018-1810-2</pub-id>.<pub-id pub-id-type="pmid">30120538</pub-id></mixed-citation>
      </ref>
      <ref id="cit0122">
        <label>122.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Rosa</surname>
<given-names>DF</given-names></string-name>, <string-name><surname>Sarandy</surname>
<given-names>MM</given-names></string-name>, <string-name><surname>Novaes</surname>
<given-names>RD</given-names></string-name>, <string-name><surname>Freitas</surname>
<given-names>MB</given-names></string-name>, <string-name><surname>Do Carmo Gouveia Pel&#xFA;zio</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Gon&#xE7;alves</surname>
<given-names>RV</given-names></string-name></person-group>. <article-title>High-fat diet and alcohol intake promotes inflammation and impairs skin wound healing in wistar rats</article-title>. <source>Mediators Inflamm</source>. <year>2018</year>;<volume>2018</volume>:<fpage>4658583</fpage>. doi:<pub-id pub-id-type="doi">10.1155/2018/4658583</pub-id>.<pub-id pub-id-type="pmid">30140168</pub-id></mixed-citation>
      </ref>
      <ref id="cit0123">
        <label>123.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Morales</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Fujio</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Navarrete</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Ugalde</surname>
<given-names>JA</given-names></string-name>, <string-name><surname>Magne</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Carrasco-Pozo</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Tralma</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Quezada</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Hurtado</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Covarrubias</surname>
<given-names>N</given-names></string-name>, et al</person-group>. <article-title>Impact of dietary lipids on colonic function and microbiota: an experimental approach involving orlistat-induced fat malabsorption in human volunteers</article-title>. <source>Clin Transl Gastroenterol</source>. <year>2016</year>;<volume>7</volume>(<issue>4</issue>):<fpage>e161</fpage>. doi:<pub-id pub-id-type="doi">10.1038/ctg.2016.20</pub-id>.<pub-id pub-id-type="pmid">27054579</pub-id></mixed-citation>
      </ref>
      <ref id="cit0124">
        <label>124.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Coras</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Kavanaugh</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Boyd</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Huynh</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Lagerborg</surname>
<given-names>KA</given-names></string-name>, <string-name><surname>Xu</surname>
<given-names>YJ</given-names></string-name>, <string-name><surname>Rosenthal</surname>
<given-names>SB</given-names></string-name>, <string-name><surname>Jain</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Guma</surname>
<given-names>M</given-names></string-name></person-group>. <article-title>Choline metabolite, trimethylamine N-oxide (TMAO), is associated with inflammation in psoriatic arthritis</article-title>. <source>Clin Exp Rheumatol</source>. <year>2019</year>;<volume>37</volume>:<fpage>481</fpage>&#x2013;<lpage>484</lpage>.<pub-id pub-id-type="pmid">30620278</pub-id></mixed-citation>
      </ref>
      <ref id="cit0125">
        <label>125.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mei</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Duan</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Chen</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Lu</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Zhao</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Shen</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Xia</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Chen</surname>
<given-names>S</given-names></string-name></person-group>. <article-title>Effect of a high-collagen peptide diet on the gut microbiota and short-chain fatty acid metabolism</article-title>. <source>J Funct Foods</source>. <year>2020</year>;<volume>75</volume>:<fpage>104278</fpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jff.2020.104278</pub-id>.</mixed-citation>
      </ref>
      <ref id="cit0126">
        <label>126.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Komine</surname>
<given-names>M</given-names></string-name></person-group>. <article-title>Recent advances in psoriasis research; the clue to mysterious relation to gut microbiome</article-title>. <source>Int J Mol Sci</source>. <year>2020</year>;<volume>21</volume>(<issue>7</issue>):<fpage>2582</fpage>. doi:<pub-id pub-id-type="doi">10.3390/ijms21072582</pub-id>.</mixed-citation>
      </ref>
      <ref id="cit0127">
        <label>127.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Smith</surname>
<given-names>PM</given-names></string-name>, <string-name><surname>Howitt</surname>
<given-names>MR</given-names></string-name>, <string-name><surname>Panikov</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Michaud</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Gallini</surname>
<given-names>CA</given-names></string-name>, <string-name><surname>Bohlooly-Y</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Glickman</surname>
<given-names>JN</given-names></string-name>, <string-name><surname>Garrett</surname>
<given-names>WS</given-names></string-name></person-group>. <article-title>The microbial metabolites, short-chain fatty acids, regulate colonic t reg cell homeostasis</article-title>. <source>Science</source>. <year>2013</year>;<volume>341</volume>(<issue>6145</issue>):<fpage>569</fpage>&#x2013;<lpage>573</lpage>. doi:<pub-id pub-id-type="doi">10.1126/science.1241165</pub-id>.<pub-id pub-id-type="pmid">23828891</pub-id></mixed-citation>
      </ref>
      <ref id="cit0128">
        <label>128.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Maslowski</surname>
<given-names>KM</given-names></string-name>, <string-name><surname>Vieira</surname>
<given-names>AT</given-names></string-name>, <string-name><surname>Ng</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Kranich</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Sierro</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Yu</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Schilter</surname>
<given-names>HC</given-names></string-name>, <string-name><surname>Rolph</surname>
<given-names>MS</given-names></string-name>, <string-name><surname>Mackay</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Artis</surname>
<given-names>D</given-names></string-name>, et al</person-group>. <article-title>Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43</article-title>. <source>Nature</source>. <year>2009</year>;<volume>461</volume>(<issue>7268</issue>):<fpage>1282</fpage>&#x2013;<lpage>1286</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nature08530</pub-id>.<pub-id pub-id-type="pmid">19865172</pub-id></mixed-citation>
      </ref>
      <ref id="cit0129">
        <label>129.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ramirez</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Guarner</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Bustos Fernandez</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Maruy</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Sdepanian</surname>
<given-names>VL</given-names></string-name>, <string-name><surname>Cohen</surname>
<given-names>H</given-names></string-name></person-group>. <article-title>Antibiotics as major disruptors of gut microbiota</article-title>. <source>Front Cell Infect Microbiol</source>. <year>2020</year>;<volume>10</volume>:<fpage>572912</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fcimb.2020.572912</pub-id>.<pub-id pub-id-type="pmid">33330122</pub-id></mixed-citation>
      </ref>
      <ref id="cit0130">
        <label>130.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Samonis</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Kofteridis</surname>
<given-names>DP</given-names></string-name>, <string-name><surname>Maraki</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Alegakis</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Mantadakis</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Papadakis</surname>
<given-names>JA</given-names></string-name>, <string-name><surname>Gikas</surname>
<given-names>AH</given-names></string-name>, <string-name><surname>Falagas</surname>
<given-names>M</given-names></string-name></person-group>. <article-title>Levofloxacin and moxifloxacin increase human gut colonization by <italic toggle="yes">candida</italic> species</article-title>. <source>Antimicrob Agents Chemother</source>. <year>2005</year>;<volume>49</volume>(<issue>12</issue>):<fpage>5189</fpage>. doi:<pub-id pub-id-type="doi">10.1128/aac.49.12.5189.2005</pub-id>.<pub-id pub-id-type="pmid">16304202</pub-id></mixed-citation>
      </ref>
      <ref id="cit0131">
        <label>131.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gu</surname>
<given-names>ZQ</given-names></string-name>, <string-name><surname>Tseng</surname>
<given-names>KY</given-names></string-name>, <string-name><surname>Tsai</surname>
<given-names>YH</given-names></string-name></person-group>. <article-title>Candida gut commensalism and inflammatory disease</article-title>. <source>Med Microecol</source>. <year>2020</year>;<volume>3</volume>:<fpage>100008</fpage>. doi:<pub-id pub-id-type="doi">10.1016/j.medmic.2020.100008</pub-id>.</mixed-citation>
      </ref>
      <ref id="cit0132">
        <label>132.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gibson</surname>
<given-names>GR</given-names></string-name>, <string-name><surname>Hutkins</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Sanders</surname>
<given-names>ME</given-names></string-name>, <string-name><surname>Prescott</surname>
<given-names>SL</given-names></string-name>, <string-name><surname>Reimer</surname>
<given-names>RA</given-names></string-name>, <string-name><surname>Salminen</surname>
<given-names>SJ</given-names></string-name>, <string-name><surname>Scott</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Stanton</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Swanson</surname>
<given-names>KS</given-names></string-name>, <string-name><surname>Cani</surname>
<given-names>PD</given-names></string-name>, et al</person-group>. <article-title>Expert consensus document: the International scientific association for probiotics and prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics</article-title>. <source>Nat Rev Gastroenterol Hepatol</source>. <year>2017</year>;<volume>14</volume>(<issue>8</issue>):<fpage>491</fpage>&#x2013;<lpage>502</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nrgastro.2017.75</pub-id>.<pub-id pub-id-type="pmid">28611480</pub-id></mixed-citation>
      </ref>
      <ref id="cit0133">
        <label>133.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Azad</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Sarker</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Yin</surname>
<given-names>J</given-names></string-name></person-group>. <article-title>Probiotic species in the modulation of gut microbiota: an overview</article-title>. <source>Biomed Res Int</source>. <year>2018</year>;<volume>2018</volume>:<fpage>9478630</fpage>. doi:<pub-id pub-id-type="doi">10.1155/2018/9478630</pub-id>.<pub-id pub-id-type="pmid">29854813</pub-id></mixed-citation>
      </ref>
      <ref id="cit0134">
        <label>134.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wang</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Xiao</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Tian</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Zhao</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Zhai</surname>
<given-names>Q</given-names></string-name>, <string-name><surname>Chen</surname>
<given-names>W</given-names></string-name></person-group>. <article-title>Rational use of prebiotics for gut microbiota alterations: specific bacterial phylotypes and related mechanisms</article-title>. <source>J Funct Foods</source>. <year>2020</year>;<volume>66</volume>:<fpage>103838</fpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jff.2020.103838</pub-id>.</mixed-citation>
      </ref>
      <ref id="cit0135">
        <label>135.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sz&#xE1;nt&#xF3;</surname>
<given-names>M</given-names></string-name>, <string-name><surname>D&#xF3;zsa</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Antal</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Szab&#xF3;</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Kem&#xE9;ny</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Bai</surname>
<given-names>P</given-names></string-name></person-group>. <article-title>Targeting the gut-skin axis-probiotics as new tools for skin disorder management?</article-title>
<source>Exp Dermatol</source>. <year>2019</year>;<volume>28</volume>(<issue>11</issue>):<fpage>1210</fpage>&#x2013;<lpage>1218</lpage>. doi:<pub-id pub-id-type="doi">10.1111/exd.14016</pub-id>.<pub-id pub-id-type="pmid">31386766</pub-id></mixed-citation>
      </ref>
      <ref id="cit0136">
        <label>136.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Muizzuddin</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Maher</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Sullivan</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Schnittger</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Mammone</surname>
<given-names>T</given-names></string-name></person-group>. <article-title>Physiological effect of a probiotic on skin</article-title>. <source>J Cosmet Sci</source>. <year>2012</year>;<volume>63</volume>:<fpage>385</fpage>&#x2013;<lpage>395</lpage>.<pub-id pub-id-type="pmid">23286870</pub-id></mixed-citation>
      </ref>
      <ref id="cit0137">
        <label>137.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lolou</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Panayiotidis</surname>
<given-names>MI</given-names></string-name></person-group>. <article-title>Functional role of probiotics and prebiotics on skin health and disease</article-title>. <source>Fermentation</source>. <year>2019</year>;<volume>5</volume>(<issue>2</issue>):<fpage>41</fpage>. doi:<pub-id pub-id-type="doi">10.3390/fermentation5020041</pub-id>.</mixed-citation>
      </ref>
      <ref id="cit0138">
        <label>138.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hong</surname>
<given-names>KB</given-names></string-name>, <string-name><surname>Jeong</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Han</surname>
<given-names>KS</given-names></string-name>, <string-name><surname>Hwan Kim</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Park</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Suh</surname>
<given-names>HJ</given-names></string-name></person-group>. <article-title>Photoprotective effects of galacto-oligosaccharide and/or <italic toggle="yes">Bifidobacterium longum</italic> supplementation against skin damage induced by ultraviolet irradiation in hairless mice</article-title>. <source>Int J Food Sci Nutr</source>. <year>2015</year>;<volume>66</volume>(<issue>8</issue>):<fpage>923</fpage>&#x2013;<lpage>930</lpage>. doi:<pub-id pub-id-type="doi">10.3109/09637486.2015.1088823</pub-id>.<pub-id pub-id-type="pmid">26470918</pub-id></mixed-citation>
      </ref>
      <ref id="cit0139">
        <label>139.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Davani-Davari</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Negahdaripour</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Karimzadeh</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Seifan</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Mohkam</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Masoumi</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Berenjian</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Ghasemi</surname>
<given-names>Y</given-names></string-name></person-group>. <article-title>Prebiotics: definition, types, sources, mechanisms, and clinical applications</article-title>. <source>Foods</source>. <year>2019</year>;<volume>8</volume>(<issue>3</issue>):<fpage>92</fpage>. doi:<pub-id pub-id-type="doi">10.3390/foods8030092</pub-id>.</mixed-citation>
      </ref>
      <ref id="cit0140">
        <label>140.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Manning</surname>
<given-names>TS</given-names></string-name>, <string-name><surname>Gibson</surname>
<given-names>GR</given-names></string-name></person-group>. <article-title>Prebiotics</article-title>. <source>Best Pract Res Clin Gastroenterol</source>. <year>2004</year>;<volume>18</volume>(<issue>2</issue>):<fpage>287</fpage>&#x2013;<lpage>298</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.bpg.2003.10.008</pub-id>.<pub-id pub-id-type="pmid">15123070</pub-id></mixed-citation>
      </ref>
      <ref id="cit0141">
        <label>141.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Leon Carrion</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Sutter</surname>
<given-names>CH</given-names></string-name>, <string-name><surname>Sutter</surname>
<given-names>TR</given-names></string-name></person-group>. <article-title>Combined treatment with sodium butyrate and PD153035 enhances keratinocyte differentiation</article-title>. <source>Exp Dermatol</source>. <year>2014</year>;<volume>23</volume>(<issue>3</issue>):<fpage>211</fpage>&#x2013;<lpage>214</lpage>. doi:<pub-id pub-id-type="doi">10.1111/exd.12333</pub-id>.<pub-id pub-id-type="pmid">24451036</pub-id></mixed-citation>
      </ref>
      <ref id="cit0142">
        <label>142.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Vollmer</surname>
<given-names>D</given-names></string-name>, <string-name><surname>West</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Lephart</surname>
<given-names>E</given-names></string-name></person-group>. <article-title>Enhancing skin health: by oral administration of natural compounds and minerals with implications to the dermal microbiome</article-title>. <source>Int J Mol Sci</source>. <year>2018</year>;<volume>19</volume>(<issue>10</issue>):<fpage>3059</fpage>. doi:<pub-id pub-id-type="doi">10.3390/ijms19103059</pub-id>.</mixed-citation>
      </ref>
      <ref id="cit0143">
        <label>143.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Al-Ghazzewi</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Tester</surname>
<given-names>R</given-names></string-name></person-group>. <article-title>Impact of prebiotics and probiotics on skin health</article-title>. <source>Benef Microbes</source>. <year>2014</year>;<volume>5</volume>(<issue>2</issue>):<fpage>99</fpage>&#x2013;<lpage>107</lpage>. doi:<pub-id pub-id-type="doi">10.3920/bm2013.0040</pub-id>.<pub-id pub-id-type="pmid">24583611</pub-id></mixed-citation>
      </ref>
      <ref id="cit0144">
        <label>144.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Fijan</surname>
<given-names>S</given-names></string-name></person-group>. <article-title>Microorganisms with claimed probiotic properties: an overview of recent literature</article-title>. <source>Int J Environ Res Public Health</source>. <year>2014</year>;<volume>11</volume>(<issue>5</issue>):<fpage>4745</fpage>&#x2013;<lpage>4767</lpage>. doi:<pub-id pub-id-type="doi">10.3390/ijerph110504745</pub-id>.<pub-id pub-id-type="pmid">24859749</pub-id></mixed-citation>
      </ref>
      <ref id="cit0145">
        <label>145.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Benhadou</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Mintoff</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Schnebert</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Thio</surname>
<given-names>H</given-names></string-name></person-group>. <article-title>Psoriasis and microbiota: a systematic review</article-title>. <source>Diseases</source>. <year>2018</year>;<volume>6</volume>(<issue>2</issue>):<fpage>47</fpage>. doi:<pub-id pub-id-type="doi">10.3390/diseases6020047</pub-id>.</mixed-citation>
      </ref>
      <ref id="cit0146">
        <label>146.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Manzhalii</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Hornuss</surname>
<given-names>D</given-names></string-name>, and <string-name><surname>Stremmel</surname>
<given-names>W</given-names></string-name></person-group>. <article-title>Intestinal-borne dermatoses significantly improved by oral application of<italic toggle="yes">Escherichia coli</italic>Nissle 1917</article-title>. <source>World J Gastroenterol</source>. <year>2016</year>;<volume>22</volume>(<issue>23</issue>):<fpage>5415</fpage>. doi:<pub-id pub-id-type="doi">10.3748/wjg.v22.i23.5415</pub-id>.<pub-id pub-id-type="pmid">27340358</pub-id></mixed-citation>
      </ref>
      <ref id="cit0147">
        <label>147.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sehgal</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Khurana</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Pandhi</surname>
<given-names>D</given-names></string-name></person-group>. <article-title>Biologics in dermatology: an integrated review</article-title>. <source>Indian J Dermatol</source>. <year>2014</year>;<volume>59</volume>(<issue>5</issue>):<fpage>425</fpage>&#x2013;<lpage>441</lpage>. doi:<pub-id pub-id-type="doi">10.4103/0019-5154.139859</pub-id>.<pub-id pub-id-type="pmid">25284845</pub-id></mixed-citation>
      </ref>
      <ref id="cit0148">
        <label>148.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Conticini</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Sota</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Falsetti</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Lamberti</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Miracco</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Guarnieri</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Frediani</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Cantarini</surname>
<given-names>L</given-names></string-name></person-group>. <article-title>Biologic drugs in the treatment of polyarteritis nodosa and deficit of adenosine deaminase 2: a narrative review</article-title>. <source>Autoimmun Rev</source>. <year>2021</year>;<volume>20</volume>(<issue>4</issue>):<fpage>102784</fpage>. doi:<pub-id pub-id-type="doi">10.1016/j.autrev.2021.102784</pub-id>.<pub-id pub-id-type="pmid">33609794</pub-id></mixed-citation>
      </ref>
      <ref id="cit0149">
        <label>149.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Johnston</surname>
<given-names>SL</given-names></string-name></person-group>. <article-title>Biologic therapies: what and when?</article-title>
<source>J Clin Pathol</source>. <year>2007</year>;<volume>60</volume>(<issue>1</issue>):<fpage>8</fpage>&#x2013;<lpage>17</lpage>. doi:<pub-id pub-id-type="doi">10.1136/jcp.2005.032300</pub-id>.<pub-id pub-id-type="pmid">17213345</pub-id></mixed-citation>
      </ref>
      <ref id="cit0150">
        <label>150.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Weersma</surname>
<given-names>RK</given-names></string-name>, <string-name><surname>Zhernakova</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Fu</surname>
<given-names>J</given-names></string-name></person-group>. <article-title>Interaction between drugs and the gut microbiome</article-title>. <source>Gut</source>. <year>2020</year>;<volume>69</volume>(<issue>8</issue>):<fpage>1510</fpage>&#x2013;<lpage>1519</lpage>. doi:<pub-id pub-id-type="doi">10.1136/gutjnl-2019-320204</pub-id>.<pub-id pub-id-type="pmid">32409589</pub-id></mixed-citation>
      </ref>
      <ref id="cit0151">
        <label>151.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Myers</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Brownstone</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Reddy</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Chan</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Thibodeaux</surname>
<given-names>Q</given-names></string-name>, <string-name><surname>Truong</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Bhutani</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Chang</surname>
<given-names>HW</given-names></string-name>, <string-name><surname>Liao</surname>
<given-names>W</given-names></string-name></person-group>. <article-title>The gut microbiome in psoriasis and psoriatic arthritis</article-title>. <source>Best Pract Res Clin Rheumatol</source>. <year>2019</year>;<volume>33</volume>(<issue>6</issue>):<fpage>101494</fpage>. doi:<pub-id pub-id-type="doi">10.1016/j.berh.2020.101494</pub-id>.<pub-id pub-id-type="pmid">32360228</pub-id></mixed-citation>
      </ref>
      <ref id="cit0152">
        <label>152.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Di Filippo</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Russo</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Attanasi</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Di Pillo</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Chiarelli</surname>
<given-names>F</given-names></string-name></person-group>. <article-title>Immunological targets of biologic drugs in allergic skin diseases in children</article-title>. <source>Biomedicines</source>. <year>2021</year>;<volume>9</volume>(<issue>11</issue>):<fpage>1615</fpage>. doi:<pub-id pub-id-type="doi">10.3390/biomedicines9111615</pub-id>.<pub-id pub-id-type="pmid">34829844</pub-id></mixed-citation>
      </ref>
      <ref id="cit0153">
        <label>153.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Forbes</surname>
<given-names>JD</given-names></string-name>, <string-name><surname>Van Domselaar</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Bernstein</surname>
<given-names>CN</given-names></string-name></person-group>. <article-title>The gut microbiota in immune-mediated inflammatory diseases</article-title>. <source>Front Microbiol</source>. <year>2016</year>;<volume>7</volume>:<fpage>1081</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fmicb.2016.01081</pub-id>.<pub-id pub-id-type="pmid">27462309</pub-id></mixed-citation>
      </ref>
      <ref id="cit0154">
        <label>154.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Simonyte Sj&#xF6;din</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Vidman</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Ryd&#xE9;n</surname>
<given-names>P</given-names></string-name>, <string-name><surname>West</surname>
<given-names>CE</given-names></string-name></person-group>. <article-title>Emerging evidence of the role of gut microbiota in the development of allergic diseases</article-title>. <source>Curr Opin Allergy Clin Immunol</source>. <year>2016</year>;<volume>16</volume>(<issue>4</issue>):<fpage>390</fpage>&#x2013;<lpage>395</lpage>. doi:<pub-id pub-id-type="doi">10.1097/aci.0000000000000277</pub-id>.<pub-id pub-id-type="pmid">27253486</pub-id></mixed-citation>
      </ref>
      <ref id="cit0155">
        <label>155.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Alzahrani</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Alesa</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Alshamrani</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Alamssi</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Alzahrani</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Almohammadi</surname>
<given-names>M</given-names></string-name></person-group>. <article-title>The role of gut microbiome in the pathogenesis of psoriasis and the therapeutic effects of probiotics</article-title>. <source>J Fami Med Primary Care</source>. <year>2019</year>;<volume>8</volume>(<issue>11</issue>):<fpage>3496</fpage>. doi:<pub-id pub-id-type="doi">10.4103/jfmpc.jfmpc_709_19</pub-id>.</mixed-citation>
      </ref>
      <ref id="cit0156">
        <label>156.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ram&#xED;rez-Bosc&#xE1;</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Navarro-L&#xF3;pez</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Mart&#xED;nez-Andr&#xE9;s</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Such</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Franc&#xE9;s</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Horga De La Parte</surname>
<given-names>J</given-names></string-name>, <string-name><surname>As&#xED;n-Llorca</surname>
<given-names>M</given-names></string-name></person-group>. <article-title>Identification of bacterial DNA in the &#x2013;&#x2013;peripheral blood of patients with active Psoriasis</article-title>. <source>JAMA Dermatol</source>. <year>2015</year>;<volume>151</volume>(<issue>6</issue>):<fpage>670</fpage>. doi:<pub-id pub-id-type="doi">10.1001/jamadermatol.2014.5585</pub-id>.<pub-id pub-id-type="pmid">25760018</pub-id></mixed-citation>
      </ref>
      <ref id="cit0157">
        <label>157.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tan</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Zhao</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Zhu</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Wu</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Shen</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Lei</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Chen</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Peng</surname>
<given-names>C</given-names></string-name></person-group>. <article-title>The <italic toggle="yes">Akkermansia muciniphila</italic> is a gut microbiota signature in psoriasis</article-title>. <source>Exp Dermatol</source>. <year>2018</year>;<volume>27</volume>(<issue>2</issue>):<fpage>144</fpage>&#x2013;<lpage>149</lpage>. doi:<pub-id pub-id-type="doi">10.1111/exd.13463</pub-id>.<pub-id pub-id-type="pmid">29130553</pub-id></mixed-citation>
      </ref>
      <ref id="cit0158">
        <label>158.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>de Francesco</surname>
<given-names>MA</given-names></string-name>, <string-name><surname>Caruso</surname>
<given-names>A</given-names></string-name></person-group>. <article-title>The gut microbiome in psoriasis and crohn&#x2019;s disease: is its perturbation a common denominator for their pathogenesis?</article-title>
<source>Vaccines</source>. <year>2022</year>;<volume>10</volume>(<issue>2</issue>):<fpage>244</fpage>. doi:<pub-id pub-id-type="doi">10.3390/vaccines10020244</pub-id>.<pub-id pub-id-type="pmid">35214702</pub-id></mixed-citation>
      </ref>
      <ref id="cit0159">
        <label>159.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Scher</surname>
<given-names>JU</given-names></string-name>, <string-name><surname>Ubeda</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Artacho</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Attur</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Isaac</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Reddy</surname>
<given-names>SM</given-names></string-name>, <string-name><surname>Marmon</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Neimann</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Brusca</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Patel</surname>
<given-names>T</given-names></string-name>, et al</person-group>. <article-title>Decreased Bacterial diversity characterizes the altered gut microbiota in patients with psoriatic arthritis, resembling dysbiosis in inflammatory bowel disease</article-title>. <source>Arthritis Rheumatol</source>. <year>2015</year>;<volume>67</volume>(<issue>1</issue>):<fpage>128</fpage>&#x2013;<lpage>139</lpage>. doi:<pub-id pub-id-type="doi">10.1002/art.38892</pub-id>.<pub-id pub-id-type="pmid">25319745</pub-id></mixed-citation>
      </ref>
      <ref id="cit0160">
        <label>160.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Huang</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Gao</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Yu</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Zhu</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Ding</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Qin</surname>
<given-names>H</given-names></string-name></person-group>. <article-title>Dysbiosis of gut microbiota was closely associated with psoriasis</article-title>. <source>Sci China Life Sci</source>. <year>2018</year>;<volume>62</volume>(<issue>6</issue>):<fpage>807</fpage>&#x2013;<lpage>815</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s11427-018-9376-6</pub-id>.<pub-id pub-id-type="pmid">30264198</pub-id></mixed-citation>
      </ref>
      <ref id="cit0161">
        <label>161.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mann</surname>
<given-names>EA</given-names></string-name>, <string-name><surname>Bae</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Kostyuchek</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Chung</surname>
<given-names>HJ</given-names></string-name>, <string-name><surname>McGee</surname>
<given-names>JS</given-names></string-name></person-group>. <article-title>The Gut microbiome: human health and inflammatory skin diseases</article-title>. <source>Ann Dermatol</source>. <year>2020</year>;<volume>32</volume>(<issue>4</issue>):<fpage>265</fpage>. doi:<pub-id pub-id-type="doi">10.5021/ad.2020.32.4.265</pub-id>.<pub-id pub-id-type="pmid">33911753</pub-id></mixed-citation>
      </ref>
      <ref id="cit0162">
        <label>162.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chen</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Ho</surname>
<given-names>HJ</given-names></string-name>, <string-name><surname>Tseng</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Lai</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Shieh</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Wu</surname>
<given-names>C</given-names></string-name></person-group>. <article-title>Intestinal microbiota profiling and predicted metabolic dysregulation in psoriasis patients</article-title>. <source>Exp Dermatol</source>. <year>2018</year>;<volume>27</volume>(<issue>12</issue>):<fpage>1336</fpage>&#x2013;<lpage>1343</lpage>. doi:<pub-id pub-id-type="doi">10.1111/exd.13786</pub-id>.<pub-id pub-id-type="pmid">30238519</pub-id></mixed-citation>
      </ref>
      <ref id="cit0163">
        <label>163.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yan</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Issa</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Afifi</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Jeon</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Chang</surname>
<given-names>HW</given-names></string-name>, <string-name><surname>Liao</surname>
<given-names>W</given-names></string-name></person-group>. <article-title>The role of the skin and gut microbiome in psoriatic disease</article-title>. <source>Curr Dermatol Rep</source>. <year>2017</year>;<volume>6</volume>(<issue>2</issue>):<fpage>94</fpage>&#x2013;<lpage>103</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s13671-017-0178-5</pub-id>.<pub-id pub-id-type="pmid">28804689</pub-id></mixed-citation>
      </ref>
      <ref id="cit0164">
        <label>164.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kierasi&#x144;ska</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Donskow-&#x141;ysoniewska</surname>
<given-names>K</given-names></string-name></person-group>. <article-title>Both the microbiome and the macrobiome can influence immune responsiveness in psoriasis</article-title>. <source>Cent Eur J Immunol</source>. <year>2021</year>;<volume>46</volume>(<issue>4</issue>):<fpage>502</fpage>&#x2013;<lpage>508</lpage>. doi:<pub-id pub-id-type="doi">10.5114/ceji.2021.110314</pub-id>.<pub-id pub-id-type="pmid">35125950</pub-id></mixed-citation>
      </ref>
      <ref id="cit0165">
        <label>165.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mosca</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Leclerc</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Hugot</surname>
<given-names>JP</given-names></string-name></person-group>. <article-title>Gut microbiota diversity and human diseases: should we reintroduce key predators in our ecosystem?</article-title>
<source>Front Microbiol</source>. <year>2016</year>:<volume>7</volume>. doi:<pub-id pub-id-type="doi">10.3389/fmicb.2016.00455</pub-id>.</mixed-citation>
      </ref>
      <ref id="cit0166">
        <label>166.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Visser</surname>
<given-names>MJE</given-names></string-name>, <string-name><surname>Kell</surname>
<given-names>DB</given-names></string-name>, <string-name><surname>Pretorius</surname>
<given-names>E</given-names></string-name></person-group>. <article-title>Bacterial dysbiosis and translocation in psoriasis vulgaris</article-title>. <source>Front Cell Infect Microbiol</source>. <year>2019</year>;<volume>9</volume>:<fpage>9</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fcimb.2019.00007</pub-id>.<pub-id pub-id-type="pmid">30838177</pub-id></mixed-citation>
      </ref>
      <ref id="cit0167">
        <label>167.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bland</surname>
<given-names>J</given-names></string-name></person-group>. <article-title>Intestinal Microbiome, akkermansia muciniphila, and medical nutrition therapy</article-title>. <source>Integr Med (Encinitas, Calif)</source>. <year>2016</year>;<volume>15</volume>:<fpage>14</fpage>&#x2013;<lpage>16</lpage>.</mixed-citation>
      </ref>
      <ref id="cit0168">
        <label>168.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhang</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>Q</given-names></string-name>, <string-name><surname>Cheng</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Buch</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>F</given-names></string-name></person-group>. <article-title><italic toggle="yes">Akkermansia muciniphila</italic> is a promising probiotic</article-title>. <source>Microb Biotechnol</source>. <year>2019</year>;<volume>12</volume>(<issue>6</issue>):<fpage>1109</fpage>&#x2013;<lpage>1125</lpage>. doi:<pub-id pub-id-type="doi">10.1111/1751-7915.13410</pub-id>.<pub-id pub-id-type="pmid">31006995</pub-id></mixed-citation>
      </ref>
      <ref id="cit0169">
        <label>169.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Rungjang</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Meephansan</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Bing Thio</surname>
<given-names>H</given-names></string-name></person-group>. <article-title>Skin and gut microbiota in psoriasis: a systematic review</article-title>. <source>Hum Microbiome</source>. <year>2021</year>. doi:<pub-id pub-id-type="doi">10.5772/intechopen.92686</pub-id>.</mixed-citation>
      </ref>
      <ref id="cit0170">
        <label>170.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Groeger</surname>
<given-names>D</given-names></string-name>, <string-name><surname>O&#x2019;Mahony</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Murphy</surname>
<given-names>EF</given-names></string-name>, <string-name><surname>Bourke</surname>
<given-names>JF</given-names></string-name>, <string-name><surname>Dinan</surname>
<given-names>TG</given-names></string-name>, <string-name><surname>Kiely</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Shanahan</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Quigley</surname>
<given-names>EM</given-names></string-name></person-group>. <article-title>Bifidobacterium infantis35624 modulates host inflammatory processes beyond the gut</article-title>. <source>Gut Microbes</source>. <year>2013</year>;<volume>4</volume>(<issue>4</issue>):<fpage>325</fpage>&#x2013;<lpage>339</lpage>. doi:<pub-id pub-id-type="doi">10.4161/gmic.25487</pub-id>.<pub-id pub-id-type="pmid">23842110</pub-id></mixed-citation>
      </ref>
      <ref id="cit0171">
        <label>171.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chen</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Zhu</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Kuang</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Chen</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Peng</surname>
<given-names>C</given-names></string-name></person-group>. <article-title>Skin and gut microbiome in psoriasis: gaining insight into the pathophysiology of it and finding novel therapeutic strategies</article-title>. <source>Front Microbiol</source>. <year>2020</year>:<fpage>11</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fmicb.2020.589726</pub-id>.</mixed-citation>
      </ref>
      <ref id="cit0172">
        <label>172.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Abrahamsson</surname>
<given-names>TR</given-names></string-name>, <string-name><surname>Jakobsson</surname>
<given-names>HE</given-names></string-name>, <string-name><surname>Andersson</surname>
<given-names>AF</given-names></string-name>, <string-name><surname>Bj&#xF6;rkst&#xE9;n</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Engstrand</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Jenmalm</surname>
<given-names>MC</given-names></string-name></person-group>. <article-title>Low diversity of the gut microbiota in infants with atopic eczema</article-title>. <source>J Allergy Clin Immunol</source>. <year>2012</year>;<volume>129</volume>(<issue>2</issue>):<fpage>434</fpage>&#x2013;<lpage>440.e2</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jaci.2011.10.025</pub-id>.<pub-id pub-id-type="pmid">22153774</pub-id></mixed-citation>
      </ref>
      <ref id="cit0173">
        <label>173.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Forno</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Onderdonk</surname>
<given-names>AB</given-names></string-name>, <string-name><surname>McCracken</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Litonjua</surname>
<given-names>AA</given-names></string-name>, <string-name><surname>Laskey</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Delaney</surname>
<given-names>ML</given-names></string-name>, <string-name><surname>DuBois</surname>
<given-names>AM</given-names></string-name>, <string-name><surname>Gold</surname>
<given-names>DR</given-names></string-name>, <string-name><surname>Ryan</surname>
<given-names>LM</given-names></string-name>, <string-name><surname>Weiss</surname>
<given-names>ST</given-names></string-name>, et al</person-group>. <article-title>Diversity of the gut microbiota and eczema in early life</article-title>. <source>Clin Mol Allergy</source>. <year>2008</year>;<volume>6</volume>(<issue>1</issue>). doi:<pub-id pub-id-type="doi">10.1186/1476-7961-6-11</pub-id>.</mixed-citation>
      </ref>
      <ref id="cit0174">
        <label>174.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ismail</surname>
<given-names>IH</given-names></string-name>, <string-name><surname>Oppedisano</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Joseph</surname>
<given-names>SJ</given-names></string-name>, <string-name><surname>Boyle</surname>
<given-names>RJ</given-names></string-name>, <string-name><surname>Licciardi</surname>
<given-names>PV</given-names></string-name>, <string-name><surname>Robins-Browne</surname>
<given-names>RM</given-names></string-name>, <string-name><surname>Tang</surname>
<given-names>ML</given-names></string-name></person-group>. <article-title>Reduced gut microbial diversity in early life is associated with later development of eczema but not atopy in high-risk infants</article-title>. <source>Pediatr Allergy and Immunol</source>. <year>2012</year>;<volume>23</volume>(<issue>7</issue>):<fpage>674</fpage>&#x2013;<lpage>681</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1399-3038.2012.01328.x</pub-id>.<pub-id pub-id-type="pmid">22831283</pub-id></mixed-citation>
      </ref>
      <ref id="cit0175">
        <label>175.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wang</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Karlsson</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Olsson</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Adlerberth</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Wold</surname>
<given-names>AE</given-names></string-name>, <string-name><surname>Strachan</surname>
<given-names>DP</given-names></string-name>, <string-name><surname>Martricardi</surname>
<given-names>PM</given-names></string-name>, <string-name><surname>&#xC5;berg</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Perkin</surname>
<given-names>MR</given-names></string-name>, <string-name><surname>Tripodi</surname>
<given-names>S</given-names></string-name>, et al</person-group>. <article-title>Reduced diversity in the early fecal microbiota of infants with atopic eczema</article-title>. <source>J Allergy Clin Immunol</source>. <year>2008</year>;<volume>121</volume>(<issue>1</issue>):<fpage>129</fpage>&#x2013;<lpage>134</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jaci.2007.09.011</pub-id>.<pub-id pub-id-type="pmid">18028995</pub-id></mixed-citation>
      </ref>
      <ref id="cit0176">
        <label>176.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lunjani</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Satitsuksanoa</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Lukasik</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Sokolowska</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Eiwegger</surname>
<given-names>T</given-names></string-name>, <string-name><surname>O&#x2019;Mahony</surname>
<given-names>L</given-names></string-name></person-group>. <article-title>Recent developments and highlights in mechanisms of allergic diseases: microbiome</article-title>. <source>Allergy</source>. <year>2018</year>;<volume>73</volume>(<issue>12</issue>):<fpage>2314</fpage>&#x2013;<lpage>2327</lpage>. doi:<pub-id pub-id-type="doi">10.1111/all.13634</pub-id>.<pub-id pub-id-type="pmid">30325537</pub-id></mixed-citation>
      </ref>
      <ref id="cit0177">
        <label>177.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Watanabe</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Narisawa</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Arase</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Okamatsu</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Ikenaga</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Tajiri</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Kumemura</surname>
<given-names>M</given-names></string-name></person-group>. <article-title>Differences in fecal microflora between patients with atopic dermatitis and healthy control subjects</article-title>. <source>J Allergy Clin Immunol</source>. <year>2003</year>;<volume>111</volume>(<issue>3</issue>):<fpage>587</fpage>&#x2013;<lpage>591</lpage>. doi:<pub-id pub-id-type="doi">10.1067/mai.2003.105</pub-id>.<pub-id pub-id-type="pmid">12642841</pub-id></mixed-citation>
      </ref>
      <ref id="cit0178">
        <label>178.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Biedermann</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Skabytska</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Kaesler</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Volz</surname>
<given-names>T</given-names></string-name></person-group>. <article-title>Regulation of T cell immunity in atopic dermatitis by microbes</article-title>. <source>The Yin and Yang of Cutaneous Inflammation Frontiers Immunol</source>. <year>2015</year>:<fpage>6</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fimmu.2015.00353</pub-id>.</mixed-citation>
      </ref>
      <ref id="cit0179">
        <label>179.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kim</surname>
<given-names>HJ</given-names></string-name>, <string-name><surname>Kim</surname>
<given-names>HY</given-names></string-name>, <string-name><surname>Lee</surname>
<given-names>SY</given-names></string-name>, <string-name><surname>Seo</surname>
<given-names>JH</given-names></string-name>, <string-name><surname>Lee</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Hong</surname>
<given-names>SJ</given-names></string-name></person-group>. <article-title>Clinical efficacy and mechanism of probiotics in allergic diseases</article-title>. <source>Korean J Pediatr</source>. <year>2013</year>;<volume>56</volume>(<issue>9</issue>):<fpage>369</fpage>. doi:<pub-id pub-id-type="doi">10.3345/kjp.2013.56.9.369</pub-id>.<pub-id pub-id-type="pmid">24223597</pub-id></mixed-citation>
      </ref>
      <ref id="cit0180">
        <label>180.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Song</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Yoo</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Hwang</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Na</surname>
<given-names>YC</given-names></string-name>, <string-name><surname>Kim</surname>
<given-names>HS</given-names></string-name></person-group>. <article-title><italic toggle="yes">Faecalibacterium prausnitzii</italic> subspecies&#x2013;level dysbiosis in the human gut microbiome underlying atopic dermatitis</article-title>. <source>J Allergy Clin Immunol</source>. <year>2016</year>;<volume>137</volume>(<issue>3</issue>):<fpage>852</fpage>&#x2013;<lpage>860</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jaci.2015.08.021</pub-id>.<pub-id pub-id-type="pmid">26431583</pub-id></mixed-citation>
      </ref>
      <ref id="cit0181">
        <label>181.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zheng</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Liang</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Miao</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Shi</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Yang</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Yuan</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Ji</surname>
<given-names>ZS</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>DK</given-names></string-name></person-group>. <article-title>Altered gut microbiota composition associated with eczema in infants</article-title>. <source>PLOS ONE</source>. <year>2016</year>;<volume>11</volume>(<issue>11</issue>):<fpage>e0166026</fpage>. doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0166026</pub-id>.<pub-id pub-id-type="pmid">27812181</pub-id></mixed-citation>
      </ref>
      <ref id="cit0182">
        <label>182.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>de Sousa Moraes</surname>
<given-names>LF</given-names></string-name>, <string-name><surname>Grzeskowiak</surname>
<given-names>LM</given-names></string-name>, <string-name><surname>de Sales Teixeira</surname>
<given-names>TF</given-names></string-name>, <string-name><surname>Gouveia Peluzio</surname>
<given-names>MDC</given-names></string-name></person-group>. <article-title>Intestinal microbiota and probiotics in celiac disease</article-title>. <source>Clin Microbiol Rev</source>. <year>2014</year>;<volume>27</volume>(<issue>3</issue>):<fpage>482</fpage>&#x2013;<lpage>489</lpage>. doi:<pub-id pub-id-type="doi">10.1128/cmr.00106-13</pub-id>.<pub-id pub-id-type="pmid">24982318</pub-id></mixed-citation>
      </ref>
      <ref id="cit0183">
        <label>183.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Uhde</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Ajamian</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Caio</surname>
<given-names>G</given-names></string-name>, <string-name><surname>de Giorgio</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Indart</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Green</surname>
<given-names>PH</given-names></string-name>, <string-name><surname>Verna</surname>
<given-names>EC</given-names></string-name>, <string-name><surname>Volta</surname>
<given-names>U</given-names></string-name>, <string-name><surname>Alaedini</surname>
<given-names>A</given-names></string-name></person-group>. <article-title>Intestinal cell damage and systemic immune activation in individuals reporting sensitivity to wheat in the absence of coeliac disease</article-title>. <source>Gut</source>. <year>2016</year>;<volume>65</volume>(<issue>12</issue>):<fpage>1930</fpage>&#x2013;<lpage>1937</lpage>. doi:<pub-id pub-id-type="doi">10.1136/gutjnl-2016-311964</pub-id>.<pub-id pub-id-type="pmid">27459152</pub-id></mixed-citation>
      </ref>
      <ref id="cit0184">
        <label>184.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Nagpal</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Ahmadi</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Hayes</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Gagliano</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Subashchandrabose</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Kitzman</surname>
<given-names>DW</given-names></string-name>, <string-name><surname>Becton</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Read</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Yadav</surname>
<given-names>H</given-names></string-name></person-group>. <article-title>Human-origin probiotic cocktail increases short-chain fatty acid production via modulation of mice and human gut microbiome</article-title>. <source>Sci Rep</source>. <year>2018</year>;<volume>8</volume>(<issue>1</issue>). doi:<pub-id pub-id-type="doi">10.1038/s41598-018-30114-4</pub-id>.</mixed-citation>
      </ref>
      <ref id="cit0185">
        <label>185.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kim</surname>
<given-names>JH</given-names></string-name>, <string-name><surname>Kim</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Kim</surname>
<given-names>W</given-names></string-name></person-group>. <article-title>Gut microbiota restoration through fecal microbiota transplantation: a new atopic dermatitis therapy</article-title>. <source>Exp Mol Med</source>. <year>2021</year>;<volume>53</volume>(<issue>5</issue>):<fpage>907</fpage>&#x2013;<lpage>916</lpage>. doi:<pub-id pub-id-type="doi">10.1038/s12276-021-00627-6</pub-id>.<pub-id pub-id-type="pmid">34017060</pub-id></mixed-citation>
      </ref>
      <ref id="cit0186">
        <label>186.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zouboulis</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Jourdan</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Picardo</surname>
<given-names>M</given-names></string-name></person-group>. <article-title>Acne is an inflammatory disease and alterations of sebum composition initiate acne lesions</article-title>. <source>J EurAcad Dermatol Venereol</source>. <year>2013</year>;<volume>28</volume>(<issue>5</issue>):<fpage>527</fpage>&#x2013;<lpage>532</lpage>. doi:<pub-id pub-id-type="doi">10.1111/jdv.12298</pub-id>.</mixed-citation>
      </ref>
      <ref id="cit0187">
        <label>187.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Penso</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Touvier</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Deschasaux</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Szabo De Edelenyi</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Hercberg</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Ezzedine</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Sbidian</surname>
<given-names>E</given-names></string-name></person-group>. <article-title>Association between adult acne and dietary behaviors</article-title>. <source>JAMA Dermatol</source>. <year>2020</year>;<volume>156</volume>(<issue>8</issue>):<fpage>854</fpage>. doi:<pub-id pub-id-type="doi">10.1001/jamadermatol.2020.1602</pub-id>.<pub-id pub-id-type="pmid">32520303</pub-id></mixed-citation>
      </ref>
      <ref id="cit0188">
        <label>188.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Guo</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Tang</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Zeng</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Wood</surname>
<given-names>RJ</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>Z</given-names></string-name></person-group>. <article-title>High fat diet alters gut microbiota and the expression of paneth cell-antimicrobial peptides preceding changes of circulating inflammatory cytokines</article-title>. <source>Mediators Inflamm</source>. <year>2017</year>;<volume>2017</volume>:<fpage>1</fpage>&#x2013;<lpage>9</lpage>. doi:<pub-id pub-id-type="doi">10.1155/2017/9474896</pub-id>.</mixed-citation>
      </ref>
      <ref id="cit0189">
        <label>189.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lee</surname>
<given-names>YB</given-names></string-name>, <string-name><surname>Byun</surname>
<given-names>EJ</given-names></string-name>, <string-name><surname>Kim</surname>
<given-names>HS</given-names></string-name></person-group>. <article-title>Potential role of the microbiome in acne: a comprehensive review</article-title>. <source>J clini med</source>. <year>2019</year>;<volume>8</volume>(<issue>7</issue>):<fpage>987</fpage>. doi:<pub-id pub-id-type="doi">10.3390/jcm8070987</pub-id>.</mixed-citation>
      </ref>
      <ref id="cit0190">
        <label>190.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Noureldein</surname>
<given-names>MH</given-names></string-name>, <string-name><surname>Eid</surname>
<given-names>AA</given-names></string-name></person-group>. <article-title>Gut microbiota and mTOR signaling: insight on a new pathophysiological interaction</article-title>. <source>Microb Pathog</source>. <year>2018</year>;<volume>118</volume>:<fpage>98</fpage>&#x2013;<lpage>104</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.micpath.2018.03.021</pub-id>.<pub-id pub-id-type="pmid">29548696</pub-id></mixed-citation>
      </ref>
      <ref id="cit0191">
        <label>191.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Smith</surname>
<given-names>RN</given-names></string-name>, <string-name><surname>Braue</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Varigos</surname>
<given-names>GA</given-names></string-name>, <string-name><surname>Mann</surname>
<given-names>NJ</given-names></string-name></person-group>. <article-title>The effect of a low glycemic load diet on acne vulgaris and the fatty acid composition of skin surface triglycerides</article-title>. <source>J Dermatol Sci</source>. <year>2008</year>;<volume>50</volume>(<issue>1</issue>):<fpage>41</fpage>&#x2013;<lpage>52</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jdermsci.2007.11.005</pub-id>.<pub-id pub-id-type="pmid">18178063</pub-id></mixed-citation>
      </ref>
      <ref id="cit0192">
        <label>192.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Volkova</surname>
<given-names>LA</given-names></string-name>, <string-name><surname>Khalif</surname>
<given-names>IL</given-names></string-name>, <string-name><surname>Kabanova</surname>
<given-names>IN</given-names></string-name></person-group>. <article-title>Vliiane disbakterioza kishechnika na techenie vul&#x2019;garnykh ugre&#x12D; [Impact of the impaired intestinal microflora on the course of acne vulgaris]</article-title>. <source>Klin Med (Mosk)</source>. <year>2001</year>;<volume>79</volume>(<issue>6</issue>):<fpage>39</fpage>&#x2013;<lpage>41</lpage>. <comment>Russian. PMID: 11525176</comment></mixed-citation>
      </ref>
      <ref id="cit0193">
        <label>193.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Holmes</surname>
<given-names>AD</given-names></string-name></person-group>. <article-title>Potential role of microorganisms in the pathogenesis of rosacea</article-title>. <source>J Am Acad Dermatol</source>. <year>2013</year>;<volume>69</volume>(<issue>6</issue>):<fpage>1025</fpage>&#x2013;<lpage>1032</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jaad.2013.08.006</pub-id>.<pub-id pub-id-type="pmid">24011460</pub-id></mixed-citation>
      </ref>
      <ref id="cit0194">
        <label>194.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Joura</surname>
<given-names>MI</given-names></string-name>, <string-name><surname>Brunner</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Nemes-Nikod&#xE9;m</surname>
<given-names>V</given-names></string-name>, <string-name><surname>S&#xE1;rdy</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Ostorh&#xE1;zi</surname>
<given-names>E</given-names></string-name></person-group>. <article-title>Interactions between immune system and the microbiome of skin, blood and gut in pathogenesis of rosacea</article-title>. <source>Acta Microbiol Immunol Hung</source>. <year>2021</year>;<volume>68</volume>(<issue>1</issue>):<fpage>1</fpage>&#x2013;<lpage>6</lpage>. doi:<pub-id pub-id-type="doi">10.1556/030.2021.01366</pub-id>.<pub-id pub-id-type="pmid">33522984</pub-id></mixed-citation>
      </ref>
      <ref id="cit0195">
        <label>195.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yang</surname>
<given-names>X</given-names></string-name></person-group>. <article-title>Relationship between <italic toggle="yes">Helicobacter pylori</italic> and Rosacea: review and discussion</article-title>. <source>BMC Infect Dis</source>. <year>2018</year>;<volume>18</volume>(<issue>1</issue>). doi:<pub-id pub-id-type="doi">10.1186/s12879-018-3232-4</pub-id>.</mixed-citation>
      </ref>
      <ref id="cit0196">
        <label>196.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Szlachcic</surname>
<given-names>A</given-names></string-name></person-group>. <article-title>The link between <italic toggle="yes">Helicobacter pylori</italic> infection and rosacea</article-title>. <source>J EurAcad Dermatol Venereol</source>. <year>2002</year>;<volume>16</volume>(<issue>4</issue>):<fpage>328</fpage>&#x2013;<lpage>333</lpage>. doi:<pub-id pub-id-type="doi">10.1046/j.1468-3083.2002.00497.x</pub-id>.</mixed-citation>
      </ref>
      <ref id="cit0197">
        <label>197.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Pinchuk</surname>
<given-names>IV</given-names></string-name>, <string-name><surname>Bressollier</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Verneuil</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Fenet</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Sorokulova</surname>
<given-names>IB</given-names></string-name>, <string-name><surname>M&#xE9;graud</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Urdaci</surname>
<given-names>MC</given-names></string-name></person-group>. <article-title>In vitro anti- <italic toggle="yes">Helicobacter pylori</italic> activity of the probiotic strain <italic toggle="yes">Bacillus subtilis</italic> 3 is due to secretion of antibiotics</article-title>. <source>Antimicrob Agents Chemother</source>. <year>2001</year>;<volume>45</volume>(<issue>11</issue>):<fpage>3156</fpage>&#x2013;<lpage>3161</lpage>. doi:<pub-id pub-id-type="doi">10.1128/aac.45.11.3156-3161.2001</pub-id>.<pub-id pub-id-type="pmid">11600371</pub-id></mixed-citation>
      </ref>
      <ref id="cit0198">
        <label>198.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Buianova</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Girnyk</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Senyshyn</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Hepburn</surname>
<given-names>IS</given-names></string-name></person-group>. <article-title>Gut-skin connection: role of intestinal biome in rosacea</article-title>. <source>Ame J Gastroenterol</source>. <year>2018</year>;<volume>113</volume>(<issue>Supplement</issue>):<fpage>S126</fpage>. doi:<pub-id pub-id-type="doi">10.14309/00000434-201810001-00216</pub-id>.</mixed-citation>
      </ref>
      <ref id="cit0199">
        <label>199.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kober</surname>
<given-names>MM</given-names></string-name>, <string-name><surname>Bowe</surname>
<given-names>WP</given-names></string-name></person-group>. <article-title>The effect of probiotics on immune regulation, acne, and photoaging</article-title>. <source>Int J Women&#x2019;s Dermatol</source>. <year>2015</year>;<volume>1</volume>(<issue>2</issue>):<fpage>85</fpage>&#x2013;<lpage>89</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.ijwd.2015.02.001</pub-id>.<pub-id pub-id-type="pmid">28491964</pub-id></mixed-citation>
      </ref>
      <ref id="cit0200">
        <label>200.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Katsinelos</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Kountouras</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Paroutoglou</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Zavos</surname>
<given-names>C</given-names></string-name></person-group>. <article-title>Alopecia areata, primary sclerosing cholangitis, and ulcerative colitis: autoimmunity and apoptosis as common links?</article-title>
<source>Dig Dis Sci</source>. <year>2007</year>;<volume>52</volume>(<issue>5</issue>):<fpage>1288</fpage>&#x2013;<lpage>1292</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s10620-006-9265-3</pub-id>.<pub-id pub-id-type="pmid">17372831</pub-id></mixed-citation>
      </ref>
      <ref id="cit0201">
        <label>201.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Simakou</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Butcher</surname>
<given-names>JP</given-names></string-name>, <string-name><surname>Reid</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Henriquez</surname>
<given-names>FL</given-names></string-name></person-group>. <article-title>Alopecia areata: a multifactorial autoimmune condition</article-title>. <source>J Autoimmun</source>. <year>2019</year>;<volume>98</volume>:<fpage>74</fpage>&#x2013;<lpage>85</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jaut.2018.12.001</pub-id>.<pub-id pub-id-type="pmid">30558963</pub-id></mixed-citation>
      </ref>
      <ref id="cit0202">
        <label>202.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Borde</surname>
<given-names>A</given-names></string-name>, <string-name><surname>&#xC5;strand</surname>
<given-names>A</given-names></string-name></person-group>. <article-title>Alopecia areata and the gut&#x2014;the link opens up for novel therapeutic interventions</article-title>. <source>Expert Opin Ther Targets</source>. <year>2018</year>;<volume>22</volume>(<issue>6</issue>):<fpage>503</fpage>&#x2013;<lpage>511</lpage>. doi:<pub-id pub-id-type="doi">10.1080/14728222.2018.1481504</pub-id>.<pub-id pub-id-type="pmid">29808708</pub-id></mixed-citation>
      </ref>
      <ref id="cit0203">
        <label>203.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ooijevaar</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Terveer</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Verspaget</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Kuijper</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Keller</surname>
<given-names>J</given-names></string-name></person-group>. <article-title>Clinical application and potential of fecal microbiota transplantation</article-title>. <source>Annu Rev Med</source>. <year>2019</year>;<volume>70</volume>(<issue>1</issue>):<fpage>335</fpage>&#x2013;<lpage>351</lpage>. doi:<pub-id pub-id-type="doi">10.1146/annurev-med-111717-122956</pub-id>.<pub-id pub-id-type="pmid">30403550</pub-id></mixed-citation>
      </ref>
      <ref id="cit0204">
        <label>204.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Xie</surname>
<given-names>WR</given-names></string-name>, <string-name><surname>Yang</surname>
<given-names>XY</given-names></string-name>, <string-name><surname>Xia</surname>
<given-names>HHX</given-names></string-name>, <string-name><surname>Wu</surname>
<given-names>LH</given-names></string-name>, <string-name><surname>He</surname>
<given-names>XX</given-names></string-name></person-group>. <article-title>Hair regrowth following fecal microbiota transplantation in an elderly patient with alopecia areata: a case report and review of the literature</article-title>. <source>World J Clin Cases</source>. <year>2019</year>;<volume>7</volume>(<issue>19</issue>):<fpage>3074</fpage>&#x2013;<lpage>3081</lpage>. doi:<pub-id pub-id-type="doi">10.12998/wjcc.v7.i19.3074</pub-id>.<pub-id pub-id-type="pmid">31624757</pub-id></mixed-citation>
      </ref>
      <ref id="cit0205">
        <label>205.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Balato</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Cacciapuoti</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Di Caprio</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Marasca</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Masar&#xE0;</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Raimondo</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Fabbrocini</surname>
<given-names>G</given-names></string-name></person-group>. <article-title>Human microbiome: composition and role in inflammatory skin diseases</article-title>. <source>Arch Immunol Ther Exp (Warsz)</source>. <year>2018</year>;<volume>67</volume>(<issue>1</issue>):<fpage>1</fpage>&#x2013;<lpage>18</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s00005-018-0528-4</pub-id>.<pub-id pub-id-type="pmid">30302512</pub-id></mixed-citation>
      </ref>
      <ref id="cit0206">
        <label>206.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kelly</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Hughes</surname>
<given-names>R</given-names></string-name>, <string-name><surname>McGarry</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Born</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Adamzik</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Fitzgerald</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Lawlor</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Tobin</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Sweeney</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Kirby</surname>
<given-names>B</given-names></string-name></person-group>. <article-title>Dysregulated cytokine expression in lesional and non lesional skin in hidradenitis suppurativa</article-title>. <source>Bri J Dermatol</source>. <year>2015</year>;<volume>173</volume>(<issue>6</issue>):<fpage>1431</fpage>&#x2013;<lpage>1439</lpage>. doi:<pub-id pub-id-type="doi">10.1111/bjd.14075</pub-id>.</mixed-citation>
      </ref>
      <ref id="cit0207">
        <label>207.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Laffert</surname>
<given-names>MV</given-names></string-name>, <string-name><surname>Helmbold</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Wohlrab</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Fiedler</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Stadie</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Marsch</surname>
<given-names>WC</given-names></string-name></person-group>. <article-title>Hidradenitis suppurativa (acne inversa): early inflammatory events at terminal follicles and at interfollicular epidermis*</article-title>. <source>Exp Dermatol</source>. <year>2009</year>;<volume>19</volume>(<issue>6</issue>):<fpage>533</fpage>&#x2013;<lpage>537</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1600-0625.2009.00915.x</pub-id>.<pub-id pub-id-type="pmid">19659829</pub-id></mixed-citation>
      </ref>
      <ref id="cit0208">
        <label>208.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>McCarthy</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Barrett</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Kirthi</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Pellanda</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Vlckova</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Tobin</surname>
<given-names>AM</given-names></string-name>, <string-name><surname>Murphy</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Shanahan</surname>
<given-names>F</given-names></string-name>, <string-name><surname>O&#x2019;Toole</surname>
<given-names>PW</given-names></string-name></person-group>. <article-title>Altered skin and gut microbiome in hidradenitis suppurativa</article-title>. <source>J Invest Dermatol</source>. <year>2022</year>;<volume>142</volume>(<issue>2</issue>):<fpage>459</fpage>&#x2013;<lpage>468.e15</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jid.2021.05.036</pub-id>.<pub-id pub-id-type="pmid">34364884</pub-id></mixed-citation>
      </ref>
      <ref id="cit0209">
        <label>209.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Nikolakis</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Join-Lambert</surname>
<given-names>O</given-names></string-name>, <string-name><surname>Karagiannidis</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Guet-Revillet</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Zouboulis</surname>
<given-names>CC</given-names></string-name>, <string-name><surname>Nassif</surname>
<given-names>A</given-names></string-name></person-group>. <article-title>Bacteriology of hidradenitis suppurativa/acne inversa: a review</article-title>. <source>J Am Acad Dermatol</source>. <year>2015</year>;<volume>73</volume>(<issue>5</issue>):<fpage>S12</fpage>&#x2013;<lpage>S18</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jaad.2015.07.041</pub-id>.<pub-id pub-id-type="pmid">26470608</pub-id></mixed-citation>
      </ref>
      <ref id="cit0210">
        <label>210.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sabat</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Jemec</surname>
<given-names>GBE</given-names></string-name>, <string-name><surname>Matusiak</surname>
<given-names>U</given-names></string-name>, <string-name><surname>Kimball</surname>
<given-names>AB</given-names></string-name>, <string-name><surname>Prens</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Wolk</surname>
<given-names>K</given-names></string-name></person-group>. <article-title>Hidradenitis suppurativa</article-title>. <source>Nat Revi Dis Primers</source> . <year>2020</year>:<page-range>6(1)</page-range>. doi:<pub-id pub-id-type="doi">10.1038/s41572-020-0149-1</pub-id>.</mixed-citation>
      </ref>
      <ref id="cit0211">
        <label>211.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Maarouf</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Platto</surname>
<given-names>JF</given-names></string-name>, <string-name><surname>Shi</surname>
<given-names>VY</given-names></string-name></person-group>. <article-title>The role of nutrition in inflammatory pilosebaceous disorders: implication of the skin&#x2010;gut axis</article-title>. <source>Australas J Dermatol</source>. <year>2018</year>:<page-range>60(2</page-range>. doi:<pub-id pub-id-type="doi">10.1111/ajd.12909</pub-id>.</mixed-citation>
      </ref>
      <ref id="cit0212">
        <label>212.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Principi</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Cassano</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Contaldo</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Iannone</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Losurdo</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Barone</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Mastrolonardo</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Vena</surname>
<given-names>GA</given-names></string-name>, <string-name><surname>Ierardi</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Di Leo</surname>
<given-names>A</given-names></string-name></person-group>. <article-title>Hydradenitis suppurativa and inflammatory bowel disease: an unusual, but existing association</article-title>. <source>World J Gastroenterol</source>. <year>2016</year>;<volume>22</volume>(<issue>20</issue>):<fpage>4802</fpage>. doi:<pub-id pub-id-type="doi">10.3748/wjg.v22.i20.4802</pub-id>.<pub-id pub-id-type="pmid">27239107</pub-id></mixed-citation>
      </ref>
      <ref id="cit0213">
        <label>213.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Eppinga</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Sperna Weiland</surname>
<given-names>CJ</given-names></string-name>, <string-name><surname>Thio</surname>
<given-names>HB</given-names></string-name>, <string-name><surname>van der Woude</surname>
<given-names>CJ</given-names></string-name>, <string-name><surname>Nijsten</surname>
<given-names>TEC</given-names></string-name>, <string-name><surname>Peppelenbosch</surname>
<given-names>MP</given-names></string-name>, <string-name><surname>Konstantinov</surname>
<given-names>SR</given-names></string-name></person-group>. <article-title>Similar depletion of protective <italic toggle="yes">faecalibacterium prausnitzii</italic> in psoriasis and inflammatory bowel disease, but not in hidradenitis suppurativa</article-title>. <source>J Crohn&#x2019;s Colitis</source>. <year>2016</year>;<volume>10</volume>(<issue>9</issue>):<fpage>1067</fpage>&#x2013;<lpage>1075</lpage>. doi:<pub-id pub-id-type="doi">10.1093/ecco-jcc/jjw070</pub-id>.<pub-id pub-id-type="pmid">26971052</pub-id></mixed-citation>
      </ref>
      <ref id="cit0214">
        <label>214.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mintoff</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Borg</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Pace</surname>
<given-names>NP</given-names></string-name></person-group>. <article-title>The clinical relevance of the microbiome in hidradenitis suppurativa: a systematic review</article-title>. <source>Vaccines</source>. <year>2021</year>;<volume>9</volume>(<issue>10</issue>):<fpage>1076</fpage>. doi:<pub-id pub-id-type="doi">10.3390/vaccines9101076</pub-id>.<pub-id pub-id-type="pmid">34696185</pub-id></mixed-citation>
      </ref>
      <ref id="cit0215">
        <label>215.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Molnar</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Mallonee</surname>
<given-names>CJ</given-names></string-name>, <string-name><surname>Stanisic</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Homme</surname>
<given-names>RP</given-names></string-name>, <string-name><surname>George</surname>
<given-names>AK</given-names></string-name>, <string-name><surname>Singh</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Tyagi</surname>
<given-names>SC</given-names></string-name></person-group>. <article-title>Hidradenitis Suppurativa and 1-carbon metabolism: role of gut microbiome, matrix metalloproteinases, and hyperhomocysteinemia</article-title>. <source>Front Immunol</source>. <year>2020</year>;<volume>11</volume>:<fpage>11</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fimmu.2020.01730</pub-id>.<pub-id pub-id-type="pmid">32082309</pub-id></mixed-citation>
      </ref>
      <ref id="cit0216">
        <label>216.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ring</surname>
<given-names>HC</given-names></string-name>, <string-name><surname>Thorsen</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Fuursted</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Bjarnsholt</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Bay</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Saunte</surname>
<given-names>DM</given-names></string-name>, <string-name><surname>Thomsen</surname>
<given-names>SF</given-names></string-name>, <string-name><surname>Jemec</surname>
<given-names>GB</given-names></string-name></person-group>. <article-title>Probiotics in hidradenitis suppurativa: a potential treatment option?</article-title>
<source>Clin Exp Dermatol</source>. <year>2021</year>;<volume>47</volume>(<issue>1</issue>):<fpage>139</fpage>&#x2013;<lpage>141</lpage>. doi:<pub-id pub-id-type="doi">10.1111/ced.14838</pub-id>.<pub-id pub-id-type="pmid">34236727</pub-id></mixed-citation>
      </ref>
      <ref id="cit0217">
        <label>217.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kurzen</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Kurzen</surname>
<given-names>M</given-names></string-name></person-group>. <article-title>Secondary prevention of hidradenitis suppurativa</article-title>. <source>Dermatol Rep</source>. <year>2019</year>;<volume>11</volume>(<issue>2</issue>). doi:<pub-id pub-id-type="doi">10.4081/dr.2019.8243</pub-id>.</mixed-citation>
      </ref>
      <ref id="cit0218">
        <label>218.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ueda</surname>
<given-names>O</given-names></string-name>, <string-name><surname>Hasegawa</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Kitamura</surname>
<given-names>S</given-names></string-name></person-group>. <article-title>Distribution in skin of ceramide after oral administration to rats</article-title>. <source>Drug Metab Pharmacokinet</source>. <year>2009</year>;<volume>24</volume>(<issue>2</issue>):<fpage>180</fpage>&#x2013;<lpage>184</lpage>. doi:<pub-id pub-id-type="doi">10.2133/dmpk.24.180</pub-id>.<pub-id pub-id-type="pmid">19430175</pub-id></mixed-citation>
      </ref>
      <ref id="cit0219">
        <label>219.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Clapp</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Aurora</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Herrera</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Bhatia</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Wilen</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Wakefield</surname>
<given-names>S</given-names></string-name></person-group>. <article-title>Gut microbiota&#x2019;s effect on mental health: the gut-brain axis</article-title>. <source>Clini Pract</source>. <year>2017</year>;<volume>7</volume>(<issue>4</issue>):<fpage>131</fpage>&#x2013;<lpage>136</lpage>. doi:<pub-id pub-id-type="doi">10.4081/cp.2017.987</pub-id>.</mixed-citation>
      </ref>
      <ref id="cit0220">
        <label>220.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Edwards</surname>
<given-names>RA</given-names></string-name>, <string-name><surname>Vega</surname>
<given-names>AA</given-names></string-name>, <string-name><surname>Norman</surname>
<given-names>HM</given-names></string-name>, <string-name><surname>Ohaeri</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Levi</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Dinsdale</surname>
<given-names>EA</given-names></string-name>, <string-name><surname>Cinek</surname>
<given-names>O</given-names></string-name>, <string-name><surname>Aziz</surname>
<given-names>RK</given-names></string-name>, <string-name><surname>McNair</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Barr</surname>
<given-names>JJ</given-names></string-name>, et al</person-group>. <article-title>Global phylogeography and ancient evolution of the widespread human gut virus crAssphage</article-title>. <source>Nat Microbiol</source>. <year>2019</year>;<volume>4</volume>(<issue>10</issue>):<fpage>1727</fpage>&#x2013;<lpage>1736</lpage>. doi:<pub-id pub-id-type="doi">10.1038/s41564-019-0494-6</pub-id>.<pub-id pub-id-type="pmid">31285584</pub-id></mixed-citation>
      </ref>
      <ref id="cit0221">
        <label>221.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hasan</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Yang</surname>
<given-names>H</given-names></string-name></person-group>. <article-title>Factors affecting the composition of the gut microbiota, and its modulation</article-title>. <source>PeerJ</source>. <year>2019</year>;<volume>7</volume>:<fpage>e7502</fpage>. doi:<pub-id pub-id-type="doi">10.7717/peerj.7502</pub-id>.<pub-id pub-id-type="pmid">31440436</pub-id></mixed-citation>
      </ref>
      <ref id="cit0222">
        <label>222.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lee</surname>
<given-names>ES</given-names></string-name>, <string-name><surname>Song</surname>
<given-names>EJ</given-names></string-name>, <string-name><surname>Nam</surname>
<given-names>YD</given-names></string-name>, <string-name><surname>Lee</surname>
<given-names>SY</given-names></string-name></person-group>. <article-title>Probiotics in human health and disease: from nutribiotics to pharmabiotics</article-title>. <source>J Microbiol</source>. <year>2018</year>;<volume>56</volume>(<issue>11</issue>):<fpage>773</fpage>&#x2013;<lpage>782</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s12275-018-8293-y</pub-id>.<pub-id pub-id-type="pmid">30353462</pub-id></mixed-citation>
      </ref>
      <ref id="cit0223">
        <label>223.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lee</surname>
<given-names>SY</given-names></string-name>, <string-name><surname>Lee</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Park</surname>
<given-names>YM</given-names></string-name>, <string-name><surname>Hong</surname>
<given-names>SJ</given-names></string-name></person-group>. <article-title>Microbiome in the gut-skin axis in atopic dermatitis</article-title>. <source>Allergy Asthma Immunol Res</source>. <year>2018</year>;<volume>10</volume>(<issue>4</issue>):<fpage>354</fpage>. doi:<pub-id pub-id-type="doi">10.4168/aair.2018.10.4.354</pub-id>.<pub-id pub-id-type="pmid">29949831</pub-id></mixed-citation>
      </ref>
      <ref id="cit0224">
        <label>224.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Penders</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Thijs</surname>
<given-names>C</given-names></string-name>, <string-name><surname>van den Brandt</surname>
<given-names>PA</given-names></string-name>, <string-name><surname>Kummeling</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Snijders</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Stelma</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Adams</surname>
<given-names>H</given-names></string-name>, <string-name><surname>van Ree</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Stobberingh</surname>
<given-names>EE</given-names></string-name></person-group>. <article-title>Gut microbiota composition and development of atopic manifestations in infancy: the KOALA birth cohort study</article-title>. <source>Gut</source>. <year>2007</year>;<volume>56</volume>(<issue>5</issue>):<fpage>661</fpage>&#x2013;<lpage>667</lpage>. doi:<pub-id pub-id-type="doi">10.1136/gut.2006.100164</pub-id>.<pub-id pub-id-type="pmid">17047098</pub-id></mixed-citation>
      </ref>
      <ref id="cit0225">
        <label>225.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Penders</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Stobberingh</surname>
<given-names>EE</given-names></string-name>, <string-name><surname>Brandt</surname>
<given-names>PAVD</given-names></string-name>, <string-name><surname>Thijs</surname>
<given-names>C</given-names></string-name></person-group>. <article-title>The role of the intestinal microbiota in the development of atopic disorders</article-title>. <source>Allergy</source>. <year>2007</year>;<volume>62</volume>(<issue>11</issue>):<fpage>1223</fpage>&#x2013;<lpage>1236</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1398-9995.2007.01462.x</pub-id>.<pub-id pub-id-type="pmid">17711557</pub-id></mixed-citation>
      </ref>
      <ref id="cit0226">
        <label>226.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhang</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Jiang</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Jiang</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Wu</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Ren</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Peng</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Lai</surname>
<given-names>Y</given-names></string-name></person-group>. <article-title>Oral antibiotic treatment induces skin microbiota dysbiosis and influences wound healing</article-title>. <source>Microb Ecol</source>. <year>2015</year>;<volume>69</volume>(<issue>2</issue>):<fpage>415</fpage>&#x2013;<lpage>421</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s00248-014-0504-4</pub-id>.<pub-id pub-id-type="pmid">25301498</pub-id></mixed-citation>
      </ref>
      <ref id="cit0227">
        <label>227.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhang</surname>
<given-names>YJ</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Gan</surname>
<given-names>RY</given-names></string-name>, <string-name><surname>Zhou</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Xu</surname>
<given-names>DP</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>HB</given-names></string-name></person-group>. <article-title>Impacts of gut bacteria on human health and diseases</article-title>. <source>Int J Mol Sci</source>. <year>2015</year>;<volume>16</volume>(<issue>12</issue>):<fpage>7493</fpage>&#x2013;<lpage>7519</lpage>. doi:<pub-id pub-id-type="doi">10.3390/ijms16047493</pub-id>.<pub-id pub-id-type="pmid">25849657</pub-id></mixed-citation>
      </ref>
      <ref id="cit0228">
        <label>228.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Delday</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Mulder</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Logan</surname>
<given-names>ET</given-names></string-name>, <string-name><surname>Grant</surname>
<given-names>G</given-names></string-name></person-group>. <article-title><italic toggle="yes">Bacteroides thetaiotaomicron</italic> ameliorates colon inflammation in preclinical models of Crohn&#x2019;s disease</article-title>. <source>Inflamm Bowel Dis</source>. <year>2018</year>;<volume>25</volume>(<issue>1</issue>):<fpage>85</fpage>&#x2013;<lpage>96</lpage>. doi:<pub-id pub-id-type="doi">10.1093/ibd/izy281</pub-id>.</mixed-citation>
      </ref>
      <ref id="cit0229">
        <label>229.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Silva</surname>
<given-names>YP</given-names></string-name>, <string-name><surname>Bernardi</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Frozza</surname>
<given-names>RL</given-names></string-name></person-group>. <article-title>The role of short-chain fatty acids from gut microbiota in gut-brain communication</article-title>. <source>Front Endocrinol (Lausanne)</source>. <year>2020</year>;<volume>11</volume>:<fpage>11</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fendo.2020.00025</pub-id>.<pub-id pub-id-type="pmid">32082255</pub-id></mixed-citation>
      </ref>
      <ref id="cit0230">
        <label>230.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Akiyama</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Iodi Carstens</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Carstens</surname>
<given-names>E</given-names></string-name></person-group>. <article-title>Transmitters and pathways mediating inhibition of spinal itch-signaling neurons by scratching and other counterstimuli</article-title>. <source>PLoS ONE</source>. <year>2011</year>;<volume>6</volume>(<issue>7</issue>):<fpage>e22665</fpage>. doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0022665</pub-id>.<pub-id pub-id-type="pmid">21818363</pub-id></mixed-citation>
      </ref>
      <ref id="cit0231">
        <label>231.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Li</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Yosipovitch</surname>
<given-names>G</given-names></string-name></person-group>. <article-title>The role of the microbiome and microbiome-derived metabolites in atopic dermatitis and non-histaminergic itch</article-title>. <source>Am J Clin Dermatol</source>. <year>2020</year>;<volume>21</volume>(<issue>S1</issue>):<fpage>44</fpage>&#x2013;<lpage>50</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s40257-020-00538-8</pub-id>.<pub-id pub-id-type="pmid">32910440</pub-id></mixed-citation>
      </ref>
      <ref id="cit0232">
        <label>232.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Miyazaki</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Masuoka</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Kano</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Iizuka</surname>
<given-names>R</given-names></string-name></person-group>. <article-title><italic toggle="yes">Bifidobacterium</italic> fermented milk and galacto-oligosaccharides lead to improved skin health by decreasing phenols production by gut microbiota</article-title>. <source>Benef Microbes</source>. <year>2014</year>;<volume>5</volume>(<issue>2</issue>):<fpage>121</fpage>&#x2013;<lpage>128</lpage>. doi:<pub-id pub-id-type="doi">10.3920/bm2012.0066</pub-id>.<pub-id pub-id-type="pmid">23685373</pub-id></mixed-citation>
      </ref>
      <ref id="cit0233">
        <label>233.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Climent</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Martinez-Blanch</surname>
<given-names>JF</given-names></string-name>, <string-name><surname>Llobregat</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Ruzafa-Costas</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Carri&#xF3;n-Guti&#xE9;rrez</surname>
<given-names>MN</given-names></string-name>, <string-name><surname>Ram&#xED;rez-Bosc&#xE1;</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Prieto-Merino</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Genov&#xE9;s</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Codo&#xF1;er</surname>
<given-names>FM</given-names></string-name>, <string-name><surname>Ram&#xF3;n</surname>
<given-names>D</given-names></string-name>, et al</person-group>. <article-title>Changes in gut microbiota correlates with response to treatment with probiotics in patients with atopic dermatitis. a post hoc analysis of a clinical trial</article-title>. <source>Microorganisms</source>. <year>2021</year>;<volume>9</volume>(<issue>4</issue>):<fpage>854</fpage>. doi:<pub-id pub-id-type="doi">10.3390/microorganisms9040854</pub-id>.<pub-id pub-id-type="pmid">33921166</pub-id></mixed-citation>
      </ref>
      <ref id="cit0234">
        <label>234.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Navarro-L&#xF3;pez</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Ram&#xED;rez-Bosc&#xE1;</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Ram&#xF3;n-Vidal</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Ruzafa-Costas</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Genov&#xE9;s-Mart&#xED;nez</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Chenoll-Cuadros</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Carri&#xF3;n-Guti&#xE9;rrez</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Horga De La Parte</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Prieto-Merino</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Codo&#xF1;er-Cort&#xE9;s</surname>
<given-names>FM</given-names></string-name></person-group>. <article-title>Effect of oral administration of a mixture of probiotic strains on scorad index and use of topical steroids in young patients with moderate atopic dermatitis</article-title>. <source>JAMA Dermatol</source>. <year>2018</year>;<volume>154</volume>(<issue>1</issue>):<fpage>37</fpage>. doi:<pub-id pub-id-type="doi">10.1001/jamadermatol.2017.3647</pub-id>.<pub-id pub-id-type="pmid">29117309</pub-id></mixed-citation>
      </ref>
      <ref id="cit0235">
        <label>235.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Blanchet-R&#xE9;thor&#xE9;</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Bourd&#xE8;s</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Mercenier</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Haddar</surname>
<given-names>CH</given-names></string-name>, <string-name><surname>Verhoeven</surname>
<given-names>PO</given-names></string-name>, <string-name><surname>Andres</surname>
<given-names>P</given-names></string-name></person-group>. <article-title>Effect of a lotion containing the heat-treated probiotic strain Lactobacillus johnsonii NCC 533 on <italic toggle="yes">Staphylococcus aureus</italic> colonization in atopic dermatitis</article-title>. <source>Clin Cosmet Investig Dermatol</source>. <year>2017</year>;<volume>10</volume>:<fpage>249</fpage>&#x2013;<lpage>257</lpage>. doi:<pub-id pub-id-type="doi">10.2147/ccid.s135529</pub-id>.</mixed-citation>
      </ref>
      <ref id="cit0236">
        <label>236.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Fabbrocini</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Bertona</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Picazo</surname>
<given-names>&#xD3;</given-names></string-name>, <string-name><surname>Pareja-Galeano</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Monfrecola</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Emanuele</surname>
<given-names>E</given-names></string-name></person-group>. <article-title>Supplementation with Lactobacillus rhamnosus SP1 normalises skin expression of genes implicated in insulin signalling and improves adult acne</article-title>. <source>Benef Microbes</source>. <year>2016</year>;<volume>7</volume>(<issue>5</issue>):<fpage>625</fpage>&#x2013;<lpage>630</lpage>. doi:<pub-id pub-id-type="doi">10.3920/bm2016.0089</pub-id>.<pub-id pub-id-type="pmid">27596801</pub-id></mixed-citation>
      </ref>
      <ref id="cit0237">
        <label>237.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mori</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Kano</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Masuoka</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Konno</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Suzuki</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Miyazaki</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Ueki</surname>
<given-names>Y</given-names></string-name></person-group>. <article-title>Effect of probiotic and prebiotic fermented milk on skin and intestinal conditions in healthy young female students</article-title>. <source>Biosci Microbiota, Food and Health</source>. <year>2016</year>;<volume>35</volume>(<issue>3</issue>):<fpage>105</fpage>&#x2013;<lpage>112</lpage>. doi:<pub-id pub-id-type="doi">10.12938/bmfh.2015-022</pub-id>.</mixed-citation>
      </ref>
      <ref id="cit0238">
        <label>238.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lee</surname>
<given-names>DE</given-names></string-name>, <string-name><surname>Huh</surname>
<given-names>CS</given-names></string-name>, <string-name><surname>Ra</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Choi</surname>
<given-names>ID</given-names></string-name>, <string-name><surname>Jeong</surname>
<given-names>JW</given-names></string-name>, <string-name><surname>Kim</surname>
<given-names>SH</given-names></string-name>, <string-name><surname>Ryu</surname>
<given-names>JH</given-names></string-name>, <string-name><surname>Seo</surname>
<given-names>YK</given-names></string-name>, <string-name><surname>Koh</surname>
<given-names>JS</given-names></string-name>, <string-name><surname>Lee</surname>
<given-names>JH</given-names></string-name>, et al</person-group>. <article-title>Clinical evidence of effects of <italic toggle="yes">Lactobacillus plantarum</italic> HY7714 on skin aging: a randomized, double blind, placebo-controlled study</article-title>. <source>J Microbiol Biotechnol</source>. <year>2015</year>;<volume>25</volume>(<issue>12</issue>):<fpage>2160</fpage>&#x2013;<lpage>2168</lpage>. doi:<pub-id pub-id-type="doi">10.4014/jmb.1509.09021</pub-id>.<pub-id pub-id-type="pmid">26428734</pub-id></mixed-citation>
      </ref>
      <ref id="cit0239">
        <label>239.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Enomoto</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Sowa</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Nishimori</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Shimazu</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Yoshida</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Yamada</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Furukawa</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Nakagawa</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Yanagisawa</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Iwabuchi</surname>
<given-names>N</given-names></string-name>, et al</person-group>. <article-title>Effects of bifidobacterial supplementation to pregnant women and infants in the prevention of allergy development in infants and on fecal microbiota</article-title>. <source>Allergol Int</source>. <year>2014</year>;<volume>63</volume>(<issue>4</issue>):<fpage>575</fpage>&#x2013;<lpage>585</lpage>. doi:<pub-id pub-id-type="doi">10.2332/allergolint.13-oa-0683</pub-id>.<pub-id pub-id-type="pmid">25056226</pub-id></mixed-citation>
      </ref>
      <ref id="cit0240">
        <label>240.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Jung</surname>
<given-names>GW</given-names></string-name>, <string-name><surname>Tse</surname>
<given-names>JE</given-names></string-name>, <string-name><surname>Guiha</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Rao</surname>
<given-names>J</given-names></string-name></person-group>. <article-title>Prospective, randomized, open-label trial comparing the safety, efficacy, and tolerability of an acne treatment regimen with and without a probiotic supplement and minocycline in subjects with mild to moderate acne</article-title>. <source>J Cutan Med Surg</source>. <year>2013</year>;<volume>17</volume>(<issue>2</issue>):<fpage>114</fpage>&#x2013;<lpage>122</lpage>. doi:<pub-id pub-id-type="doi">10.2310/7750.2012.12026</pub-id>.<pub-id pub-id-type="pmid">23582165</pub-id></mixed-citation>
      </ref>
      <ref id="cit0241">
        <label>241.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kimoto-Nira</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Aoki</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Sasaki</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Suzuki</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Mizumachi</surname>
<given-names>K</given-names></string-name></person-group>. <article-title>Oral intake of heat-killed cells of <italic toggle="yes">Lactococcus lactis</italic> strain H61 promotes skin health in women</article-title>. <source>J Nutr Sci</source>. <year>2012</year>:<fpage>1</fpage>. doi:<pub-id pub-id-type="doi">10.1017/jns.2012.22</pub-id>.</mixed-citation>
      </ref>
      <ref id="cit0242">
        <label>242.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Vijayashankar</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Raghunath</surname>
<given-names>N</given-names></string-name></person-group>. <article-title>Pustular psoriasis responding to probiotics &#x2013; a new insight</article-title>. <source>Our Dermatol Online</source>. <year>2012</year>;<volume>3</volume>(<issue>4</issue>):<fpage>326</fpage>&#x2013;<lpage>329</lpage>. doi:<pub-id pub-id-type="doi">10.7241/ourd.20124.71</pub-id>.</mixed-citation>
      </ref>
      <ref id="cit0243">
        <label>243.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Torii</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Torii</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Itoh</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Urisu</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Terada</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Fujisawa</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Yamada</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Suzuki</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Ishida</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Nakamura</surname>
<given-names>F</given-names></string-name>, et al</person-group>. <article-title>Effects of oral administration of <italic toggle="yes">Lactobacillus acidophilus</italic> L-92 on the symptoms and serum markers of atopic dermatitis in children</article-title>. <source>Int Arch Allergy Immunol</source>. <year>2011</year>;<volume>154</volume>(<issue>3</issue>):<fpage>236</fpage>&#x2013;<lpage>245</lpage>. doi:<pub-id pub-id-type="doi">10.1159/000321110</pub-id>.<pub-id pub-id-type="pmid">20861645</pub-id></mixed-citation>
      </ref>
      <ref id="cit0244">
        <label>244.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kim</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Ko</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Park</surname>
<given-names>YK</given-names></string-name>, <string-name><surname>Kim</surname>
<given-names>NI</given-names></string-name>, <string-name><surname>Ha</surname>
<given-names>WK</given-names></string-name>, <string-name><surname>Cho</surname>
<given-names>Y</given-names></string-name></person-group>. <article-title>Dietary effect of lactoferrin-enriched fermented milk on skin surface lipid and clinical improvement of acne vulgaris</article-title>. <source>Nutrition</source>. <year>2010</year>;<volume>26</volume>(<issue>9</issue>):<fpage>902</fpage>&#x2013;<lpage>909</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.nut.2010.05.011</pub-id>.<pub-id pub-id-type="pmid">20692602</pub-id></mixed-citation>
      </ref>
      <ref id="cit0245">
        <label>245.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gu&#xE9;niche</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Bastien</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Ovigne</surname>
<given-names>JM</given-names></string-name>, <string-name><surname>Kermici</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Courchay</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Chevalier</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Breton</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Castiel-Higounenc</surname>
<given-names>I</given-names></string-name></person-group>. <article-title><italic toggle="yes">Bifidobacterium longum</italic> lysate, a new ingredient for reactive skin</article-title>. <source>Exp Dermatol</source>. <year>2010</year>;<volume>19</volume>(<issue>8</issue>):<fpage>1</fpage>&#x2013;<lpage>8</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1600-0625.2009.00932.x</pub-id>.</mixed-citation>
      </ref>
      <ref id="cit0246">
        <label>246.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kang</surname>
<given-names>BS</given-names></string-name>, <string-name><surname>Seo</surname>
<given-names>JG</given-names></string-name>, <string-name><surname>Lee</surname>
<given-names>GS</given-names></string-name>, <string-name><surname>Kim</surname>
<given-names>JH</given-names></string-name>, <string-name><surname>Kim</surname>
<given-names>SY</given-names></string-name>, <string-name><surname>Han</surname>
<given-names>YW</given-names></string-name>, <string-name><surname>Kang</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Kim</surname>
<given-names>HO</given-names></string-name>, <string-name><surname>Rhee</surname>
<given-names>JH</given-names></string-name>, <string-name><surname>Chung</surname>
<given-names>MJ</given-names></string-name>, et al</person-group>. <article-title>Antimicrobial activity of enterocins from <italic toggle="yes">Enterococcus faecalis</italic> SL-5 against propionibacterium acnes, the causative agent in acne vulgaris, and its therapeutic effect</article-title>. <source>J Microbiol</source>. <year>2009</year>;<volume>47</volume>(<issue>1</issue>):<fpage>101</fpage>&#x2013;<lpage>109</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s12275-008-0179-y</pub-id>.<pub-id pub-id-type="pmid">19229497</pub-id></mixed-citation>
      </ref>
      <ref id="cit0247">
        <label>247.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wickens</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Black</surname>
<given-names>PN</given-names></string-name>, <string-name><surname>Stanley</surname>
<given-names>TV</given-names></string-name>, <string-name><surname>Mitchell</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Fitzharris</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Tannock</surname>
<given-names>GW</given-names></string-name>, <string-name><surname>Purdie</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Crane</surname>
<given-names>J</given-names></string-name></person-group>. <article-title>A differential effect of 2 probiotics in the prevention of eczema and atopy: a double-blind, randomized, placebo-controlled trial</article-title>. <source>J Allergy Clin Immunol</source>. <year>2008</year>;<volume>122</volume>(<issue>4</issue>):<fpage>788</fpage>&#x2013;<lpage>794</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jaci.2008.07.011</pub-id>.<pub-id pub-id-type="pmid">18762327</pub-id></mixed-citation>
      </ref>
      <ref id="cit0248">
        <label>248.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sistek</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Kelly</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Wickens</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Stanley</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Fitzharris</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Crane</surname>
<given-names>J</given-names></string-name></person-group>. <article-title>Is the effect of probiotics on atopic dermatitis confined to food sensitized children?</article-title>
<source>Clin Exp Allergy</source>. <year>2006</year>;<volume>36</volume>(<issue>5</issue>):<fpage>629</fpage>&#x2013;<lpage>633</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1365-2222.2006.02485.x</pub-id>.<pub-id pub-id-type="pmid">16650048</pub-id></mixed-citation>
      </ref>
      <ref id="cit0249">
        <label>249.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Weston</surname>
<given-names>S</given-names></string-name></person-group>. <article-title>Effects of probiotics on atopic dermatitis: a randomised controlled trial</article-title>. <source>Arch Dis Child</source>. <year>2005</year>;<volume>90</volume>(<issue>9</issue>):<fpage>892</fpage>&#x2013;<lpage>897</lpage>. doi:<pub-id pub-id-type="doi">10.1136/adc.2004.060673</pub-id>.<pub-id pub-id-type="pmid">15863468</pub-id></mixed-citation>
      </ref>
      <ref id="cit0250">
        <label>250.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Rosenfeldt</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Benfeldt</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Valerius</surname>
<given-names>NH</given-names></string-name>, <string-name><surname>P&#xE6;rregaard</surname>
<given-names>A</given-names></string-name>, and <string-name><surname>Michaelsen</surname>
<given-names>KF</given-names></string-name></person-group>. <article-title>Effect of probiotics on gastrointestinal symptoms and small intestinal permeability in children with atopic dermatitis</article-title>. <source>J Pediatr</source>. <year>2004</year>;<volume>145</volume>(<issue>5</issue>):<fpage>612</fpage>&#x2013;<lpage>616</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jpeds.2004.06.068</pub-id>.<pub-id pub-id-type="pmid">15520759</pub-id></mixed-citation>
      </ref>
      <ref id="cit0251">
        <label>251.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Rautava</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Kalliom&#xE4;ki</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Isolauri</surname>
<given-names>E</given-names></string-name></person-group>. <article-title>Probiotics during pregnancy and breast-feeding might confer immunomodulatory protection against atopic disease in the infant</article-title>. <source>J Allergy Clin Immunol</source>. <year>2002</year>;<volume>109</volume>(<issue>1</issue>):<fpage>119</fpage>&#x2013;<lpage>121</lpage>. doi:<pub-id pub-id-type="doi">10.1067/mai.2002.120273</pub-id>.<pub-id pub-id-type="pmid">11799376</pub-id></mixed-citation>
      </ref>
      <ref id="cit0252">
        <label>252.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kalliom&#xE4;ki</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Salminen</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Arvilommi</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Kero</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Koskinen</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Isolauri</surname>
<given-names>E</given-names></string-name></person-group>. <article-title>Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial</article-title>. <source>The Lancet</source>. <year>2001</year>;<volume>357</volume>(<issue>9262</issue>):<fpage>1076</fpage>&#x2013;<lpage>1079</lpage>. doi:<pub-id pub-id-type="doi">10.1016/s0140-6736(00)04259-8</pub-id>.</mixed-citation>
      </ref>
      <ref id="cit0253">
        <label>253.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Isolauri</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Arvola</surname>
<given-names>T</given-names></string-name>, <string-name><surname>S&#xFC;tas</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Moilanen</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Salminen</surname>
<given-names>S</given-names></string-name></person-group>. <article-title>Probiotics in the management of atopic eczema</article-title>. <source>Clini Exp Allergy</source>. <year>2000</year>;<volume>30</volume>(<issue>11</issue>):<fpage>1605</fpage>&#x2013;<lpage>1610</lpage>. doi:<pub-id pub-id-type="doi">10.1046/j.1365-2222.2000.00943.x</pub-id>.</mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>